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Abstract
Aim and Objectives: To explore the feasibility of accessing biological information and 
associated health information through a standards-based electronic health record. The 
objectives include constructing: a condition specific knowledge base prototype; an EHR 
system prototype based on a standard record architecture; and an interface that connects 
the two.
Method: An ontology was constructed to organise biological and health information in 
a formal and structured way. Cystic fibrosis was selected as an exemplar condition and 
the Continuity of Care Record was selected for an EHR prototype application. The 
sequence variations information and health information in the knowledge base are 
presented through the EHR prototype's interface and the results are evaluated.
Results: A substantive knowledge base prototype of cystic fibrosis was constructed. The 
content includes: the most common genetic mutations related to cystic fibrosis; 
time-oriented descriptions of cystic fibrosis; Cochrane conclusions; and gene therapy 
for cystic fibrosis. The content is organised on both time and problem oriented axes. It 
was found to be possible to present bio-health information that was case-specific 
through the EHR prototype interface.
Conclusion: Sequence variations information and associated health information can be 
made accessible through a standards-based electronic health record prototype. Complex 
knowledge can be accessed, to some extent automatically, thereby providing a starting 
point for integrating formal and structured biological information within health record 
systems which can be deployed in clinical settings.
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Chapter 1 Introduction
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1.2 Research goal and aim
1.3 Research objectives
1.4 Research method introduction
1.5 Contributions
1.6 Structure of the thesis
1.7 Summary
Chapter 1 Introduction
In this chapter, the general research background and motivation, research questions, 
research goal, aim and objectives, major contributions and structure of this thesis are 
presented.
1.1 Background and motivation
There has been a huge and rapid increase in biological information as a result of the 
development of genetic technology. However, little of this information has been made 
readily available in the clinical setting 1 2 Although biological information plays a 
critical role in understanding life activities, including health and disease status 4 , the 
connection between biological information and disease status has not been completely 
revealed and is still a matter for research. Another reason why such information is not 
readily available is that although there are many biological information resources for 
biomedical researchers^, these have been designed or compiled with the researchers" 
requirements in mind rather than for the purpose of direct clinical use. Therefore they 
are not ideally suitable in a consultation scenario for example, in which there is limited 
time and where the participants are not necessarily specialists in genetics. Doctors in 
such settings do need biological information but only a selected amount, and they 
require it to be tailored to their use.
Here, the major research question relates to the feasibility of offering formal and 
structured biological information through systems likely to be found in the clinical 
setting.
Doctors already face information overload It is important that we do not make this 
worse and this is of concern in the selection of technology. Ontologies and knowledge 
bases are increasingly important tools in managing the complexity of knowledge and 
also have the potential for information reuse, sharing and extension8(p2-5).
However, biological information is not an isolated resource and, consequently, 
providing such information will increase the quantity and complexity of information 
offered to the doctor and runs the risk of swamping the doctor. During the consultation 
between the doctor and patient a great deal of demographic and health information is 
already available to the doctor. As more becomes known in the domain knowledge area, 
the connections between the different types of information will increase dramatically.
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Therefore it is desirable to use what doctors know as a way of interfacing their clinical 
knowledge with new biological information, and by so doing make the new information 
more accessible. Furthermore the amount of new information can be managed and 
controlled by using the patient's individual characteristics as recorded in their record.
In today's clinical consultation, the electronic health record (EHR) is becoming 
indispensable. It has become, in our view, not only a static repository for patient specific 
information but also an important dynamic tool through which to interface different 
types of information, including biological information, and a means of offering the 
doctor 'relevant' information.
A standards-based EHR was considered the best vehicle to use to carry out this research. 
Semantic interoperability has been identified as one of the most challenging parts for 
any EHR system9 I0 and formal standards play a key part in solving such problems. 
Although this research only uses an EHR prototype, a standards-based prototype may 
benefit future standards development. This has the potential to influence many systems 
rather than a single isolated implementation.
In this thesis the concept of 'relevant information' refers to some definite relationship 
between an item of biological information and one or more items of health information. 
These relationships have been proven by biomedical researchers (domain researchers) 
and therefore provide a starting point for this investigation. These relationships are 
captured from published papers, text books etc in the domain knowledge ontology that 
will interface with the EHR.
The concept of 'relevant information' is also used within the EHR and an EHR system 
prototype had been developed to display such information. In the EHR system prototype 
general information is transformed to personalised information: i.e. the original set of 
information has been customised such that the information is shown as being relevant to 
a particular patient. [Note: in the individualised record, we may indicate not only 
confirmed relationships but also candidate relationships, i.e. factors, which the doctor 
may wish to consider or have investigated.]
1.2 Research goal and aim
The ultimate research goal is to bring together the different types of knowledge
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seamlessly, in order to illuminate disease status with respect to genetic information. A 
more modest research aim for this PhD is to explore the feasibility of offering formal, 
structured bio-health information that is relevant to health care in a simulated clinical 
system.
1.3 Research objectives
The research aim comprises three objectives and these can be considered as a set of 
paired abstract and physical artefacts. This research therefore uses and constructs 
specifications, which are at the abstract level, and maps these to physical artefacts 
which are developed on the concrete level. The objectives are:
  The organisation of biological and health information in a formal and 
structured way; at the abstract level this specification is a schema or model for 
a knowledge base; at the concrete level, a knowledge base prototype is 
constructed.
  To simulate a clinical system to access and manage bio-health information. At 
the abstract level, a standard specification for an EHR is used; at the concrete 
level a standards-based EHR prototype is developed.
  To interface biological information with health information so that both are 
accessible. At the abstract level this is specification of bridging points common 
to both; at the concrete level this is a set of headings and containers that show 
the content and structure of the knowledge base prototype, via patient specific 
filters.
1.4 Research method introduction
For our purposes cystic fibrosis was selected as an exemplar condition; the content was 
formally structured into the knowledge base prototype so that it might be used to deliver 
case-specific bio-health information. The formal and structured biological and health 
information was organised by a knowledge management editor: Protege-OWL 11 An 
EHR system prototype, which was built using Microsoft Visual Basic and Microsoft 
Access, used the international standard Continuity of Care Record (CCR) 1 " The 
knowledge base prototype was connected with the system prototype. The personalised 
biological and relevant health information has been made accessible through the EHR
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interface and has been tested by hypothetical test records.
1.5 Contributions
There are several contributions claimed from this research project:
  The bringing together of sequence variations information with health 
information using a standards-based EHR.
  The construction of an ontology-based cystic fibrosis bio-health model (the 
first of its kind) and knowledge base prototype.
1.6 Structure of the thesis
The major structure of the thesis is as follows:
Chapter 1: The Introduction chapter discusses the thesis in a general way. It includes 
background, motivation, research questions, research goal, aim and 
objectives, major contributions and structure of the thesis.
Chapter 2: The Literature review chapter introduces key topics and provides evidence 
related to:
r The motivation behind this research and the reasons why it is important to 
integrate biological and health information within the clinical setting.
r Current examination of existing research in similar fields and a comparison 
with this research.
r Background introduction to semantic web technology; the reasons for the 
selection of semantic web technology to represent and organise the 
relationships between biological and health information.
>- Introduction to the EHR.
>- Introduction of existing biological information resources and tools.
>- The choice of cystic fibrosis as an exemplar condition.
Chapter 3: The Methodology chapter introduces:
r The research conceptual framework and research strategy.
'r- Detailed solutions to achieve the research objectives and their evaluation.
Chapter 1 Introduction -6-
'> The requirements and functions of the solutions.
? The reason for choosing CCR and the development environment of the 
prototype.
Chapter 4: The knowledge base prototype- OntoKBCF construction chapter includes: 
r How the ontology-based knowledge base prototype is constructed.
'f The decisions underpinning the scope, granularity, organisation and 
construction of the knowledge base prototype.
> The reasons underlying these decisions. 
~f The construction result and its limitations.
Chapter 5: The EHR system prototype construction and connection with OntoKBCF 
chapter includes:
f The overall design of the CCR-based EHR system prototype.
r The interfacing and integration of the bio-health ontology with the EHR 
system prototype.
r Testing of customised bio-health information through the EHR system 
prototype by test records.
Chapter 6: The Discussion chapter introduces:
r The research significance and implications.
r- Research limitations and some technical obstacles.
f Potential benefit
r Future directions.
Chapter 7: The Conclusion summarises the research and presents recommendation for 
future work and the conclusion of the thesis.
1.7 Summary
In this introductory chapter the general research context and the research questions have 
been introduced and defined briefly: what are the questions to be focused on and why 
this research question is important. The research goal, aim and objectives have been
Xia .ling. Constructing a bio-health knowledge base for access via a standardised EHR prototype -7-
listed. What contributions have been claimed based on this research and the structure of 
the thesis has also been included. The next chapter will review the literature and 
consider the existing work. The key topics will be discussed and the evidence for taking 
this approach will be set in context.
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In this review chapter the major topics dealt with are: the research context and 
motivations, research that is related to the study; and the rationale for choosing the 
particular solution; introduction of technologies and the exemplar condition used in this 
research.
2.1 Terminology
It is necessary to clarify what is meant by "biological information' in this thesis, because 
it is a very broad term. In this thesis 'biological information' is intended to refer to 
genetic information in general, and more specifically still to 'mutation information' 
'Mutation information' is still a very general term and actually 'sequence variation' is 
used as a starting point. The detail of the exact sequence variations of interest in this 
thesis will be discussed in Chapter 4 (4.3). The genotype is a type of biological 
information. The genotype is the genetic constitution (the genome) of a cell, an 
individual or an organism. It can pertain to all the genes or to a specific gene \
Health information is also a very broad category, covering many concepts. In this thesis 
it is used to refer to the organism level description which is restricted to the human 
being; for example description relates to diseases, symptoms, diagnostic or treatment 
related information and demographic information. Health information is typical of the 
information which is recorded in the electronic health record. The phenotype is the 
appearance or physical manifestation of an individual, which results from the 
interaction of the person's genetic makeup with his or her environment' 3 There are 
three levels of phenotype: molecular, cellular and organismal 14 In this thesis the 
organism level disease phenotype is referred to as a type of health information.
2.2 Research context
2.2.1 Bio-health informatics research
With more and more biological information being discovered, researchers are trying to 
cooperate to bring biological information together with health information, and to 
explore the merging of the two areas (bio-health informatics, BHI)2 ' l5 Martin-Sanchez 
and colleagues2 named the new field as biomedical informatics (BMI). The merging and 
cooperation will bring benefits for both biological research and health care; the benefits
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for biological research include more precise mechanisms in interpreting life phenomena 
and disease status etc; the benefits for health care include new diagnosis and treatment 
methods, personalised health care service etc" Blake also held a similar view about 
biomedical research: "genetic elements played a fundamental role in understanding 
disease, and information systems were major tools for data management"
Bio-health informatics research faces many challenges, of which some of these are of 
direct concern to this research:
  To examine genetic information in more than one health care situation during the 
entire individual's life; to offer correct interpretation of the genetic information to 
the health care professionals during the consultation 17 .
  To include sequence and genetic information within the medical record as more 
new biological information is revealed 18 (p640); to include gene information in the 
individual's medical record will be a requirement for future molecular medicine
  To present the sequence information to clinicians in useable and useful ways \\ithin 
the record 18
It is still a major challenge to identify the genetic contributions to disease, i.e. to 
elucidate the precise relationships between biological information and health 
information, especially between genotype and phenotypeJ , and there have been many 
explorations of this topic. In addition to experimental validation of the phenotype 
through the genotype 19 , other research attempts: to analyze the relationship between 
genotype and phenotype based on accumulation data from both genotype and phenotype 
related to particular genes- for example WT1 and CARD15 2 " 21 ; to infer genotype from 
the clinical phenotype through knowledge-based algorithms for simple genetic 
diseases22 ; to develop a knowledge framework for cancer's molecular-disease 
relationships, which is a foundation for further automatic computation J ; to analyze 
possible relationship between clinical phenotype and genetic information by clustering 
phenotype24 ; to develop visualisation tools to display genotype-phenotype relations 
from OMIM25 ; to bridge genomic with clinical discovery science by using knowledge 
base of clinical decision support system for genomic discovery" ; to use natural 
language processing to extract phenotype information from literature27 ; to use 
mathematical methods to relate survival times with gene expression profiles .
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Although there is much research into biological information and health information, it is 
hard to identify the precise relationships. Often the research is based upon a model 
organism instead of the human being. And it is very hard to conduct research starting 
from the organism phenotype, because the organism phenotype is hard to standardise 
and quantify. However, if there is sufficient genotype and organism phenotype 
information available, there will be great potential in establishing meaningful 
relationships between them. There are already huge amounts of organism phenotypes in 
the clinical setting, especially in clinical records. Consequently if the genotype 
information can be integrated into the clinical records then the clinical record itself 
becomes a rich environment in which the research on the relationship between genotype 
and phenotype may be conducted.
This research provides biological information into a clinical software environment, and 
seeks matching points to integrate biological and health information. This is an 
extension and a complement to current BHI research. Considering the important 
potential that genetic information might play in future medicine (detail will be in 2.4.2), 
bringing biological information into the clinical setting is a worthwhile pursuit.
The following is a current review of the tuo research directions that are related to the 
solution of this research: i.e., to provide formal and structured bio-health information of 
cystic fibrosis (i.e. exemplar) in a knowledge base through a simulated clinical system 
EHR system prototype.
2.2.2 The absence of biological information in the EHR
As noted, with the increase of biological information, many scientists and researchers 
have identified the need to bring biological information into the EHR system"9 J . 
However, there are at present few concrete published examples of research on this topic 
and most papers are either from a subjective viewpoint offering insight and/or 
prediction. Authors of the published papers have tended to focus more on what should 
be done rather than what has been done in this particular area although they do usually 
agree that biological information plays a key role in the clinical setting.
Hoffman 29 suggested developing a new laboratory system to include formatted 
molecular diagnosis and cytogenetic findings and to adopt a new standard/vocabulary 
for clinically significant genomic information. The view given involves including
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genomic information into an EHR system but without stating what type of genomic 
information should be included or how to achieve this view.
Sax and Schmidt3 reviewed the available standards' formats for phenotype and 
genotype data, and assessed the data model for adequacy of representation. However the 
comparison and assessment given were quite general, without any detailed explanation 
being given about how or what to use in a real situation. They were more concerned 
with identifying current problems in this area rather than addressing how to solve these 
problems.
Robson and MusrmV 1 studied how to assemble patients' clinical genomic records, 
especially for patients' protein information in clinical records. However, the authors' 
focused on the technological aspects of transmission of clinical and biomedical data. 
Clinical data was formatted by the clinical document architecture (CDA) while genomic 
data consisted of the DNA sequence and protein sequence. However, in that paper 
Robson did not explain how to make the annotation data formal or structured, nor how 
to use genomic data in a clinical setting, but focused instead on encoding and decoding.
In the HL7 Version 3 set of standards there is work related to clinical genomics, i.e. 
Clinical Genomics, Pedigree which is under the clinical domains"1 " This is a 
specification for communication of a patient's family history betueen different parties, 
such as healthcare professionals, patients, genetic test suppliers and EHR systems. The 
genomics data is a part of the family history. The interoperability is the focus of the 
specification. However, although the same reference model for the EHR communication 
is used in the CDA, little progress has been made to co-represent the genomic and 
health data.
Current research into trying to include biological information in EHR is still immature 
and incomplete. The ambiguous relationship between biological information and health 
information makes it more difficult to decide what type of data (gene data, protein data, 
structure data etc) should be included and how detailed these data should be. Is it 
feasible to include formal and structured biological information associated with health 
information in an EHR system? If so, how should biological information be included? 
These are two problems which still lack clear and definite answers from the literature. 
Several related but different research projects are introduced and are later compared
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with the work in this research.
2.2.3 Current research on biomedical knowledge bases
There are several reviews which discuss the trends and challenges in biomedical 
ontologies: for example, ontology was considered as a method to consistently annotate 
features from genotype to phenotype for biologists33 ; there are desiderata for reference 
ontologies in biomedicine, and five desirable characteristics for reference ontologies are 
presented e.g. "good lexical coverage, good coverage in terms of relations, 
compatibility with standards, modularity, and ability to represent variation in reality" 14 ; 
the principal and the current issues in designing and developing bio-ontologies: the 
ability to query across databases and the constructing ontologies that describe complex 
knowledge (such as phenotypes)^4 These are valuable principles/suggestions for 
knowledge base construction.
Rubin and colleagues reviewed the research which attempts to offer both biological and 
health information from the same knowledge resource 0 . On investigation, it became 
clear that there are some defects or missing parts in many of the projects reviewed; for 
example the format is not formal or the content is not structured or health information 
especially the phenotype is simplified with only the disease name. To the author s 
knowledge none of the existing knowledge sources that were reviewed focus on both 
genotype and phenotype information which is for direct clinical use. Every project has 
its own purpose and associated advantages and disadvantages, but for brevity the 
following introduction will focus more on the missing parts.
HGVbase is a phenotype/genotype database at a summary level (group level aggregated 
data) instead of at the individual level 36 and HGVbase describes relationships between 
human DNA variations and phenotypes. There were around 119 different studies 
(diseases) in the new version of HGVbaseG2P37, however, for most diseases the 
phenotype was only disease name without further details; the phenotype is much more 
complex than a single disease name. HGVbase was based on conventional database 
technology.
PhenomicDB is a new cross-species genotype/phenotype resource developed in 
Germany38 and it shows phenotypes associated with corresponding genes and grouped 
by gene across different species. Although there were phenotype description, phenotype
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keyword and phenotype ontology ID in PhenomicDB, only the phenotype description 
had more detail, although this was in free text.
PharmGKB J ' is a pharmacogenetics and pharmocogenomic knowledge base which 
includes gene, drug, disease and effects of gene variation on their relationships; 
knowledge resources come from both the literature and from original experimental data. 
Phenotype data follows certain formats and terminology in PharmGKB, but with more 
molecular and cellular phenotype information; clinical measures were content related to 
lab results and pharmacodynamics data.
Other related work include Gupta's Parkinson's disease ontology, which was designed 
for inference and computation41 , toxicogenomics42 , and asthma J knowledge resources, 
both of which were based on database technology.
From the above review it seems that the relationship between genotype and phenotype, 
the phenotype representation, ontology-based data storage, and the management and 
interchange of these data types are attracting attention to knowledge bases in 
biomedicine.
2.3 Comparison of this work with other related research 
2.3.1 Delivering relevant information in the clinical setting
 Infobuttons' is a project led by Dr. James J. Cimino44 4? at Columbia University. It is a 
study to provide automated, context-specific links between the clinical information 
system and other online knowledge resources. Infobuttons is a very practical means of 
helping clinicians get relevant information within the clinical information system (CIS). 
The information needs came from observation of clinicians, surveys, focus groups 
interviews, and analysis of system log files, scenario-based assessment and knowledge 
acquisition46"49 . The results provided by Infobuttons are links, and this strategy removes 
the need to update remote knowledge resources. Using generic questions is a creative 
solution for identifying retrieval questions. Infobutton Manager is used to create generic 
questions for the query. Other contextual information including user type, patient age 
and sex, the clinician's task etc is also used to filter query results. This is an effective 
way to tackle information overload in the process of information query within clinical 
system. However, Infobuttons was limited to handling specific questions44 Generic
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questions sacrifice query precisions. However, if every single specific question was 
listed usability would suffer. This is seen as a difficult balance point among query 
precision, usability and information overload.
Both Infobuttons and this research try to "link" outside information resources with the 
clinical system to provide relevant information support. The information resource in this 
research focuses on bio-health related material, which has an overlap with Infobuttons' 
However, it is not clear how Infobuttons handles biological information during the 
information support, whereas a major aim of this research is to bring biological 
information to the clinical system, especially sequence variations information. 
Nevertheless, this is a long term goal that will require extensive large scale testing 
beyond the scope of the present work.
ShethV work was an application of semantic web technology in the electronic medical 
record. However, the work focused more on the management side, especially billing and 
insurance checks and cover. On the health care side the work focused more on 
medication, for example guidance on dosage, interaction check and allergy reminder etc. 
OWL ontology and semantic rules were used in representing domain knov\ ledge and 
allowed the system to make decisions. The paper did not mention if or ho\\ biological 
information was dealt with.
2.3.2 Delivering biological information in the clinical setting
HoffmanV 1 research aimed "to develop a curated resource, the Clinical Bioinformatics 
Ontology (CBO), a semantic network appropriate for describing clinically significant 
genomics concepts." His research combined the medical vocabulary with biological 
concepts which can be used in molecular finding: mutations, polymorphisms, allele 
naming and chromosome structures. Hoffman also imported the resource into a 
commercial healthcare information system (HIS). His work provided term/vocabulary 
support for the HIS. Hoffman's research and this research share the idea about the 
technology choice- both projects are ontology-based, and the general target fields 
biological and clinical fields, but the application and functional intention of his research 
are different.
Kumar s32 research of connecting proteins to biological processes and establishing 
relationships not represented in Gene Ontology (GO), aimed to provide a unified
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representation which could help in answering the difficult questions which arise at the 
borders of medical informatics and bioinformatics. However, Kumar did not define the 
scope of the work in that paper. Theoretically, the wider the scope of a knowledge base 
the better. However, it is neither realistic nor practical to complete if there is not a clear 
boundary. The involved relationships in the ontology had been explained in detail by 
logic. Both statistical and probabilistic approaches were used to find associations among 
GO terms. There was no description of how the associations and the concepts from 
disease level to molecular level were organised.
PheGe"' was a platform for exploring genotype-phenotype relations at cellular and 
organism levels, which was aimed at automatic network analysis on the organism level. 
This was a project based on database technology and a pilot scheme for virtual system 
biology. PheGe assisted in analyzing regulatory, metabolic and neuronal circuits; this is 
totally different from the aim of this research. PheGe and this research share the initial 
aim of helping to reveal relationships between genotype and phenotype; however the 
objectives and methods are different.
Although generally all the three studies have attempted to bring biological information 
into a clinical environment, they are quite different from this research either in approach, 
explicit granularity or in the type of technology used. Hoffman's research had been 
focused on biological vocabulary support, whereas this research stresses knowledge fact 
support. Kumar's research lacked detailed description about how to organize the 
concepts from disease level to molecular level, whereas this research uses this as a main 
part of the integration. PheGe research was based on database technology, whereas a 
key part of this research focuses on knowledge base technologies as a way of managing 
the complex semantics.
2.3.3 Other bio-health resources
Genetics Home Reference34 D5 is a consumer resource designed by researchers from the 
University of Missouri and NLM. It is a web site about genetic conditions and the genes 
or chromosomes responsible for those conditions. Most of the contents are listed as 
questions and answers with cross reference in free text; it is user-friendly. This research 
focuses upon clinical use, hence the contents are narrower, the knowledge 
representation is more formal and the target user is a non-specialist doctor, such as a GP.
Chapter 2 Literature review -17-
Gene Ontology (GO)56 and Unified Medical Language System (UMLS) 57 are tools for 
terminology (vocabulary). Again, such tools are very useful but would only contribute 
part of a solution based on the requirements of this research.
Although these are similar in some respects, this research aims to merge biological and 
health information in a formal and structured way and to make the information 
accessible through a simulated EHR system which makes it quite distinct.
2.4 Research motivations
The motivations for this research are summarised:
1) There has been a huge and rapid increase in biological information as a result 
of genetic research, however little published research has focused on to making 
this information readily available in a clinical setting.
2) Biological information is one of the most important material bases for the 
understanding of life activities, including disease and health status. However, 
the connection between biological information and disease status is still being 
studied.
3) There are a large numbers of sequence information resources alread\ in 
existence, but they have not been designed and compiled for direct clinical care. 
Therefore they are not ideally suited to a consultation scenario, in \\hich there 
is limited time and where the participants are not specialist in genetics.
2.4.1 The growth and use of biological information
In the past decade with establishment of new technologies (e.g. automation of DNA 
sequencing and large-scale sequencing) and the completion of Human Genome Project, 
there is more and more biological information available, especially with respect to gene 
sequences. In GenBank, the genetic sequence database in the US National Institute of 
Health, an annotated collection of all publicly available DNA sequences, the base count 
rose from 9.5 billion in Aug. 2000 to 85 billion in Feb. 200838 ' 59 . According to statistics 
from the Protein Data Bank (PDB) web sites, in PDB the number of protein structures 
which can be viewed were 5008 in 1996 and rose to 51079 in 200860 .
Despite the increased pace of identification of gene sequence and protein structure.
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biological information remains poorly understood and used in clinical practice3 (some 
examples will be given in section 2.4.3). Because the precise relationship between 
biological information and diseases phenotype has not been elucidated explicitly, it is 
hard for doctors to use biological information directly in their daily practices.
For biomedical researchers (domain researchers), the next step is to translate biological 
sequence information into health benefits3 , such as more effective treatment or faster 
and reliable diagnostic method. The intelligent and proper use of human gene sequence 
data could lead to significant advances in our understanding of genetic basis of diseases 
at the molecular level, and further tangible health benefits61 .
Although many biologists and biomedical researchers predict the critical role and bright 
prospects that genetic information will play in the medicine of 'tomorrow' , there is a 
lack of answers to some basic questions, for example 1) how to use genetic information 
in clinical setting, especially during consultation; 2) what to use? At this time it would 
be true to say that most research is exploratory.
2.4.2 The role of genetic information
An important part of the argument for this research is the increasing importance and 
pervasiveness of biological information, as described in the last section. In this section 
the focus will be why genetic information is important. In this thesis "genetic 
information" is used to refer to nucleic acids and proteins information specifically.
Nucleic acid is the material basis of life. A nucleic acid is composed of chains of 
nucleotides. A gene's nucleotide sequence encodes the amino acid chain, which coils 
and folds to form the functional protein62(p!74-177). Figure 2-1 is a representation of 
the biological hierarchy. It is the nucleic acid that guides a protein's synthesis, and it is 
the proteins that are functional for life activities, for example structural support, 
protection, transport, catalysis, defence, regulation and movement63 (p42). So the 
nucleotide sequence provides a key and basis in determining the organism. There is an 
example of how protein affects phenotype in cystic fibrosis in section 2.8.3.
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Figure 2- 1 Diagram of basic biological hierarchy
The ability to produce the correct proteins depends on nucleic acid, or more precisely, 
upon the DNA sequence64(p46). "Abnormalities in nearly all classes of proteins, 
including enzymes, transport proteins, receptor proteins, and structural proteins, have 
been implicated in genetic diseases"63 (p397). For example: an abnormal single enzyme, 
which is dysfunctional - phenylalanine hydroxylase- is the cause of phenylketonuria 
(PKU), while abnormal haemoglobin is the reason for sickle-cell disease63(p377-378). 
There are also environmental factors involved with the disease status apart from the 
DNA sequence: "for most common diseases it is interactions of many genes and 
proteins and the enviromnet"63 (p379).
There are about 20000-25000 genes for human DNA. It is possible almost all human 
genes can cause disease if they are altered substantially65 ' 66 . In the following context 
haemophilia was used to describe possible relationships between genotype and 
phenotype in genetic disease. The genetic material basis for cystic fibrosis will be 
introduced in section 2.8.3.
There is often a logical relation between a person's genotype (DNA sequence) and their 
health outcome (phenotype). For example, there are quite different clinical presentations 
for haemophilia patients: patients with moderate bleeding problems can live to 
adulthood and lead relative normal lives without trauma or surgery; whereas a patient 
with severe spontaneous bleeding in their early childhood will rarely survive to 
adulthood. There are also patients in between with intermediate clinic severity67 . The 
various mutations of the haemophilia A gene correspond to different health outcomes: a 
large gene deletion in the DNA sequence of the haemophilia A gene results in the failure
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of gene transcription, which then leads to severe status (the patient has severe 
spontaneous bleeding and rarely survives to adulthood). Genetic inversion and a small 
change in DNA sequence of the gene leads to amino acid substitutions in factor VIII 
protein, and causes mild to moderate disease67 . The various mutations explain the 
different phenotypes in haemophilia A, however the correlations between genotype and 
phenotype in monogenetic diseases such as cystic fibrosis, are not always linear. The 
relationship between genotype and phenotype is much more complex.
Genetic information plays a critical role in understanding genetic diseases' mechanisms, 
especially monogenetic diseases. This is the main reason to choose genetic information, 
as it is a key material basis for life phenomena in both health and disease states.
2.4.3 Clinical use of sequence information resources
With the huge increase in the amount of biological information, especially sequence 
information, more and more sequence information resources are becoming available, for 
example: Nucleotide68 , DDBJ69 , EMBL 70 etc. It has been noted, however, that most of 
these resources have not been designed for direct clinical use, nor follow the clinical 
related recommendation71
Besides these general sequence information resources, there are also some 
locus-specific databases (LSDB, i.e. gene-specific mutation database)7" 7 , some of 
which involve both genotype and phenotype. The LSDB with phenotype has the 
potential to be used clinically. For example NPC-db 74 was a disease database of 
Niemann-Pick type C disease, which is an autosomal-recessive disease. NPC-db 
included both variations information and phenotype data. RAMEDIS75 was a metabolic 
diseases database, which included variation information and structured clinical 
information. However, in NPC-db, the author did not mention how the phenotype data 
was organised and it is not clear if the phenotype data was free text, terminology 
compatible or structured data. In addition both NPC-db and RAMEDIS are based on 
database technology and have not been integrated with any electronic health record.
2.4.4 Information overload
Information overload is a big challenge in the information era and is a fact faced by 
doctors. Information overload comes not only from increasing information amounts, but
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also from the diversity of available information6 . More than 400000 articles are added 
to the biomedical literature each year7 . In addition to published articles, other 
information resources include textbooks, guidelines, references, databases, knowledge 
bases, discussion groups, newsletters, e-mail alerts, internet sources etc. When the 
increasingly amounts of health information are joined by rapid increases of biological 
information, doctors' information overload, already acute, becomes critical6 76 Offering 
biological information in the clinical setting should be designed to not make the 
information overload situation faced by doctors even worse.
Different methods have been used to help alleviate the information overload, such as 
offering a guideline summary by an official group7 ; offering a web-based intranet 
application 77 , or developing a knowledge management system 78 . The emergence of 
semantic web technologies, however, brings new hope in data sharing and reusing, both 
of which are critical in handling information and the associated diversity. Semantic web 
technology provides some relief for information overload from the file format 
perspective, while the ontology-based organisation of knowledge facts provides some 
relief for information overload from the file content perspective. A detailed introduction 
to the semantic web and ontologv \\ill be given in section 2.5.
Reference sources of new information and knowledge have both advantages and 
disadvantages for busy doctors. From an ethical perspective, no one would deny that 
evidence based practice is the ideal; the more evidence the better. However, the reality 
of everyday practice is far from ideal. It is still a big challenge for doctors to get the 
right amount and type of information at the right situation. Operational factors often 
frustrate the search for relevant details, which are often dispersed across multiple 
sources and buried deep within databases. The search results are often unstructured, 
redundant and/or too comprehensive to be usable. Both Smith and Mickan and 
Askew80 mentioned the information need from doctors' viewpoint in the information 
overload era: individual related patient information is needed. So it is important to 
consider information filters as a means to provide relevant personalised information to 
doctors.
2.5 Knowledge base
In this section the semantic web, ontology, OWL, the meaning of knowledge bases and
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databases will be introduced, and the reason why ontology-based knowledge base was 
chosen to organise bio-health information will be explained.
2.5.1 The semantic web and ontologies
The Semantic web was conceived by Tim Berners-Lee, the inventor of the World Wide 
Web, the Uniform Resource Identifier (URI), Hypertext Transfer Protocol (HTTP), and 
Hypertext Markup Language (HTML)81 ' 82 . The major objective of the semantic web is 
to improve data reuse, data sharing and data integration in the data-centric new 
generation web82 The World Wide Web is document-centric, where a document is the 
basic processing unit. In the semantic web, data is processed automatically, 
voluminously, precisely and efficiently. ''The Semantic Web is a vision for the future of 
the web, in which information is given explicit meaning, making it easier for machines 
to automatically process and integrate information available on the web" . The 
semantic web is a better annotated version of the existing web; i.e., data is well-defined 
and linked. The semantic web is evolving and is the current direction of web research, 
providing a universally accessible platform that allows data to be shared and processed 
by automated tools as well as by people, in order to reach its full potential
However, semantic web technologies are still in their infanc\ M . and there are not yet 
enoimh tangible higher level applications. Most of the existing efforts focus more on 
lower layers. In the semantic era, apart from the establishment of corresponding
87specifications, the first thing to do is to put data into semantic web formats " As 
ontology is a key enabling technology for the semantic web83 , ontology and 
knowledgebase construction will become important infrastructure components for the 
semantic web.
The following description of what an ontology is, is provided by John Sowa:
"The subject of ontology is the study of the categories of things that exist or may 
exist in some domain. The product of such a study, called an ontology, is a catalog of 
the types of things that are assumed to exist in a domain of interest"
Thus organising things helps one not merely to retain them, but also to find , reuse and
Q-J
share them .
An ontology is a form of 'catalogue', in which the basic domain knowledge units and 
their relationships are represented and computer-usable. Ontologies are used by people,
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databases, and applications that need to share domain information. They encode both 
knowledge in a domain and knowledge that spans domains. Knowledge is reusable 
through ontologies88 Knowledge sharing and reuse provided by ontology technology 
play key roles in information use. An ontology can be used to specify a knowledge 
base's structure and its classification scheme89 .
According to the description of the semantic web from W3C, a standards development 
organisation, there are two major parts to the semantic web: one is the common format 
for data interchange; the other is language that is used to record data which corresponds 
to real world objects . The semantic web syntax is based on resource description 
frameworks (RDF) to represent data, and three URIs can be combined to form a RDF 
statement ' RDF is a generic format which can be processed easily and automatically 
in data interchange 81 Web ontology language (OWL) is a vocabulary extension of 
RDF92
2.5.2 Introduction to OWL
OWL is a semantic mark up language for publishing and sharing data by ontologies on 
the web9 ~ , supporting advanced web search, software agents and knowledge 
management90 OWL is intended to be used in information processing by machines 
rather than understood only by human beings8j Compared with the extensible markup 
language (XML), RDF, and RDF-Schema, OWL has more semantic representation 
ability, and thus OWL goes beyond those languages in representing machine 
interpretable content8 " OWL is a vocabulary extension of RDF and is based on the 
DAML+OIL web ontology language, which it extends J ~ ~ OWL ontologies can be 
encoded in different syntactic forms including RDF/XML J , which is defined by 
XML syntax for RDF 94 . An introduction to RDF is found in Appendix A.
There are three sublanguages of OWL: OWL Lite, OWL DL (description logic) and 
OWL Full (the complete OWL language). Detailed introductions to the three 
sublanguages can be found in Appendix A. We chose OWL DL as the ontology 
language in the knowledge base prototype construction, as it provides computational 
properties which can be used in reasoning systems "
OWL is used to represent vocabularies and their relationships in an ontology, and this 
representation is directly machine-usable83 OWL has already been integrated as a
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plug-in with Protege, which is a popular & recognised ontology editor from Stanford 
University. In Chapter 3 there will be a detailed introduction to this tool. There is also a 
platform to support ontology modelling via the Protege-OWL editor". Protege-OWL 
has a user-friendly interface to define class, property, instance and their relationships 
following OWL syntax. The OWL ontology from the Protege-OWL platform is encoded 
in XML. There is no barrier for information exchange in XML format between different 
systems or different computers9 ^ OWL statements make the ontology-based knowledge 
base consistent, extensible and computer-readable. Aranguren and colleagues 
conducted a recasting of Gene Ontology by OWL and have proved these advantages.
The above provides a background introduction to the semantic web, ontology and OWL. 
Next 1 clarify what I mean by knowledge base and database before I justify my choice 
for this study's implementation.
2.5.3 Databases
Definition of 'database* from the High-Tech Dictionary96 :
1. A large collection of data organized for rapid search and retrieval. 2. A program that 
manages data, and can be used to store, retrieve, and sort information.
"Database" refers to a collection of organised data in this thesis, \\hich is the underlying 
meaning, rather than a strict literal definition. "A datum is a single observational point 
that characterizes a relationship. It generally can be regarded as the value of a specific
1 8parameter for a particular object at a given point in time" (p64).
2.5.4 Knowledge bases
Definition of'knowledge base' from Lemaire 7 :
A knowledge base is a model, a structure to store, organize and access a set of 
knowledge. Knowledge base is the result of a modelling process.
This definition is focused more on the function that the knowledge base can achieve. 
I do not intend to give a universal definition of the term 'knowledge base'; rather, 
and more simply, I intend to explain what I mean when I use the term in the thesis: 
i.e., a knowledge base is a structure to store, to organise and to retrieve 
computerised domain knowledge, including facts and rules.
A knowledge base 1) has inference capability by integrating a specific application
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domain knowledge within a database; and 2) can provide sharing, ease of 
maintenance and reusability of domain knowledge98(p2). Compared with a database, 
a knowledge base has more capabilities in presenting, sharing, reusing and 
processing complex domain knowledge.
In this thesis 'knowledge base' is used as the general term, whereas 'knowledge 
base model' specifically refers to the logic specification for the knowledge base. 
'Knowledge base prototype' is used to refer to the physical artefact of the logical 
specification for a knowledge base.
2.5.5 Ontology-based knowledge base
The goal of this research is to explore the feasibility of providing formal, structured and 
relevant bio-health information in a simulated clinical system. There are varieties of 
methods that could be used to provide bio-health information: for example dynamic 
links and tool support, which includes: databases, knowledge bases, retrieval tools etc.
Although dynamic links avoid content update, the links still need to be updated, and 
users need to choose the ideal links, which can be a burden for them. Another potential 
disadvantage related with dynamic linking is related to medico-legal reasons. For 
example there is a legal requirement to preserve and track what was the referenced 
knowledge fact at a particular time for a particular user. Retrieval tools have the same 
problem: searching for and then selecting correct results increases the load on the users" 
information use. The aim of this research is to provide the final relevant knowledge 
facts, providing a one-stop-shop experience, rather than a portal.
There are some requirements in providing formal, structured and relevant bio-health 
information for doctors' daily practice: the information should be provided in an active 
and intelligent way (i.e. in an automatic, context sensitive way); the content should be 
computer-readable, meaningful (i.e., semantic integrity), consistent and extensible. An 
ontology-based knowledge base is known to satisfy many of these requirements: with 
characteristics from both ontology (such as logic and consistent structure and 
explicitness) and knowledge base (representation capability, computer processability). It 
was therefore chosen as the knowledge management tool. We chose OWL as the 
ontology language because, as described in 2.5.2: it has explicit representation ability, 
more expressive semantics, and the representation of content is machine interpretable J
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OWL statements make the ontology-based knowledge base consistent, extensible and 
computer-readable, computer-processable, and to have potential for communication and 
integration. It is unlikely that the knowledge base prototype we are trying to construct 
will work as a module of an isolated EHR system. Such a thing would be expensive and 
limited in value. It is more feasible that the knowledge would be communicated, and the 
prototype will be one of several key components in a complete system; meanwhile the 
knowledge base has all characteristics of OWL statements.
This is the rationale for the decisions to use an ontology-based knowledge base to 
provide bio-health information. There follows a brief review of how the research relates 
to the EHR.
2.6 Electronic Health Record (EHR)
Biological information, such as sequence variation information plays a key role in 
understanding disease, although the precise connection between biological information 
and clinical manifestations is far from clear, and hence poorly used in current clinical 
practice"1 " 61 If biological information can be accessed easily by doctors \\hen the\ are 
using patients clinical information, it may broaden clinical care support and may 
provide potential for understanding the relationships between biological information 
and disease. Before anything like this can be achieved in practice, ho\\ever. it is 
necessary to determine how this can be done, and what might be the means for 
delivering such benefits.
It is only relatively recently that doctors have begun to use computers directly as part of 
their note-taking, reading and work processes. According to Benson in the UK, "in 1975 
the health centre at Ottery St. Mary, near Exeter, became the world's first paperless 
general practice"", and it was much later to develop clinical functionality rather than 
the more administrative tasks of repeat prescriptions and appointments. Whereas now 
virtually every GP uses EHR's and systems", it is still rare to find complete systems 
within secondary care 100 A new phenomenon, particularly in the US is the advent of the 
personal health record (PHR). There is now a pervasive trend towards using systems for 
supporting care. EHRs are used more by clinical staff, whereas the PHR is used by 
patients themselves to enter and update their personal health data. The control of the 
content in a PHR is therefore seen more to be the patient's responsibility.
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In this research the EHR is targeted because of the clinical focus. However, there are an 
increasing number of technical information standards which seek to define content 
or/and function or communication of EHR systems, for example the HL7 Electronic 
Health Record System Functional Model, EN 13606, CCR etc. These standards are 
applicable (at least in part) to both types of record system. It is through these 
increasingly standards-based systems that bio-health information will be delivered, 
accessed and used during the consultation between doctor and patient.
2.6.1 Meaning of EHR in this thesis
I used both the term 'EHR' and 'EHR system' (EHR-s) in this thesis. There are 
definitions of both terms in Shortliffe and Cimino's book lo '(p448):
 'An electronic health record (EHR) is a repository of electronically maintained 
information about an individual's lifetime health status and health care, stored such that 
it can serve the multiple legitimate users of the record."
"A computer-based patient-record (EHR) system adds information management tools to 
provide clinical reminders and alerts, linkages \\ith knowledge sources for health care 
decision support, and analysis of aggregate data both for care management and for 
research."
In this thesis - EHR' refers to all electronic bio-medical and health related data of an 
individual patient, excluding finance data; 'EHR-s' is a management tool or platform for 
capturing, storing, displaying, retrieving, transferring and managing electronic 
individuals' electronic health records.
The 'EHR-s prototype' is another term used in this thesis. The definition of a prototype 
system from Shortliffe and colleagues' book lb(p208) is:
"Prototype systems are working models that exhibit the essential features of the system 
under development. Users develop a realistic idea of what the system will look like, 
how it will work, and what it will do."
'EHR-s prototype' is used to refer to an EHR working model, which can be 
demonstrated in the same way as an EHR-s; it has a subset of functions sufficient for 
this research but not all the functions found in a commercial product.
2.6.2 EHR-s in the clinical setting
EHR-s is still maturing and hence any review is incomplete and the results suggest 
much more can be done. For example 1) there is no EHR-s that can seamlessly integrate 
data or can coordinate processes across the entire continuous procedures of health care
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services; 2) there remain challenges from technology, human resources and 
organisational perspectives in EHR-s development and application 102 (plO); 3) the 
results of a systematic review of electronic medical records (EMR) to improve 
physician performance and patient care, are quite conservative 103 .
However, the trend is for more and more of these systems to emerge. Arguments in their 
favour include the facts that they are much easier and more flexible to access, manage, 
communicate with and use for storage than paper is. Indeed, the first recommendation 
from the Committee on Improving the Patient Record, Institute of Medicine in the US is 
"health care professionals and organisations adopt the computer-based patient record as 
the standard for medical and all other records related to patient care"' 02 (pl80). In the 
UK. there is a National Programme for IT to bring modern computer systems and 
technology into the National Health Service (NHS), and electronic patient records are 
part of this programme °4 3 National EHR architecture models have emerged in the 
US and Australia The US is ambitious to offer most Americans EHRs before 2014 106 
Although existing EHR-s are not perfect, EHR-s or EHR components in a bigger system 
will play a key role in clinical setting, and especially in doctors' consultation with 
patients. The trend means that EHRs are the most likely candidate medium for 
displaying/accessing/viewing biological information along with other clinical data. In 
the next section the major structure of an EHR. the requirements of an EHR-s and major 
challenges for an EHR-s will be introduced.
2.6.3 Structure of an EHR and requirements of EHR-s
The patients' health record has a long history, arguably from the earliest days of clinical 
practice. The EHR is a digital version of the patients' health record. Although there are 
some distinct characteristics for EHR particularly, paper versions of the health record 
and EHR have common content and characteristics. Currently with the emergence of 
EHR there is a trend to move from a healthcare provider-centred record to a more 
patient-centred record 107(p90), and from an administrative record to a clinical-use 
record.
There are some milestones in the history of the health record. The Problem-oriented 
Health Record (POMR) and Subjective, Objective, Assessment and Plan (SOAP) data 
categorisation were proposed by Weed in the 1960s' 07(pl01), while the History,
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Observations, Assessment, Plan (HOAP) was proposed by Donnelly in 1992 l07(pl01). 
Van de Velde & Degoulet 107 (pi 18) viewed the structure of EHRs in four different ways: 
a longitudinal life-long record; a problem-oriented record; an episode-based record and 
a pragmatic record.
Van de Velde & Degoulet I07(pll8) summarised the gold standard for attributes of a 
computer-based health record system:
"a problem list; to measure the patient's health status and functional levels; to document 
clinical reasoning and rationale; a longitudinal view that provides timely linkages with 
other patient records; guaranteed confidentiality, privacy, and audit trails; continuous 
access for authorized users; support for simultaneous multiple user views; direct data 
entry by physicians; support for practitioners in measuring or managing costs and 
improving quality; flexibility in supporting existing or evolving needs of clinical 
specialties"
Some of these attributes can be used as reference in building the EHR-s prototype.
Most of the current EHR-s are passive; the so called active EHR-s' 07(p91) will 
increasingly interact with users (doctors or other professionals) and so offer more 
support for direct patient care. For this to happen some challenges need to be overcome, 
an important one being to connect with formalised kno\\ ledge sources to support the 
doctors'work' 07(p93).
In the next section the available EHR tools for this research \\ ill be introduced. 
2.6.4 Available EHR tools
There are many EHR tools, of which OpenEHR 108 , INDIVO (formerly named PING) 109 , 
EHR ontology" 0 and HealthFrame"' were selected as candidates for this research.
In OpenEHR there are complete and detailed specifications for the EHR 108 However, at 
the time my work was carried out there was no available tool from OpenEHR. Although 
there was a JAVA core application 112 , it still lacked a usable interface. There are several 
other coherent tools for OpenEHR, developed by Ocean Informatics" 3 , such as 
Template Designer, Archetype Editor etc. However, none of the tools were designed to 
be used directly during a clinical consultation. Archetype Editor is a tool for clinical 
data specifications (i.e. archetypes). Template Designer is a user friendly tool with 
archetype-enabled data entry. Both Archetype Editor and Template Designer are 
important tools. However, neither of the tools could be used directly for our purpose.
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INDIVO is a patient-driven open source digital health records platform 109' " 4 . This is a 
project developed in cooperation between Harvard Medical School, MIT and Children's 
Hospital Boston and the Dossia Consortium. The INDIVO system is a complete and 
secure copy of personal medical records, across sites and over time. However, INDIVO 
is difficult to configure and to get the different versions of tools to cooperate with 
properly without conflicts.
The EHR ontology is based on OpenEHR, but the ontology is at a higher level and it is 
hard to use directly no
HealthFrame is a commercial user friendly system which is based on CCR 1 " This is a 
tool aiming at organising entire family members' lifelong health care and wellness 
information. It includes all health-related information about the family member, from 
medical records from doctors and hospitals, to family history and personal life style. It 
is a personal health information hub, which is meaningful in keeping personal health 
information complete and correct. There is a free trial version with time limitation for 
evaluation. Although it is an ideal end user system, the source code was not available 
for our study.
Giving the limitations of time and available technical support and the cost of proprietary 
systems it was decided to build a system prototype based on an international standard.
2.6.5 Consideration of target user
There are many potential users of EHR systems" 5 , such as health care professionals and 
administrative staff, including specialists, general practitioners, nurses, laboratory 
technicians, biomedical researchers, medical students, administrative staff and patients 
etc. It is impossible to meet every user's demand in this study. The focus is to offer 
biological information in a clinical setting and to target non-specialist doctors, for 
example general practitioners, who might need biological information support during 
their consultation with patients with genetic diseases. The demands of other specialists 
such as biomedical researchers, can be readily satisfied by a large number of existing 
biological information databases. It is assumed that, compared with biological 
information experts, the non-specialist doctor will need more support with basic terms, 
such as a specific mutation names, rather than detailed biological information. This 
consideration will influence the content, structure and format of the knowledge base
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organisation.
In the next section the candidate resources and tools will be reviewed. These resources 
and tools are potentially useful in knowledge base prototype construction.
2.7 Biological information resources and tools
In this section: 'tool', refers to the service from an electronic source such as a database; 
while 'resource', refers to the content.
In this research different types of information about cystic fibrosis have been considered: 
scientific publications, gene sequence data, genetic information and concept 
descriptions. I have been pragmatic in the choice of tools.
The inclusion criteria for tools were: (1) domain coverage, which is focus; (2) free 
access, which is financial friendly and convenient; (3) maintained by a recognised 
organisation, which is credible; (4) evidence of updates, which is updated^ " 6~" 8 .The 
exclusion criteria were: (1) protein data resources, which are not in the scope of this 
research; (2) genome resources; (3) resources without qualifiers for effective retrieval, 
\\hich would not be efficient in use; (4) resources that can be processed further only by 
natural language processing; (5) resources for patients only; (6) commercial web sites, 
which could conflict with commercial bias.
I selected two books" 9 I2°. and the following tools: PubMed " , Nucleotide . 
EMBL-EBI 70 l22 , DDBJ 69 I2 \ OMIM 124 125 , Cystic Fibrosis Mutation Database 
(CFMDB)' 26 , MeSH 127 , ICD-10 128 , GO 56 , UMLS 57 , The Cochrane Library 129 , and CF 
web pages/sites. PubMed, Nucleotide, OMIM and MeSH are all services provided by 
the National Centre for Biotechnology Information (NCBI) in the US. Although the 
interfaces are similar, the main content and focus are different. There was overlap 
between databases, for example between EMBL, Nucleotide and DDBJ. Some of the 
tools will be introduced in detail (Table 2-1), most of the others and comparison of the 
different gene related resources with respect to cystic fibrosis were introduced in a 
published paper 130
GO and UMLS are references for knowledge base hierarchies; The Cochrane Library is 
used to form clinical requirement questions; other resources are used to acquire
Xia Jing, Constructing a bio-health knowledge base for access via a standardised EHR prototype -32-
knowledge manually for knowledge base construction. ICD-10, GO and UMLS have 
different perspectives for description of diseases, biological concepts and medical 
related concepts. They are good references relating to the structure of the basic concepts 
in knowledge base construction.
Table 2- 1 General introduction of some tools used in this research
Name
Books " 9 - 120
GO56
UMLS' 7
The 
Cochrane 
Library 129
CFweb
pages/sites
Properties/functions
Main body of CF knowledge; health information resources
Three structured, controlled vocabularies about gene products 
(biological processes, cellular components and molecular functions in a 
species-independent manner)
To facilitate the development of computer systems that behave as if they 
"understand" the meaning of the language of biomedicine and health
Supplies high quality and updated evidence to inform people providing 
and receiving care, and those responsible for research, teaching, funding 
and administration at all levels
From Mayo Clinic and NLM, Human Genome Project Information, web 
sites from Oxford University and so on 66 ' ljMj6
Background facts about cystic fibrosis and v\hy it was chosen as the exemplar condition 
will be introduced in the next section.
2.8 Cystic fibrosis
To carry out the research in a concrete \va\. c\stic fibrosis was chosen as the exemplar 
condition.
2.8.1 Cystic fibrosis as an exemplar condition
Cystic fibrosis is a monogenetic disease. Cystic fibrosis transmembrane conductance 
regulator (CFTR) gene mutations cause the condition. Monogenetic disease is caused by 
changes or mutations that occur in the DNA sequence of one gene66 Polygenetic 
diseases are due to the interactions of multiple genes and environmental factors6^. 
Compared with polygenetic diseases such as heart disease, high blood pressure, 
Alzheimer's disease, arthritis, diabetes, cancer, and obesity, there are far fewer variables 
in considering the relationship between diseases and related factors in monogenetic 
diseases (these include cystic fibrosis, sickle cell anemia, Marfan syndrome, 
Huntington's disease, and hereditary hemochromatosis etc.)66
The incidence of cystic fibrosis in white people is relatively high. Cystic fibrosis is the 
most common profoundly life-shortening genetic disease in white populations' 20^)- In
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the US it occurs in around 1/3300 white births, 1/15300 black births, and 1/32000 
Asian-American births. Cystic fibrosis is carried by approximately 3% of the white 
population " It is a lifelong disease and the life expectancy of cystic fibrosis patients 
has increased from an expectation of one year in 1960 to a median survival age of about 
40 years in 2002 J The longer life expectancy means that the cystic fibrosis patient 
will have more chances to be seen by doctors outside of specialist clinics.
2.8.2 Why choose cystic fibrosis
There are several reasons for choosing cystic fibrosis as an exemplar:
1) Cystic fibrosis involves multiple systems and associated symptoms, especially 
respiratory, digestive and reproductive systems. The nature of the condition 
will impact on a number of clinical services, involving both specialist and 
generalist.
2) Normally the symptoms present from an early age and persist throughout the 
patient's whole life. The chronic and persistent symptoms require consistent 
support from doctors. This will require 'continuity of care' and the associated 
records and record systems to support the patient over time.
3) New information, including biological information \vill emerge over the 
patient's lifetime and new information will need to be integrated into health 
care service and therefore will be introduced to doctors (and to patients) during 
the long term health care support process.
4) As cystic fibrosis has a relative high incidence and it is the most common 
life-threatening genetic disease in the UK, it has been studied for a long time 
and there is a relatively mature knowledge body. In CF many relationships 
between genotype and phenotype are known although it is still far from 
complete. Even so it means that there are more available resources for 
constructing a prototype knowledge base so as to test the research hypothesis.
5) Cystic fibrosis is a monogenetic disease, which is much simpler than 
polygenetic disease and therefore is useful for developing prototype solutions. 
The long term goal of this research is to integrate different types of knowledge 
seamlessly into the clinical setting, but we are 'walking before attempting to 
run'
Xia Jing, Constructing a bio-health knowledge base for access via a standardised EHR prototype -34-
6) Given that the totality of relationships between bio and health information are 
incomplete, it is useful if a platform can be constructed that will give the 
clinician opportunity to consider whether or not there is any new link between 
the data types presented. The prototype system is not a diagnosis system; rather 
it is a vehicle for joint presentation of different types of information.
7) Due to what is already known, the life expectancy of the cystic fibrosis patient 
has increased dramatically and survival expectancy is now far beyond the 
teenage years. Health care support for individual patients therefore will last 
longer than previously and new co-morbidities will appear and new links will 
be made. The range of services and the generalist nature of the clinicians seeing 
cystic fibrosis patients can be expected to increase and it is anticipated that they 
will need better tools than what are presently available as new problems 
emerge.
2.8.3 The molecular and pathological mechanisms of cystic fibrosis
Cystic fibrosis is an autosomal recessive monogenetic disorder. A defective gene- 
CFTR- alters a protein that regulates the normal movement of salt (sodium chloride) in 
and out of cells. Under normal conditions. CFTR protein plays a role as a chloride 
channel pumping chloride ions out of the cell. In cystic fibrosis, the chloride 
conductance is increased within cells; in the sweat glands, cation is prevented from 
absorption because the chloride cannot be absorbed as well 138 ' Ij9(p54). The fluids 
secreted are higher in sodium and chloride concentration, with increased salt. This leads 
to abnormal 'salty' secretions which promote bacterial colonisation, and result in thick 
and sticky secretions in the respiratory and digestive tracts, as well as in the 
reproductive system, and in salty sweat on the skin 114 This thick and sticky mucus clogs 
the lungs and leads to severe lung infections. The thick secretions also clog the pancreas, 
preventing digestive enzymes from reaching the intestines to help break down and 
absorb food 131
Symptoms can include weight loss, troublesome coughs, repeated chest infections, salty 
sweat and abnormal stools 132 . Other common problems encountered in cystic fibrosis 
include nasal polyps, rectal prolapse, cirrhosis and diabetes mellitus, meconium ileus 
and congenital bilateral absence of the vas deferens in males'.140
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2.8.4 Cystic fibrosis transmembrane conductance regulator (CFTR)
The CFTR gene is located in chromosome 7q31 and has 27 exons. The biological 
vocabulary is listed in the Appendix J for reference. CFTR protein- membrane bound 
glycoprotein, contains 1480 amino acids with a molecular weight of 168 kDa. The 
protein is comprised of two, six-span membrane-bound regions, and its primary role is 
to act as a chloride channel 126 ' I4°. There were 1571 CFTR gene mutations reported, 
including missense, frameshift, splicing, nonsense, deletion and sequence variation. The 
most common mutations are AF508 (70%), G542X (3%) and G551D (2%) 126 ' 14°. AF508: 
deletion of 3 nucleotides between 1652 and 1655 (positions of CFTR nucleotides 
sequence), results in loss of Phenylalanine at 508 (position of CFTR amino acids 
sequence) "" The loss of amino acid leads to CFTR protein alteration, which causes the 
pathological changes of cystic fibrosis (2.8.3).
The genot\ pe-phenotype relationships in cystic fibrosis are complex, and are affected 
by many factors: pollution, smoking, bacterial infection, malnutrition, and certain 
therapeutic agents. From a genetic view, within all the CFTR gene mutations, the delta 
F508 mutation is not only the most frequently encountered but also the most severe 
genetic lesion for homozygotes 141 The CFTR genotype is related to the patients 
pancreatic status, about 85% of cystic fibrosis patients with pancreatic insufficiency and 
about 15% with pancreatic sufficiency; the correlations between the CFTR genotype 
and pulmonary, liver, and gastrointestinal expression are debatable 142 Although much 
research about the relationship between genotype and phenotype of CFTR was 
undertaken, their precise relationship is not well understood
2.8.5 Cystic fibrosis gene therapy
Gene therapy is a technique for correcting defective genes which are causes of disease66 
The most common therapy is to insert  normal' genes to replace 'abnormal' genes. A 
vector is used to deliver the 'normal' gene. There are viral vectors and non-viral vectors 
in gene therapy. Viral vectors used in cystic fibrosis gene therapy include adenovirus 
and adeno-associated virus 143 . Cationic lipids or polymers are non-viral vectors 144 Viral 
vectors are unsuited to repeat dosing, while non-viral approaches appear to be more 
suitable to repeat dosing, although they are less effective 1 5 Three collaborative 
research groups in the UK have found liposome-mediated CFTR genes can be
Xia Jing. Constructing a bio-health knowledge base for access via a standardised EHR prototype -36-
transferred into the nasal epithelium 146 . This treatment can correct the chloride defects, 
but not sodium defects, with no toxic problems 146 . Gene therapy research promises 
some hope in future for cystic fibrosis patients and has made some progress in basic 
research . However, so far none of the clinical investigations using adenovirus or 
adeno-associated virus, cationic lipids or polymers has shown a persistent correction of 
the ion transport defects in cystic fibrosis patients 144 , and none of these trials have 
actually become tangible therapeutic benefit 147 .
2.9 Summary
This chapter has presented the reason for undertaking this research, and a review of 
related work. A description of the available technology involved in this research has 
been given, as well as a brief introduction to the possible biological candidate tools. The 
exemplar condition cystic fibrosis was introduced together with the reasons for using it 
in this study. In this chapter, the rationale, the theoretical basis and the pragmatic 
constraints of the research have also been given. The following chapters will outline the 
research methodology.
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This chapter is a brief outline of the research methodology. It provides an overview of 
the 1) research question; 2) conceptual framework; 3) research strategy, including 
abstract and concrete solutions; 4) description of detailed solutions and the reasons for 
these solutions; 5) introduction of the research evaluation; 6) requirements and 
functions of the concrete parts of the solutions; 7) reasons for choosing CCR as the 
standard and 8) introduction to the development environments.
This is a proof of concept research study and the intention is to deliver biological 
information through a simulated clinical system. The definition for 'proof of concept' 
comes from the Technology Source Archives 148 : "A proof of concept is a test of an idea 
made by building a prototype of the application. It is an innovative, scale-down version 
of the system you intend to develop. In order to create a prototype, you require tools, 
skills, knowledge, and design specifications." The reasons for doing this research and 
the background have been presented in the literature review chapter. Here I restate the 
research question to introduce the research methodology.
3.1 Research question
The research question is: "to what extent is it feasible to deliver formal and structured 
biological information associated with a subset of health information through a 
standards-based clinical record'?
3.2 Conceptual framework
Gates' definition about a conceptual framework states: "A conceptual framework makes 
explicit how you structure your thinking about your research topic and the process 
undertaken" 149(p34). The following context discusses the processes used in tackling the 
research question. A knowledge base model was designed to organise and to represent a 
subset of bio-health information for cystic fibrosis. A CCR-based EHR system 
prototype was built to simulate the clinical record system and to make the content and 
structure of the knowledge base accessible. Hypothetical test records were used to show 
personalised bio-health information through the EHR prototype.
Figure 3-1 presents the conceptual framework, which relates to the knowledge base 
prototype construction and the intended connection via the record interface. This
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represents an overview of the method for tackling the research question. The detailed 
processes, i.e. the ontology construction methods and the EHR prototype and 
connection are dealt with in Chapter 4 and 5 respectively.
i
Key
Green rectangle: knowledge base prototype (KB); red rectangle: EHR system prototype; the overlap part 
is connection between KB and EHR.
Figure 3-1 Overview of the conceptual framework showing the physical artefacts
The general research approach is based on two literature reviews of 1) existing research 
in bio-health informatics and 2) the testing of a selection of electronic tools and 
resources. The latter review focused on selecting and comparing candidate electronic 
knowledge sources for bio-health information and cystic fibrosis. This was published 
and has been included in the literature review.
3.3 Research strategy
According to Gates' definition of 'research strategy', which states "A strategy is your 
overall approach to answering your research question" I49(p35), this is a design and 
creation 149(p!08) research study. "The design and creation research strategy focuses on 
developing new IT products, also called artefacts, including constructs, models, 
methods and instantiations" I49(p 108). The data collection method in this research has 
involved using documents which include published journal papers, conference papers, 
textbooks, and online resources.
In this research the major work has been to create logical specifications and then to 
construct the designed physical artefacts according to the logical specifications. The
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physical artefacts construction process gives feedback to the logical specifications. 
Figure 3-2 shows the abstract and concrete parts of the work.
Abstract:
  Logical Specifications 
created
  Ontology for 
cystic fibrosis 
(exemplar)
  Subset of CCR 
specification
  Linkage via 
bridging/filter 
points
c>
Concrete:
  Physical artefacts
designed/ implemented
  Knowledge base
(Protege-OWL) , 
/  EHR prototype
(MS VB, Access)
  Connection &
interface of EHR
Prototype
Figure 3- 2 Overview of the research strategy
(Note: specifications on the left side guide construction of physical artefacts on the right side 
and construction provides feedback to improve specifications)
Three major specifications ha\e been created: 1) an ontology specification for cxstic 
fibrosis. which is used to guide the knowledge base construction; 2) a subset of the CCR 
specification, which is used to build the EHR prototype; 3) linkages between biological 
and health information, \\hich are used in the connection and interface of the EHR 
prototype.
The specifications are embodied in a complete prototype, which comprises the three 
physical artefacts from Figure 3-2. Meanwhile, the physical artefacts are used to sho\\ 
what the research is, to show what can be achieved in this research, to help 
communicate with peer researchers and to give feedback to improve the specifications.
3.4 Description of the research solutions 
3.4.1 Detailed research solutions
The solutions for these objectives included 150.
1) A knowledge base prototype designed to hold and to represent biological and 
health related information for persons having the condition, cystic fibrosis 1 " 
The relationships which are represented are those which have been shown by 
domain research to exhibit significantly higher than normal level probability of 
manifestation. For example, an adolescent patient with cystic fibrosis has a
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higher than normal probability of delayed puberty. Thus, these relationships 
provide 'candidate' observations concerning the type of patients not 
necessarily the facts about the individual patient. The major challenge here is to 
devise a methodology and structure for the systematic representation of 
bio-health research findings into an ontology based on the Protege-OWL tool. 
These methods provide a paradigm which may be used for the creation of other 
bio-health ontologies. It needs to be noted that the requirements for integrating 
the bio-health information into the EHR necessitate extending what one might 
recognise as a conventional domain ontology by the addition of EHR structural 
features into the ontology.
2) To build a simulated clinical system i.e. an Electronic Health Record (EHR)
system prototype. This is a conventional EHR system based upon the
Continuity of Care Record (CCR) standards but enhanced as follows:
f An extra sub-division of investigations has been added so as to be able to
capture mutation results, e.g. sequence variations. 
r A facility is provided whereby, given the accumulated demographic and
clinical information concerning the individual patient, candidate facts (e.g.
signs, results, mutations) are suggested as possible investigations to be
considered, i.e. the supplied information from the ontology is personalised
according to the patient's age, sex, ethnicity etc.
3) To provide an interface allowing the transfer of information from the 
Protege-OWL knowledge base into the EHR. This presented one of the most 
technically difficult aspects of the study. Protege-OWL is very powerful in the 
creation of ontologies, but lacks tools for integration with other systems. The 
solution was to design and build a tool which took a complete download of a 
version of the ontology. This was analysed and used to populate a conventional 
database which could then be used by the EHR application. These methods are 
extensible, i.e. they may be applicable across other clinical and biological 
domains (and beyond).
3.4.2 Reasons for these solutions
Each solution step was appropriate, given the PhD constraints and available resources. 
The reasons for choosing these solutions included:
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> Cystic fibrosis is a monogenetic disease with a relative stable knowledge body; 
the life expectancy of cystic fibrosis patients increased from 1 year in 1960 to a 
median survival age of about 40 years by 2002. It is increasingly common for 
patients with this condition to be treated on an ongoing basis by non-specialist 
doctors, such as GPs, rather than more specialist clinics. This is partly the reason 
GPs are considered as an example set of target users.
r Organising bio-health information as an ontology makes it shamble, reusable and 
extensible. These attributes offer advantages for a framework which must deal 
with uncertain and changing bio-health information over time.
f The EHR is increasingly used in clinical settings to manage many types of 
health-related information; a simulated prototype is a good choice for proof of 
concept. Since the nature of the biological information is new compared with 
demographic information and clinical information in the clinical record, there is a 
need to design and build an "enhanced" system based on international standards 
which will include biological information.
f Following a standards-based approach has the potential to provide a common 
underlying model for many EHR systems, irrespective of implementation. This 
should help future communication between systems.
r Offering customised bio-health information is important to avoid increasing the 
information overload faced by doctors, and also meets the demand for more 
personalised health care. Currently sequence variations are used as biological 
information examples.
3.5 Research evaluation
According to Oates, "criteria for evaluation of an IT artefact include functionality, 
completeness, consistency, accuracy, performance, reliability, usability, accessibility, 
aesthetics, entertainment, fit with organization and so on" 149(Pl 15).
The outputs of this design and creation research are a combination of models and their 
instantiation. More specifically, the models are the ontological model and the EHR 
model; the instantiations are the knowledge base prototype, the EHR prototype and the 
connection between the two.
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For this research, functionality and accessibility were selected to evaluate the work. 
Other evaluation criteria mentioned above are related to the final product, however the 
innovations in this research are: 1) biological information has been included; 2) formal 
and structured biological and health information are organised into an ontology; 3) 
bio-health information from the ontology can be personalised through the EHR interface. 
This research at the current stage aims to prove feasibility, and to demonstrate that 
innovations can be achieved, rather than to produce a final commercial product. The 
evaluation is therefore into utility evaluation, and further research should consider 
evaluation related to usability.
There are three major parts that need to be evaluated: logical structure of the ontology; 
accessibility of the knowledge base through an EHR prototype; and functionality of the 
connection including personalised information. The evaluation is objective-based
I o
evaluation (p296) and will be of the research objectives set out beforehand. A detailed 
description can be found in Chapter 5 (5.7).
3.6 Requirements and functions of the physical artefacts
3.6.1 Requirements of the knowledge base
Several requirements were imposed on the bio-health knowledge base (2.2.3) JJ ~"°:
  To have the potential to share, reuse and expand knowledge.
  To be compatible with major existing knowledge or terminology tools.
  To have the potential to map onto future EHR systems, with respect to both 
basic concepts and final knowledge facts as they pertain to biological and 
health information.
These factors influenced the design regarding technology, content, structure and 
methods of construction for the knowledge base prototype.
3.6.2 Contents of the knowledge base
Whereas the trigger parameters provide an important bridging function, it is, of course 
necessary to have sufficient content and structure to populate the model. This section 
outlines the scope of the knowledge base, including the content and structures in the 
current version of the knowledge base model, and shows the potential characteristics
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intended for future versions (Table 3-1). The parameters in the following table guided 
the construction, and the content was based on consideration of how the knowledge 
base prototype would be used. The whole construction process is an interactive process, 
which helped to make the scope and granularity clear. The Table 3-1, therefore, is a 
combination of content from before and after construction. More specific details, such 
as reasons for choosing the content and design decisions, are presented in Chapter 4.
Table 3- 1 Overview of knowledge base prototype content and structure
Current Future
Biological information
Nucleotide mutation
Amino acid change
Protein structure
Gene mutation location
Gene/protein mutation dissection
+
+
+
+
X
Health information
Demographic data (age, sex, ethnicity etc.)
Symptoms
Diagnostic tests/diagnosis
Treatment facts
Prognosis
Prevention
+
+
+
H
 : 
Structure
Basic concepts
Combined concepts
Final knowledge facts
EHR data representation structure
-*-
+
+
+
3.6.3 Requirements of the EHR system prototype
There are many EHR systems in place and these systems are very different to each other 
even within the same areas of service. For example secondary and primary care 
systems are often very different both in function and in terms of the degree of clinical 
focus. A major requirement of the research is to seek a potentially generic solution that 
can be applied to multiple implementations and reduce the complexity of new 
innovations. For this reason a standards-based solution is investigated.
The EHR system prototype should provide a series of patient-centric snapshots, which 
can be used to simulate a longitudinal record. The prototype should have the capability 
of editing, displaying and storing bio-health data and have accessed to the background
knowledge 107, 152
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The knowledge base prototype plays a role as a 'plug-in' to the EHR system prototype. 
Individual patients' parameters trigger default displays. Parameters such as age, sex, 
ethnicity and specific bio-health characteristics act as a "bridge" between the EHR 
system prototype and the knowledge base. The displayed results can be modified by 
changing the patient's parameters.
There are several reasons for choosing this particular set of triggers:
1) The EHR system is the principal communication interface, therefore the data items 
common to such systems become the primary candidates; all the chosen triggers are 
classic demographic data for many if not all EHR systems.
2) Cystic fibrosis is one of the most heavily researched genetic conditions, and it 
became clear that these particular parameters were significant to the conditions 
manifestation and impact the treatment delivered.
3) Finally, some of these parameters are believed to be important to many genetic 
conditions, and this supports the intention of providing a generic solution.
3.6.4 Functions for the EHR system prototype
The EHR system prototype is used to simulate the clinical system the proposed target 
users will be non-specialist doctors, for example the general practitioner (GP). Given 
the increasingly widening role of primary care, and the increasing longevity of the 
cystic fibrosis patient. GPs are envisaged as the example target in the simulated scenario. 
This does not preclude the extension of the user group to other clinicians or even to 
patients in the future.
There are of course many different doctor-patient situations. This research has been 
simplified by considering only patients with an existing diagnosis of cystic fibrosis. 
This is not a diagnosis system. However, an individual without the condition will also 
have to be considered, in order to show how the interface works without a cystic 
fibrosis presentation. The knowledge base output is displayed as a reference or reminder 
through the EHR interface; the recommendation function may be considered in future.
In addition to the knowledge base prototype, the EHR system prototype will comprise 
additional modules and functionality. Within this research the focus is on the ideal 
situation in the patient-doctor consultation. If the current target functions can be
Chapter 3 Research methodology: an overview -46-
achieved successfully, then more complex situations may be considered in the future.
Table 3-2 is a summary of the EHR system prototype's application environment and the 
major functions which have been included, along with indications for future work.
Table 3- 2 Overview of EHR system prototype- application environment and functions
Current Future
Target users
Non-specialist doctor (e.g. GP)
Patients/& Other clinical professionals
+
Patient's condition
With CF diagnosis
Without CF diagnosis
+
+
EHR system prototype
Edit patients' demographic & bio-health data
Snapshot patients' records
Longitudinal patients' records
+
+
+
Knowledge base display
Reference knowledge facts
Reminder
Recommendation
+
+
Communication
With patient's parameters
With other reference tools
+
  : 
3.7 Why choose CCR?
The CCR architecture is a standard specification developed by the American Society for
Testing and Materials (ASTM) 12
"The CCR is a core data set of the most relevant administrative, demographic, and 
clinical information facts about a patient's healthcare. covering one or more healthcare 
encounters" 12
The CCR standard is increasingly used in the US. The major characteristic of the CCR 
is "continuity", which will ultimately require all of a patient's record of healthcare to be 
documented. This concept is essential for safe care of an individual over time and will 
be managed by an EHR system. However, such a record will have fine-grained 
individual data, whereas the facts derived from the knowledge base, OntoKBCF, are 
more general, covering generic attributes of the population rather than individual traits.
The increasing importance of CCR and its increasing popularity in the US (currently in
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America with a very low level of physician EHR adoption rate, only 17% of physicians 
reported using a fully functional or basic system 153 ) suggest that the CCR standard will 
influence many implementations in the future. Furthermore, the decision to create a 
prototype based on CCR is supported by the fact that it has a dataset which is in some 
respects close to my requirements for interfacing diversely sourced data. The design 
which has been utilised resembles Healthframe's, which was one of the first commercial 
systems to be based on the CCR. CCR was adopted since, like EN 13606, it is based on 
a formal standard. Unlike EN 13606, however, it is a simpler standard with ready-made 
headings to structure content.
3.8 Development environments
Protege-OWL 3.3.1 has been used for the knowledge base prototype construction. This 
is a popular and credible knowledge management tool. Protege-OWL 3.3.1 originated at 
Stanford University and has been extended at Manchester University. The developers 
claimed there were approximately about 100000 users currently registered, including 
many international users" The active Protege community has contributed main 
plug-ins and ontologies. There are two platforms: Protege-frame and Protege-OWL. The 
Protege-OWL platform supports OWL. The Protege-OWL editor is used as a tool for 
OWL ontology construction, is freely available and is a mature and reliable tool for 
knowledge base construction
Microsoft Visual Basic (.NET 2003) and Access 2003 were used as the development 
tools for the EHR system prototype and to effect the connection with the knowledge 
base prototype.
3.9 Summary
In this chapter the research methodology has been outlined and the overview of the 
research approach explained. The functional requirements of the proposed applications, 
the general scope and the boundaries of the knowledge base prototype and EHR 
prototype system, the tools and the development environment have also been introduced.
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4.1 Overview
The research aim requires the construction of the knowledge base prototype, its 
implementation using an ontology web language tool, and delivery to the target 
audience of the content of the knowledge base prototype in a context-sensitive manner. 
The knowledge base prototype is based on an ontology and is named OntoKBCF to 
reflect its basis (ontology), its purpose (knowledge base) and its application (cystic 
fibrosis). This chapter concentrates on the design and construction of the ontology 
including 1) a concise rationale as to why an ontology-based knowledge base prototype 
is appropriate to offer bio-health information; 2) construction approach; 3) design 
decisions; 4) examples and 5) discussion. It explains the meaning of 'knowledge base 
prototype' and 'knowledge base model' to clarify these terms when they are used.
Terminology notes:
  'knowledge base prototype" is used when a specific reference is made to 
OntoKBCF, while its logical specification uses 'knowledge base model';
  'knowledge base' is used generally to refer to a structure which stores, organises 
and retrieves computerised domain knowledge, including facts and rules, with 
ontology schema and instances;
  'class' and 'concept' are used to refer to an OWL class in OntoKBCF;
  'basic concept', 'combined concept", 'complex concept', 'supporting 
concept", "final knowledge fact" and 'knowledge fact" are terms used specifically 
in OntoKBCF construction; their meaning and relationships are listed in Table 4-1 
and shown in Figure 4-1;
  'concept" is used for class in the UMLS following its original usage;
  'term' is used for class in GO and it also follows its original use.
4.2 Introduction
The long term goal of the research is to provide different types of knowledge seamlessly 
in a clinical setting. The ontology-based knowledge base was chosen to provide domain 
knowledge facts (in this example about cystic fibrosis), in order to organise bio-health 
information. The knowledge base prototype was then embedded into an EHR system
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prototype at a later stage of the research. Semantic web technology is the major 
technology that has been used in the knowledge base prototype construction.
Table 4- 1 Major terms used in construction of OntoKBCF
Name
Basic 
concept
Combined 
concept
Complex 
concept
Supporting 
concept
Final 
knowledge 
fact
Knowledge 
fact
Explanation & example
The atomic concept from UMLS, GO or domain 
knowledge, such as Gly, which is an amino acid 
Glycine
Combination of basic concepts, such as Gly542, which 
is Gly's location- 542 in the CFTR amino acid chain
A subset of combined concept explained through the 
EHR interface, such as Patient_CF_with_Gly542X, 
which is a type of CF patient with a type of mutation 
Gly542X
Consists of basic concepts and combined concepts. 
Used in explaining the complex concept.
A domain statement, represented in OntoKBCF 
through combination of basic concepts or combined 
concepts with properties and logic relationships, such 
as property and description of 
Patient CF with Gly542X
Any above concept is a subset of this one. It includes 
1) hierarchy of concepts, both basic and combined 
concepts; 2) property description of the concept.
Reference section
HI. 3 in Appendix 
H
HI. 3 in Appendix 
H
HI. 4 in Appendix 
H
Figure H2 in 
Appendix H
Complex concept 
Combined concept
Figure 4- 1 Relationships of terms used in construction of OntoKBCF 
(Note: final knowledge facts are supporting concept with description of properties)
The semantic web is the evolving direction of the current world wide web82 . In contrast 
to the conventional web, which considers only machine and human processable
89documents, the semantic web formally considers the data within documents . Semantic 
web technology is different from natural language processing and machine learning in 
artificial intelligence82 . Semantic web technology is not to do with "real understanding" 
of content by machines. Rather, semantic web technology makes productive use of the 
"labels" associated with data elements, thus allowing machines to process the data more
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precisely.
There are therefore two important facets related to semantic web technology: i.e., 
common formats and language. Common formats are useful for data sharing, data reuse 
and data exchange; while language is used for representing and relating to real objects90 . 
Other characteristics associated with the semantic web include: data interoperability, 
machine processability, and semantic understandability.
An ontology is an important infrastructure and tool in the semantic web world. It shares 
similar characteristics with the semantic web in that it provides the basis for a "common 
understanding of a domain"8:> (p5). The use of an ontology provides opportunities to 
improve knowledge management83 (p5).
The characteristics of an ontology include:
  universal format; this is offered by a uniform resource identifier (UR1);
  expression capability which is achieved by representing data related to real 
objects;
  extensibility, which can be achieved by using standard resources or tools.
These three characteristics are appropriate for delivering bio-health information in a 
clinical setting. Consequently, the ontology-based knowledge base was selected to 
construct the knowledge resource.
4.3 Scope
The first task in constructing a knowledge base is to define its boundary which makes 
the scope clear' 34 There are several considerations in deciding the prototype's boundary. 
First it is necessary to consider the intended beneficiaries. Since the knowledge base 
prototype is intended to become a module to an EHR system prototype, the principle 
target users are doctors and it is therefore important to consider doctors' information 
needs.
4.3.1 Doctors' information needs
There are several ways to learn about the doctors' information needs including 
surveys' 33 , questionnaires' 36 , interviews' 57, observation 158 , and system log file analysis
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etc - In this study the information needs were identified from the literature for the 
purpose of structuring the research prototype. I used PubMed and IS1 Web of 
Knowledge as main tools. In PubMed I combined MeSH terms (such as information 
service/utilization, V is used in PubMed to associate MeSH heading and sub-heading) 
and free texts (such as clinic*, information demand*, requirement*, need*, the star 
symbol is used as a wildcard in PubMed). The MeSH terms maybe restricted to "major 
MeSH topic" or to "Title" according to the retrieved records. In ISI Web of Knowledge 
the same free texts as in PubMed were used and the free texts were restricted to "Topic" 
or "Title" The retrieved papers have been reviewed in order to judge if they were 
relevant.
Although 1 was unable to find research specifically focused on doctors' information 
needs on cystic fibrosis, it would not be unreasonable to assume there are common 
needs across different specialties. According to research by Lappa ls6 , Smith 79 and Seol47 , 
the most common clinical question relates to treatment. Davies 160 conducted a 
systematic review of doctors* information-seeking behaviour; information need was the 
first theme of that paper. The paper concluded that "the top categories of information 
need are treatment or therapy" "" . Arroll and colleagues' reported similar results, 
noting that questions about treatment were the most common questions asked by family 
physicians; with respect to content the most often raised question pertained to medical 
fact, followed by medical opinion and non-medical reminders
Given the purpose of this research, the '"treatment" information need" and "medical 
facts" became the two major factors in the content selection for the knowledge base.
4.3.2 Considerations on selection of sources and tools
Apart from information needs, there are several other important factors that need to be 
considered in offering a knowledge resource in a clinical setting:
  available, reliable and valid knowledge sources are required;
  matching points need to be considered between the knowledge base prototype and 
the EHR system. Note: this includes matching points for both biological 
information and health information;
  compatibility with other major terminology tools at the terminology level will be
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required. 
4.3.3 Knowledge base prototype scope
In considering the scope, and in particular what is inside the boundary, attention is now 
turned to the knowledge base prototype's content. The two main content parts in the 
knowledge base prototype are the domain knowledge and the EHR structure. This 
section focuses on domain knowledge, while the EHR structure will be introduced in 
section 4.10.
There are four parts of the domain knowledge included in the current knowledge base. 
These are:
1) gene therapy with regard to cystic fibrosis' 43 ' 14h ;
2) time related cystic fibrosis descriptions 119 ;
3) cystic fibrosis data related to the Cochrane review conclusion 129 ;
4) the most common CFTR mutations and their characteristics 120 l62
Fine detail of this content is given in Appendices B to F. Three examples in section 4.9.2. 
4.9.3 and 4.9.4 show how the domain content is organised within OntoKBCF For 
information concerning the structure and nomenclature of nucleotides, which are crucial 
to much of the biological information within OntoKBCF, the reader is referred to 
Appendix G, while the genetic vocabulary involved in OntoKBCF is given in Appendix 
J.
The feasibility research question required the construction of a knowledge base 
'prototype', rather than a complete and comprehensive commercial product. 
Consequently, selected Cochrane review topics (such as airway clearance techniques for 
cystic fibrosis patients have short-term effects in terms of increasing mucus transport) 
were chosen as the starting clinical requirements, with an emphasis upon treatment. In 
addition, time-oriented cystic fibrosis descriptions (such as for adult male cystic fibrosis 
patients, manifestations include delayed puberty, sterility and bronchiectasis) were also 
included. Cochrane review conclusions, the most common CFTR mutations and their 
characteristics, and time-orientated descriptions have enabled the knowledge base 
prototype to be used in the prototype EHR system, and have also provided matching
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points with the data typically found within EHR records. In the prototype, patients' age, 
sex, ethnicity and clinical manifestation are taken as the matching points between the 
knowledge base prototype and the prototype EHR system.
As 'treatment' is the most common clinical focus and the research aim was to provide 
bio-health information for doctors, gene therapy became a natural join point.
With regards to factor (4), i.e. mutations, the amount of information required to be 
entered into the knowledge base is significantly reduced because of the intended clinical 
application. For although there are about 1600 CFTR mutations reported 126 , 
approximately 70% of patient conditions can be explained by the most common CFTR 
mutations 1 ' 0 ' l62 It is the mutated gene together with environmental factors that 
determines the manifestation of the disease. The most common CFTR mutations are 
included in the knowledge base prototype, in order to provide a potential foundation for 
future understanding of the precise mechanism between gene and disease. However, 
only a subset of the content in Appendices E and F has been represented in the 
knowledge base prototype. The criteria for choosing the mutational representation 
samples included are as follows:
1) For mutation among the same ethnicity group, only the higher prevalence type 
was selected; for example among Spanish cystic fibrosis patients, there are two 
types of mutation that are quite common, Gly542X and 2789+5G->A; 
Gly542X was represented because it has the higher prevalence.
2) Mutation types which overlapped as shown in Appendices E and F, were 
included.
3) The most common types were selected irrespective of other considerations, 
such as [Delta] Phe508. Although this type belongs to no particular ethnicity 
group, the prevalence of it is approximately 66%.
4) Those mutation types which were common in some ethnicity groups and were 
known to have clinical characteristics.
Only the uncontested knowledge facts about cystic fibrosis were represented in the 
knowledge base prototype. The knowledge facts may be used to answer questions about 
"what", such as:
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  what is Gly542X?
  what is the hierarchy of cystic fibrosis?
Disease mechanisms, such as the way the CFTR gene mutation affects CFTR protein 
function, may be used to answer questions about "how"; reasons or explanation, 
whereas facts concerned with the relationship between a cystic fibrosis patient and 
respiratory infection, may be used to answer questions about "why".
Fact content about "what" was included and content about "how" and "why" were 
generally excluded in the current version. In part this is because some of the causal 
detail is contested, but also because the prototype is required only to show how 
bio-health information could be matched consistently, rather than being comprehensive.
Considering the requirements for the knowledge base prototype meant making 
pragmatic decisions concerning scope. In the light of this, the "what" knowledge facts 
were considered to be sufficient to prove the concept. More complex knowledge 
representation has been left for future work.
4.4 Bio-health resources and their role in the ontology construction
There are three interrelated sources: basic concepts, combined concepts and final 
knowledge facts in OntoKBCF. The review work suggested that we construct a specific 
knowledge base prototype about bio-health information on cystic fibrosis and base it on 
existing work. At the terminology level, most of the basic concepts and their structure 
were selected from UMLS57 (mostly using the Medical Subject Headings [MeSH]), 
their semantic types and GO56 . Most combined concepts were derived from combining 
basic concepts according to the final knowledge fact. Both basic concepts and combined 
concepts are supporting concepts. The final knowledge facts include both health and 
biological content. The health information specific part was drawn mainly from The 
Cochrane library 129 - i.e., knowledge about cystic fibrosis treatment, while 
time-oriented descriptions of cystic fibrosis were from Harris and Super's book" 9 . The 
biological part, i.e. the most common CFTR mutations, were from Orenstein' 20, 
Zielenski 162 and the Cystic Fibrosis Mutation Database (CFMDB) 126 Other resources 
include several papers 143 ' l46 ' 162 , web sites (such as cystic fibrosis charities' 3 '' l32 and 
cystic fibrosis descriptions from Mayo Clinic service'"4 and Merck Manual' 11 ) and
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Nomenclature for the Description of Sequence Variations 163 164 
4.4.1 Methods to obtain domain knowledge
The major methods used in obtaining domain knowledge in the OntoKBCF construction 
include 1) self directed learning, including on line education material, literature and 
cystic fibrosis societies,, 2) consultation with a human genetics expert and 3) discussion 
with supervisors and peer students. And the whole process (to learn, to understand, to 
consult, to discuss, to construct and to revise) is iterative.
The author of OntoKBCF has a Bachelor's degree of Medicine, and has been trained 
systematically under medical education. This is an important foundation from which to 
understand the health aspects of cystic fibrosis. Biochemistry and Cell Biology were 
two major basic medical subjects in her medical education. In preparation for the 
research, she learned Molecular Biology by herself from a number of resources, 
including text books, online training and tutorials. These three subjects are important to 
understand the biological aspects of cystic fibrosis.
The human genetics' expert \\as consulted about molecular genetics during the 
construction of OntoKBCF. The expert has a MSc and a PhD in Human Genetics and 
has worked for a Molecular Biology & Genetics laboratory in John Hopkins University 
for three years. Her role was to explain and to confirm any biological confusion that the 
author met during the construction.'to
4.5 Rationale for the approach
Note: Much of this section relates to the structure and nomenclature of nucleotides and 
amino acids. For those unclear on this subject it is suggested that Appendix G is 
consulted.
The general idea of the hierarchy construction has to do with external knowledge fact 
analysis, using a process of dissection. Reconstruction work starts from basic concepts, 
and then the basic concept is modified step by step until the basic concept is turned into 
a meaningful composite (a combined concept some combined concepts are complex 
concepts), representing a subject for the final knowledge fact within the prototype. For 
example, if a patient with Gly542X mutation needs to be represented, it takes several
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steps to achieve:
  'Gly' stands for Glycine, a type of amino acid; another abbreviation name is 'G\ 
however the one letter abbreviation name is not used in OntoKBCF since it can 
cause confusion with one of the nucleotides 'G\ This is a basic concept.
  'X' is the nonsense codon (cross reference Appendix J), which terminates the 
translation; this is a basic concept.
  'Gly542' is defined as an amino acid location in the human CFTR protein; this is 
a combined concept.
  'Gly542X' is defined as an amino acid substitution in human CFTR protein; this 
is a combined concept.
  'Pcitient_CF_with_Gly542X' is defined as a cystic fibrosis patient with the amino 
acid change. This is a combined concept and also a complex concept, which will 
be explained through the EHR interface (further details are provided in section 
4.10.2 and Table 4-15).
Every later concept uses the former ones in its representation. The final concept may be 
used as the subject to describe characteristics for patients with this t\pe of amino acid 
change. When the user uses the final knowledge fact, the former basic concepts can all 
be accessed b\ dissecting the more complex and specific concepts.
Figure 4-2 represents the general ideas behind analysis and construction of OntoKBCF.
A: Gly
B: Gly542
C:GK542X
D: Patient CF with GK542X
Figure 4- 2 General analysis and construction ideas for OntoKBCF
Figure 4-3 is a graphical interpretation of knowledge fact represented in OntoKBCF. In 
this case the subject is a female adolescent cystic fibrosis patient, which is the
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intersection of three bigger ellipses (Patient with CF, Adolescent, and Female). This 
intersection part represents all possible properties related to female adolescent cystic 
fibrosis patients. The knowledge facts (the representation of the subject) describing this 
subject in OntoKBCF are a subset of the intersection- i.e. the pattern-filled ellipse.
/*«.
Patient CF \
I \
s/ 
.'*' x
''  -...... Pe'male" - _ .
Figure 4- 3 Representation for adolescent female cystic fibrosis patient in OntoKBCF
[Note: the filled ellipse represented in OntoKBCF, compared with the whole set of properties 
for the subject (intersection of three bigger ellipses means all the possible properties related to 
an adolescent female CF patient)]
4.6 Design decisions 
4.6.1 General design issues
To construct such a knowledge base would be an endless process without a realistic aim, 
a clear scope 154 and the practical design decisions. The former two have been introduced 
previously; some of the decisions taken in the construction of OntoKBCF will be 
introduced in this section.
Although the subject of both the knowledge base prototype and the EHR system 
prototype, was 'a human being', to create the potential for wider use some of the classes 
were specifically named, such as 'Human_CFTR_gene > and 
iHuman_CFTR_gene_exon\ to differentiate them from any additional classes that may 
concern other animals.
There are 22 types of amino acids, so there are many more possibilities for amino acid 
change compared with nucleotide mutation; only the changes that fell within the scope 
of the work were included (detail in section 4.9.5). In contrast, as there are 8 types of 
nucleotides which consist of DNA and RNA, with a smaller number of possible
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mutations, the complete set of possible nucleotide mutations in coding DNA (cDNA) 
for deletion, insertion, transversion and transition were included (detail in section 4.9.5).
In the prototype the final expression of nucleotide mutation can be distinguished from 
amino acid change as 1) their labels contained 'minus' or 'plus', or 'Ins' or 'Del' (such 
as 'AA2183_minus' or i G621_plus_l', '061394' or '/«s5P05'); 2) a three letter 
abbreviation name was used for amino acid. 'Minus' and 'plus' were used to represent 
nucleotide position, and examples will be given in the following paragraph. 'Ins' was 
used for nucleotide insertion and 'Del' is used for nucleotide deletion. In theory, not all 
nucleotide mutations have to be labelled with one of these 4 values - however, no such 
example has been found in the construction of OntoKBCF 163' 165 .
4.6.2 Decisions relating to the use of Protege-OWL
The Protege-OWL tool provides a number of features and imposes certain restrictions 
which impact upon the representation of the bio-health information in the ontology. 
This short section describes the decisions taken with regards to the use of this tool.
Protege-OWL 3.3.1 will not accept a class name that starts with a number, and will not 
accept '>' or '+' symbols as part of the class name; these are necessary symbols for 
nomenclature of mutation 164 ' 165 . '>' generally indicates a substitution of nucleotide at 
the DNA level (e.g. c.76A>T means the nucleotide number is 76 in the cDNA sequence 
and substitution is from A to T) or RNA level (e.g. r.76a>u means the nucleotide number 
is 76 in RNA sequence and substitution is from A to U) 163 . In OntoKBCF CFTR 
mutations are related only to cDNA and protein levels.
The symbols '+' or '-' indicate the nucleotide position at the beginning of the intron (+) 
or at the end of the intron (-). This would be represented as 'plus' and 'minus' in 
OntoKBCF for nucleotide substitutions. For example, in the following context I will 
explain the meaning of 'G621_plus_l_T': 621 is the last nucleotide for the preceding 
exon, G is the first nucleotide for the following intron and G is substituted by T. 
Therefore, in OntoKBCF this would be represented as G621_plus_l_T. Amino acid 
substitution is handled in a similar way. 'GlySSlAsp ' means that for amino acid number 
551, glycine changes to aspartate.
In the prototype "Del_A and i !ns_A" were used to represent nucleotide deletion or
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insertion. The name 'Ins3905_T means insertion in nucleotides 3905 (number) of T.
The following basic name rules are used in OntoKBCF: 1) for amino acid change (i.e. 
protein level), a three letter abbreviation name was used; 2) for cDNA level nucleotide 
change, a one letter name (such as 'A', T', 'C', 'G') was used; 3) a mutation name 
which has strictly followed the nomenclature recommendation 163 ' 165 has been kept in 
the "annotation" part for reference; 4) there were only cDNA and protein level 
descriptions of CFTR mutation name, not including RNA level description.
Although the nomenclature recommendation 163 ' 165 about mutation has not been 
followed strictly, it is acceptable considering the aim of the prototype which is to 
attempt to use the prototype to explain explicitly the meaning of mutation, instead of 
using a reference dictionary to map all possible mutations. The principle of the 
recommendation is upheld while accommodating the naming rules of the tool- 
Protege-OWL 3.3.1. Another reason for not following the nomenclature 
recommendation strictly is related to the paper162 , book120 and CFMDB 126 used as the 
knowledge resources and some mutation names follow the domain knowledge 
resources.
For property restrictions in the OWL representation, only someValuesFrom was used as 
the property restriction (appearing as 'some' in the text); it would be inappropriate to 
use allValuesFrom (appearing as 'only" in the text), because for 'all properties', it 
cannot be guaranteed that their value classes are fully specified and mutually exclusive 
and exhaustive. It is wiser to use "some" in most representations to leave space for 
future efforts to complete the description. For example: from Figure H2 (Appendix H), 
cystic fibrosis patient with Gly542X, the subject had the mutation property "some" 
Gly542X because it is possible that Gly542X is not the only mutation property for this 
type of patient.
According to Horridge's OWL tutorial 166 , the "Domain" and "Range" conditions in the 
"Property" tab of the Protege-OWL interface, are not used as constraints. They are used 
for class inference. These properties are outside of the scope of this project and 
consequently the "Domain" and "Range" widgets were left blank for all properties.
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4.7 General construction procedures - domain knowledge structure
The general construction procedures, which were mainly influenced by Rector and 
colleagues' documents on Ontology Engineering 154 , include:
  to look for doctors' information needs;
  to decide the knowledge base prototype's scope, main axes and granularity;
  to analyze and dissect selected knowledge facts into basic knowledge units;
  to list all involved basic knowledge units and relevant vocabularies (this step is 
only used if relevant concepts in UMLS or GO cannot be found);
  to select proper concepts/terms used in the domain according to definitions 
from UMLS and GO;
  to organise, create and arrange the concepts into a proper structure through an 
ontology editing tool, along with the original identities and alternative 
vocabularies;
  to represent the knowledge facts by the creation of proper representations and 
combination with properties by logic symbols;
  to discuss with other experts and iterate the whole construction process until 
the terms' positions become stable.
Figure 4-4 shows the general procedures of the knowledge base prototype construction.
Information 
need =^ KB scope, axes, granularity =$ Dissection into basic concepts H Relevant vocabularies
n
Creation and 
combination
Organisation
and 
arrangement
Extract target
concepts from
UMLS or GO
^~  
_-
Figure 4- 4 General procedures of the knowledge base prototype construction
These are the general procedures used in the prototype construction. In the next section 
the main axes and granularity of the knowledge base prototype and the major 
construction principles will be introduced.
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4.8 Knowledge base prototype characteristics
4.8.1 Main axes and granularity
The main axes in the knowledge base prototype are time and problem orientation. The 
time-oriented axis considers how cystic fibrosis may announce itself at different ages of 
the subject. The problem-oriented axis here is totally different from Weeds' 
Problem-Oriented record 107 (plOl). Here the problem-oriented axis is used to organise 
content to answer questions. Theses questions arise from the most common CFTR 
mutations, the Cochrane review conclusions and from questions about gene therapy. 
The entire Cochrane review conclusions about cystic fibrosis were not included. 
According to the Cochrane reviews' conclusion only definite and positive conclusions 
were considered; negative (no solid evidence to support the conclusion) and uncertainly 
(not sufficient evidence to support the conclusion) conclusions were excluded. The 
definite positive conclusions were sufficient for proving the concept at the current stage 
and they are clinically more robust. Negative and uncertainty conclusions can be 
considered for further research.
In OntoKBCF the most fine-grain level for biological information starts at nucleobase. 
which is the most important component for the elementary units (nucleotides) of RNA 
and DNA. On the other hand for health information in OntoKBCF the most fine-grain 
level starts from relatively atomic concepts, such as diarrhea, nausea or coughing.
It is very important to decide the scope and granularity of any knowledge base 
prototype. Knowledge and the splitting of knowledge facts into subunits are 
theoretically endless; at this stage the knowledge base prototype is only required to be 
constructed within the claimed scope.
Major axes are used to organise both basic concepts and combined concepts. The final 
knowledge facts are also organised along the main axes. The major axes integrate the 
knowledge base prototype as without these the knowledge base prototype would be 
fragmented.
4.8.2 Major construction principles
The knowledge base prototype is constructed bottom up 154 , starting from the basic
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concepts, then combining basic concepts and finally representing knowledge facts. 
Dissection is used in analysing knowledge facts, and combination is used in 
construction. The general criterion in the dissection is based on the scope and 
granularity of OntoKBCF; otherwise dissection would be an endless process. Only 
necessary superclass concepts have been chosen rather than a detailed and complete 
subsets of UMLS and GO. Only the properties and constraints within the scope of the 
work are represented in OntoKBCF, rather than a complete and comprehensive 
description for each class.
Most of the hierarchies of basic concepts in the knowledge base prototype follow 
UMLS and GO. Relationships or classes are also added or adjusted if there are no 
proper choices. For example, 'sex_group' was used to connect 'population_group' and 
'female'. The concept 'CFTR gene' in UMLS was adapted to 'Human CFTR gene' in 
OntoKBCF.
'Patient CF' was created together with all its subclasses, i.e.
Patient_CF
Patient_CF_with_ age_group 
Patient_CF_with_amino_acid change 
Patient_CF_with_neonatal_screening_for_cystic fibrosis 
Patient_CF_with_nucleotide_mutation 
Patient_CF_with_therapy
4.9 Knowledge base prototype construction (OntoKBCF)
In this section, and its associated annexes, the construction of the knowledge base 
prototype will be explained in detail by using three pieces of knowledge facts as 
examples, and the organisation of biological concepts will be introduced in detail along 
with the major EHR structure in the prototype. Why and how EHR structure has been 
organised will be introduced in Chapter 5. The subjects of the cystic fibrosis domain 
knowledge description are cystic fibrosis patients.
4.9.1 Overview of the examples
Considering the space limitation, it is not possible to describe how every piece of 
knowledge fact in the knowledge base prototype has been organised. Three examples
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that may be seen as representative of three major parts of the knowledge base prototype 
content (cross reference 4.3.3 for knowledge base prototype scope) will be used. The 
first example is a time-oriented cystic fibrosis description; the second is about 
characteristics for one of the most common CFTR mutations; the third is to do with a 
Cochrane review conclusion. The three examples have relatively comprehensive 
concepts compared with other corresponding knowledge facts. I intend to give readers 
an outline of how to organise the domain part of knowledge facts through the three 
examples.
Representation font rules used in these examples (also apply to Appendices H and I)
In the following examples:
  class names are presented in bold (such as Cystic_fibrosis), and the
  classes defined locally within OntoKBCF are represented in bold and italic 
(such as Adolescent_female_CF);
  properties are presented in italic, e.g. has_diagnosis
  restriction terms are presented underlined, e.g. some
Representation examples
Asserted Conditions (which is a widget on the OWL Classes tab in Protege-OWL - 
3.3.1) might appear thus:
has_diagnosis some Cystic_fibrosis
'some' refers to the OWL: 'someValuesFrom'.
The formal OWL representation has two dialects as shown below:
PatientjCF has ^ diagnosis someValuesFrom Cystic_fibrosis (W3C OWL
syntax)
PatientjCF hasjdiagnosis some Cystic fibrosis (Manchester OWL syntax)
The Manchester OWL syntax is used in the following description.
Please note, Example 1 will be presented next in detail; Examples 2 and 3 will only be 
introduced here, but the interested reader can find the full descriptions in the 
Appendices H and I respectively.
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4.9.2 Example 1: time-oriented cystic fibrosis description
A cystic fibrosis patient will have different manifestations at different ages. Age is one 
of the important filters in customising bio-health information in the next stage of 
research. This is an example about manifestations of a female adolescent cystic fibrosis 
patient, and the clinical manifestations include infertility, presence of scanty cervical 
mucus and bronchiectasis.
4.9.2.1 Analyzing and dissecting the knowledge fact into basic concepts
Basic concepts for the first example:
  sex: female;
  age group: adolescent;
  diseases: cystic fibrosis, infertility, respiratory tract diseases- 
bronchiectasis;
  human being group: patient;
  quantitative concept: scanty;
  body substance: cervical mucus
4.9.2.2 Selecting concepts from UMLS
The corresponding concepts from UMLS were chosen according to the basic concepts 
required from 4.9.2.1 and their superclasses and UMLS's definitions. The Tables 4-2 to 
4-5 organise the necessary concepts for example 1 and show their hierarchies from 
UMLS. The hierarchies in the tables are not exhaustive.
In UMLS there was no specific concept for patients in different disease categories. 
There was only one concept named Patient in UMLS.
Table 4- 2 Population group related concepts from UMLS
Conceptual_entity
Group
Population_group
Female
Age_group
Adolescent_age_group
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Table 4- 3 Disease related concepts from UMLS
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Phenomenon_or_process
Pathologic_function
Disease_or_syndrome
Diseases
Cystic_fibrosis
Infertility
Respiratory_tract_diseases
Bronchial diseases
Bronchiectasis
Table 4- 4 Quantitative related concepts from UMLS
Conceptual_entity
Idea_or_concept
Quantitative_concept 
Scanty
Table 4- 5 Body substance related concepts from UMLS
Physic al_object
Substance
Body_substance
Mucous_body_substance
Cervix mucus
4.9.2.3 Creating and organising concepts
When concepts from UMLS were organised in OntoKBCF the original identities and 
alternative vocabularies were kept as comment properties. In this case the original 
identities have a concept unique identifier (CUI), which can be used to track the concept 
over time 167 and may also be used as a "primary key" for further applications. 
Alternative vocabularies are synonyms. Both CUI and synonyms were recorded in the 
"Annotations" widget in the "OWL Classes" tab.
The new class 'Patient_CF was created as a subclass of 'Humanjbeing' to represent 
patients diagnosed with cystic fibrosis. A patient with cystic fibrosis has different 
properties, such as different age groups, different mutations and different therapies, and 
these were the subjects for representation of the chosen knowledge facts.
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The concept 'PatientjCF was split further. The hierarchy for 'Patient_CF is shown in 
Table 4-6. There are several other sibling classes of 'Adolescent_CF', such as: 
lAdult_CF, l Child_CF, 'Infant_CF, and ' Infant_newborn_CF.
The 'Patient_CF was defined as the intersection of (1) Humanjbeing; (2) 
hasjliagnosis some Cystic_fibrosis. Figure 4-5 is the screen shot.
'has_diagnosis' is a property used to describe a human being with a particular disease or 
syndrome.
Table 4- 6 Hierarchy of Adolescent_female_CF in OntoKBCF
Physical_object
Humanjbeing
Patient CF
Patient_ CF_ \vlth_ age_group
Adolescent CF
Adolescent_female_ CF
Asserted Conditions
——.__ NECESSARY & SUFFICIENT
_ Humanjieing
© has_diagnosis some Cysticjibrosis
- NECESSARY
Figure 4- 5 Representation ofPatient_CF
According to the exemplar knowledge fact, female adolescent cystic fibrosis patients 
need to be represented. Subclasses oi'PatientjCF were defined as follows:
'Patient_CF_with_age_group': this class was only an abstract and interim class which 
was used for organising subclasses.
'Adolescent_CF' was an intersection of (1) Patient_CF_with_age_group; (2) 
occur<Jn_age_group some Adolescent_age_group; the hierarchy is shown in Figure 
4-6.
'occur_in_age_group' was a sub property of 'occur'. It was a property to describe 
human beings in different age groups.
<AdolescentJemalejCF' was an intersection of (1) Adolescent_CF; (2) 
occur Jn_sex_group some Female (Figure 4-7).
Xia Jing, Constructing a bio-health knowledge base for access via a standardised EHR prototype____-68-
'occur_in_sexjrroup' was another sub property of 'occur'. It was a property to describe 
a human being in a male or female group.
Asserted Condition:
- NECESS/SRY & SUFFICIENT
• Patient_CF_with_age_group
© occur_in_age_group some Adolescent_agejjroup
€> has_manifestatlon some Deferred_puberty 
© has_manifestatlon some Bronchiectasis
--————----- INHERITED
|(romPatient_CF)[~C~|€> has_«agnosis some Cysttejibrosis
Figure 4- 6 Representation for the AdolescentjCF 
4.9.2.4 Representing the knowledge fact
After organising and rearranging the basic asserted hierarchy, it is now necessary to 
represent the final knowledge fact by combining the classes and properties. The final 
representation of this fact was under the 'Adolescent_Jemale_CF class as a necessary 
condition: hasjnanifestation some (Infertility and Scanty_cervix_mucus). There were 
also inherited descriptions from higher-level classes. Figure 4-7 shows both the 
representation and the hierarchical view of the Adolescent_Jemale_CF.
'hasjnanifestation' was a property to describe the manifestation of a human being's 
diseases or syndromes.
' Scanty_cervix_mucus' was defined as in intersection of (1) Cervix_mucus; (2) 
has_quantitative_property some Scanty (Figure 4-8).
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Figure 4- 7 Whole screenshot for the representation of Adolescent_female_CF
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'has_quantitative_property' is a property used to describe objects with quantitative 
properties such as incomplete or scanty.
Asserted Conditions
™ ——-——— ———————————•• ————-—————————————————————————————————————• NECESSARY & SUFFICIENT
Cervixjnucus 
© has_quantitative_property some Scanty
————• NECESSARY
• Symptoms | E |
Figure 4- 8 Representation of Scanty_cervix_mucus
4.9.3 Example 2: one of the most common CFTR mutations- Gly542X description
This example is presented in full in Appendix H. This is a description of Gly542X, one 
of the most common CFTR gene mutations. Gly542X is located in exon 11 of the CFTR 
gene and has a higher prevalence among Spanish cystic fibrosis patients. Patients with 
Gly542X have pancreatic insufficiency and many of them have meconium ileus.
CFTR mutations are related to ethnicity, which is another important filter used in 
individualising patient information. In this case Gly542X is related to Spanish patients.
The major focus illustrated in this example relates to cystic fibrosis patients with a 
Gly542X and includes an explanation of the mutation and relationships to ethnic 
characteristics and clinical manifestations.
4.9.4 Example 3: A Cochrane review topic description
This example is presented in full in Appendix I. The knowledge fact of Example 3 is: 
intravenous pamidronate treatment increases bone mineral density at axial sites in cystic 
fibrosis patients, although it can cause severe bone pain in participants not receiving 
corticosteroids.
Some Cochrane review conclusions about cystic fibrosis have been included in the 
knowledge base prototype. This is the part which can provide matching points with 
health information (such as symptoms). This health information has also been used in 
individualising patient information.
4.9.5 Overview of the biological hierarchy in OntoKBCF
In this section the structure of biological contents in OntoKBCF will be introduced. 
Since the major content of OntoKBCF is bio-health information on cystic fibrosis, for
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the health part (i.e. phenotype), most of the basic concepts and their hierarchies follow 
UMLS; for the biological part (i.e. genotype), most of the basic biological concepts are 
organised hierarchically according to common biological knowledge as found in the 
literature. There is no tool in the biological field corresponding to UMLS.
In this section I will introduce how the biological contents are organised in OntoKBCF, 
and then will introduce:
1) mutation phenomena through 'Nucleotide_mutation\ 'Amino_acid_change'
and
2) the basic components of nucleotide and protein through 
'Nucleic_acid_nucleoside_or_nucleotide' and 
'Amino_acid_peptide_or_protein'.
4.9.5.1 Major organisation of biological concepts
The major biological concepts in OntoKBCF were organised into three classes:
1) spatial concepts location of amino acids, nucleotides, arm of chromosome, 
gene exon and intron;
2) phenomenon or process- nucleotide mutation and amino acids translation 
change;
3) physical objects- amino acids, nucleotides and patients with different CFTR 
gene mutations.
The major biological facts in OntoKBCF were the location of the most common CFTR 
gene mutations, protein alterations, nucleotide mutations and amino acids changes, 
corresponding patients' characteristics (mapping points) and necessary basic concepts 
used to represent the mutation. The granularity started from amino acids, nucleotides 
and nucleobases.
4.9.5.2 Hierarchy of <Nucleotide_mutation' and 'Amino_acid_change'
In this section gene mutation and amino acids change related concepts and hierarchies 
in OntoKBCF will be introduced. The major hierarchies of <Nucleotide_mutation' and 
'Amino_Acid_change' are shown in Table 4-7.
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Under 'Nucleotide_deletion' all the possible subclasses in cDNA level: Del_ A, C, G, T, 
were listed (Table 4-8). 'Del394_ TT was classified as a subclass of 'Del T and its 
representation is shown in Figure 4-9.
'Nucleotidejnsertion'was quite similar to 'Nucleotide_deletion\ with Ins A, C, G, T,
u as subclasses.
Table 4- 7 Hierarchy of mutation related classes in OntoKBCF
Phenomenon_or_process
Nucleotide mutation
Nucleotide deletion
Nucleotide insertion
Nucleotide transition
Nucleotide tranversion
Amino_acid_change
Amino acid deletion
Amino acid insertion
Amino acid substitution
There are four possible nucleotide transitions, ' A_transition_G ', ' C_1ransition_T\ 
' G_transition_A'', and ' T_transition_C\ Ever> specific transition could be classified 
into one of the subclasses (Table 4-9). Figure 4-10 is an example representation of 
specific transition- 'G1717 minus 1 A'.
Table 4- 8 Hierarchy of Nucleotide_deletion and its subclasses in OntoKBCF
Phenomenon_or_process
Nucleotide muation
Nucleotide deletion
Del A
AA2183 minus G
Del C
Del G
Del T
Del394 TT
Del u
Nucleotide_deletion_in_human_CFTR_gene
AA2183 minus G
Del394 TT
There are eight possible transversions as subclasses of 'Nucleotidejransversion '. Table
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4-10 shows the hierarchy detail and Figure 4-11 shows the representation of a specific 
tranversion-' G621_plus_l_ T'.
The complete hierarchy for 'Amino_acid_change' and its subclasses are shown in 
Table 4-11.
D has_deletion_property some Del_T
D locatejn some Del394
9 locatejn some Human_CFTR_gene_exon_3
It locatejn come Del39S
Asserted Conditions
NECESSARY 6 SUFFICIENT
O Del_T
• Mutationj-esult
@Nucteotide_deletionJn_human_CFTR_gene 
Related J3el394_TT
€> delete some T
€» has_deletion_property some (Del_A or Del_C or Del_G or Del_T or Oel_u)
& occur some Human_CFTR_gene
[fromDel_T][~5~ 
[from Nueleotide_deletion] | c 
[from Nucleotlde_deletionjn Jiumari_CFTR_gene] | E
Figure 4- 9 Representation of Del394_TT'm OntoKBCF
Asserted Condition
Q hasJransSion_property some G_transition_A
© locatejn some G1717_minus_1
Q locatejn some HumanjCFTRjgeneJntron_10
————————————— NECESSARY « SUFFICIENT
) G_transition_A 
) Mutation j-esult
©Nucleobase_transitionjnJiuman_CFTR_gene 
Related_G1717_minus_1 _A
?' hasJransJionjproperty some (A_transition_G or C_transition_T or G_transition_A or T_transHon_C3from Mucleotaase ] 
<gf occur some Human_CFTRjaene [from Nucleobase_transition_in_human_CFTR_gene] 
€J substitutejrom some G [from GJransition.A]
;• substitute with some A [from G Jransition_A]
Figure 4- 10 Representation of G1717_minus_l_A in OntoKBCF
Table 4- 9 Hierarchy of Nucleotide_transition and its subclasses in OntoKBCF
Phenomenon_or_process
Nucleotide_muation
Nudeotidejtransltwn
A transition_G
AA2183_minus_G
C_transition_T
G_transition_A
Gl 71 7_minus_l_A
Nucleotide_transition_in_human_CFTR_gene
AA2183_minus_ G
Gl 71 7_minus_l_A
T transltionjC
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Table 4- 10 Hierarchy of Nucleotidejtransversion and its subclasses in OntoKBCF
Phenomenon_or_process
Nucleotide muation
Nucleotide transversion
General transversion
A transversion C
A transversion T
C transversion A
C transversion G
G transversion C
G transversion T
G621_plus_l_T
T transversion A
T transversion G
Nucleotide_transversion_in_human_CFTR_gene
G621jplus_l_T
4.9.5.3 Hierarchy of 'Amino_acid_peptide_or_protein' and 
'Nucleic_acid_nucleoside_or_nucleotide'
Basic components for amino acid and nucleotide will be introduced in this section. The 
general hierarchies of 'Amino_acid_peptide_or_protein' and 
'Nucleic_acid_nucleoside_or_nucleotide' are shown in Table 4-12. 'Nonsense_codon' 
and 'X" were equivalent classes to represent translation termination codon (Table H-9). 
Under 'Amino_acids' all the amino acids' three letter abbreviation names were listed.
Asserted Condition
0 hasjransversionjjroperty some GJransversionjr
© locatejn some G621 _plusj
© locatejn some Human_CFTR_gene_intron_4
NECESSARY £ SUFFICIENT
© GJransversion_T
• Mutation_result 
@NuclecbaseJransversion_in_human_CFTR_gene
• Related_G621 _plus_1 _T
occur some Human_CFTR_gene 
substtute_from some G 
substitute_w*h some T
[from Nucleobase_transversionJn_human_CFTR_gene] 
[from G_transversion_Tl 
[from G_transversion_T]
Figure 4-11 Representation of G621_plus_l_T in OntoKBCF
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Table 4- 11 Hierarchy of Amino_acid_change and its subclasses in OntoKBCF
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Phenomenon_or_process
Amino_acid_change
Amino acid deletion
Amin o_ acid_deletion_ in_ h uman_ CFTRjprotein
Delta Phe508
Amino acid insertion
Amino acid substitution
Amino_acid_substitution_in_human_CFTR_protein
Arg553X
AsnUOSLys
Gly542X
GlySSlAsp
Trpl282X
'Nucleotide' was used as a subclass of 'Nucleic_acid_nucleoside_or_nucleotide' and
superclass of all the nucleotides consisting of DNA (A, C, G, T) and RNA (a, c, g, u). 
'Nucleobase was chosen to organise all the nucleotide bases with full names, such as 
Adenine and Cytosine. Both nucleotides and nucleobases were also classified into 
'Purines_and_derivatives' (including A, G a, g, Adenine, Guanine) and 
'Pyrimidines_and_derivatives' (including C, T, c, u, Cytosine, Thymine and Uracil).
The detail hierarchy of'DNA' is shown in Table 4-13.
Table 4- 12 Hierarchy of amino acid and nucleic acid in OntoKBCF
Physical_object
Substance
Chemical
Amino_acid_peptide_or_protein
Amino acids
Human CFTR_protein
Nucleic acid nucleoside_or nucleotide
DNA
mRNA
Nonsense codon
Nucleobase
Nucleotide
Purines and derivatives
Pyrimidines_and_derivatives 
RNA
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The preceding sections in this chapter have focused on the structure of biological related 
concepts. In the next section the EHR structure will be introduced.
Table 4- 13 Hierarchy of DNA and its subclasses in OntoKBCF
Physical_object
Substance
Chemical
Nucleic acid nucleoside or nucleotide
DNA
DNA nonsense codon
Exon
Human_ CFTR_gene_exon
Human_CFTR_gene_exon_3
Human_ CFTR_gene_exon_10
Intron
Human_ CFTR_gene_intron
Human_CFTR_gene_intron_4
Human_ CFTR_gene_intron_10
4.10 Structures used to facilitate the integration of OntoKBCF and an EHR 
4.10.1 The nature of the requirements
OntoKBCF covered cystic fibrosis related bio-health knowledge facts. However, 
making available the information to the target users in a useful and context-sensitive 
manner within an EHR system provides a major challenge. The nature of the challenge 
is three-fold.
1) Within an EHR, information is generally categorised and organised under
certain headings, but such categorisations are generally absent in an ontological 
representation of data. For example, an ontology entry for "scanty cervical 
mucus' needs to be recognised as a 'symptom' in the EHR.
2) When using the Protege-OWL it is possible, if one is experienced in its use, to 
identify relationships or inferences. These are of the type: for a newborn cystic 
fibrosis patient, the manifestation could be prolonged icterus. Such inferences 
may be complex, involving Boolean operators such as 'and' or 'or\
3) Certain entries within the ontology are only understandable to those with 
specialist training. This applies particularly to the representation of mutations.
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Generally, these are provided with explanations, which are held as relationships 
or properties within the ontology.
All these types of relationships or properties can be made available in the ontology, but 
there are no current tools which facilitate their export into an external system such as an 
EHR. This presented a major problem. The Protege-OWL and its representation are not 
suitable for the general clinician, yet the knowledge base representation is powerful and 
rigorous. A bridge is required.
4.10.2 The adopted solution
OntoKBCF was expanded so as to include a set of EHR-related meta-data which could 
be exported into an EHR. In effect the following structure was adopted (Figure 4-12). 
The explanation of the related concepts will be in the following context.
Thing 
EHR CCR OntoKBCF
// \\
Activity / physical Therapy
/-  j- ' ' object 
Codl"g Relationsh,p_ Statement Conceptua| phenomenon
grouPs entity or process
Figure 4- 12 Major structure in OntoKBCF
OntoKBCF retains its conventional structure and the EHR-CCR 'points to' entries in the 
ontology which have the additional relationships. CCR is used in the EHR system 
prototype development and it will be introduced in Chapter 5.
The major structural elements of the EHR part in OntokBCF are shown in Table 4-14. 
Most of subclasses of 'Coding' (the categorisation elements) come from CCR, except 
for lMutation_resulf which is not currently a CCR category. In Table 4-14 only the 
major structure is listed, i.e. not all classes are fully expanded.
In construction of the ontology it was necessary to identify which leaf-node should be 
provided with the additional information that they may be categorised as a Condition, 
Therapeutic procedure, Mutation _result etc. For example, iAA2183_minus_G', 
'Delta_Phe508\ and 'Gly542X' were all made subclasses of   Mutationjresult'. All
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subclasses of 'Coding', such as a particular problem, procedure or result, were used to 
represent the structure and content of the EHR system prototype.
Table 4- 14 Major structure of the EHR part in OntoKBCF
EHR CCR
Data_representation
Coding
Problems
Conditions
Symptoms
Procedures
Diagnostic_procedure
Therapeutic_procedure
Results
Diagnostic_result
Mutation result
Therapeutic_result
Relationship_groups
Statement
In addition to the categorisation of certain ontology class elements, 
'Relationship groups' and 'Statement' were used to index complex concepts, such as 
'Patient_CF_with_Gly542X' and supporting concepts in EHR system prototype.
Table 4-15 and 4-16 list some subclasses for Relationship_groups' and - Statement 
separately. The subclasses of Relationship_groups" were different groups, in which the 
piece of complex concept and its supporting concepts (as explanation units) were 
grouped together under one superclass. For example under 'Related_Gly542X" there are 
three subclasses, i Patient_CF_with_Gly542X', 'Gly542X and 'Gly542\ All the three 
classes were defined rather than drawn directly from UMLS; the latter two were 
explanation units (also described as supporting concepts) for the first class, which was a 
complex concept and the subject with many properties and constraints for the final 
knowledge fact.
Only the appearance and structure of classes are introduced in this section. How these 
two classes would be used will be introduced in Chapter 5. Through this representation 
the user can get properties and constraints used to describe the final knowledge fact and 
can also split and trace down the meaning of subunits used for the final knowledge fact.
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' Statement' was the collection of the subjects for final knowledge facts which could be 
accessed through the EHR system prototype. This is the major EHR structure in 
OntoKBCF.
Table 4- 15 Example groups of the Relationship_groups in OntoKBCF
EHR CCR
Data_representation
Relationsh ip_groups
Related_Gly542X
Gly542
Gly542X
Patient_ CF_ with_ Gly542X
Related AA2183 minus G
AA2183 minus
AA2183 minus G
Patient CF with AA2183 minus G
Table 4- 16 Example subclasses of the Statement in OntoKBCF
EHR CCR
Data_representation
Statement
Patient CF with AA2183 minus G
Patient_ CF with_A rg553X
Patient_ CF with_ Gly542X
Patient CF with Ins3905 T
Insufficient_digestive_enzymes
4.11 Results and summary of OntoKBCF
There were two major content sections in OntoKBCF: one was for the cystic flbrosis 
domain and the other was for EHR structure. In the cystic flbrosis domain part concepts 
were organised into five classes: (1) activity; (2) conceptual entity; (3) phenomenon or 
process; (4) physical object; (5) therapy. In the EHR structure part the major classes 
were (1) coding part; (2) relationship group and (3) statement.
Figure 4-13 shows the general hierarchy of OntoKBCF and Figure 4-14 shows the 
general tree structure of OntoKBCF.
Table 4-17 is statistics about OntoKBCF provided by Protege-OWL 3.3.1.
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Figure 4- 13 General hierarchy in OntoKBCF
Table 4- 17 Statistic results about the content in OntoKBCF
Name
Named classes
Defined named classes
Anonymous classes
Mean named parents
Max named parents
Mean siblings
Max siblings
Properties
Number
405
112
208
3
6
9
20
35
The cystic fibrosis domain knowledge is organised by time and by problems. The 
content of OntoKBCF includes basic biological and health concepts, combined concepts 
and final knowledge facts. Knowledge facts include Cochrane conclusions, 
time-oriented description of cystic fibrosis, and the most common CFTR gene 
mutations description and gene therapy of cystic fibrosis.
Figure 4-15 shows what is included in OntoKBCF. In this figure the whole bio-health 
knowledge body is represented as a grid. However, the content represented in 
OntoKBCF is a small subset of the whole cystic fibrosis bio-health knowledge body.
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Figure 4-14 The tree structure of OntoKBCF
(Note: the structure inside the oval on the left bottom is the whole structure of OntoKBCF and 
the right side part is the zoom out result of the square inside the oval)
D
Bio
Health
Mutation
Age/sex
Gene 
therapy
Treatment/ 
Cochrane
Figure 4-15 Contents represented in OntoKBCF
(Note: P = patient focused information; D = doctor focused information; Bio = biological 
information; Health = health information)
The user can start from biological or health knowledge fact (the most complex 
representation in OntoKBCF, such as knowledge fact in example 1 or 2), then trace 
down to the most basic biological or health concepts (such as 'Bronchiectasis' or 
'Glycine' in Table 4-3 and Table H-l). The basic concepts and some combined 
biological or health concepts (such as: > Gfy542X> in Table H-6, 'Adolescent_CF in 
Table 4-6) are both components for the final knowledge facts representation (Figure 4-6 
and Figure H-2).
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4.12 Discussion
It should be noted that OntoKBCF contains only a subset of cystic fibrosis bio-health 
knowledge facts and thus may not meet the needs of applications that operate outside 
the scope of the work. Limitations in the construction, mapping possibilities with upper 
ontologies and preparation for further steps will be discussed in the next section.
4.12.1 Upper ontology
There have been a number of attempts to develop agreed upper level ontologies, such as 
Medical Ontology, SnapBFO (snapshot ontologies, indexed by times) and SpanBFO 
(videoscopic ontology) 168 . These were not used in the construction of OntoKBCF. 
OntoKBCF has been constructed as a vehicle for transferring formal and structured 
bio-health information to a clinical setting. Thus the focus has been on pragmatic 
development rather than on a more philosophical formal representation. OntoKBCF is a 
purposive knowledge base prototype rather than a complete biomedical vocabulary. In 
addition, the lack of clear and complete definitions for the classes of existing upper 
ontologies makes it difficult at present to develop OntoKBCF according to such a 
framework, or to map it post hoc.
4.12.2 Problem concepts
An attempt was made to represent all the contents selected for the knowledge base 
prototype. However, several relatively imprecise contents could not be represented. For 
example, "nasal polyps, especially if recurrent" is highly relevant when diagnosing 
older children with cystic fibrosis. But it is difficult to represent concepts like 
"especially" in OWL. It is also difficult to represent the difference between relative 
expressions such as "very common" and "sometimes" - such expressions are quite 
common in clinical descriptions. Other problematic concepts include prevalence and 
percentages. In these difficult cases the original expression (real meaning) of every 
knowledge fact retained as an annotation serves to preserve their exact meaning.
4.12.3 Preparation for further steps
Both clinical and biological data will be available within the EHR prototype. In order to 
deliver both biological information and health information, 'mapping points' were
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introduced as a potential bridge between OntoKBCF and the EHR prototype. In 
OntoKBCF age, sex, ethnicity, mutation type and treatment are all considered to be 
'mapping points' that determine how content from OntoKBCF might be displayed 
through the EHR prototype. Detailed content will be introduced in Chapter 5.
4.13 Summary
In this chapter, the construction of the knowledge base prototype OntoKBCF has been 
considered in detail. OntoKBCF includes two major parts: cystic fibrosis bio-health 
domain information and a structure to support or interact with the EHR. Concerning 
cystic fibrosis, the knowledge facts range from nucleotide mutation, amino acid change, 
basic biological concepts to biological and health knowledge facts of cystic fibrosis. 
Although horizontally the prototype is far from complete, vertically, it is able to bridge 
knowledge of different types, and at different levels. The description of sex, age, 
ethnicity, mutation and clinical manifestations provides mapping points with the EHR 
system prototype. Semantic web technologies offer consistent, extensible, machine 
processable and sharable knowledge sources. OntoKBCF is an attempt to focus upon 
information about the sequence variations (both nucleotides and amino acids) associated 
with health information about cystic fibrosis. As this is important for a complete 
understanding of the disease, the goal is to deliver the information and to make it usable 
in a clinical setting.
While recognising that the current state of the art does not permit a seamless transition 
from biological to clinical knowledge, the organisation of OntoKBCF is designed to 
provide appropriate access to biological knowledge in the clinical setting.
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Part 1 of this research combines formal and structured biological and health information 
into a knowledge base for cystic fibrosis 151 . This is described in Chapter 4. Part 2 
(described here) explores how this information can be made accessible via a 
standards-based Electronic Health Record system prototype.
Note: A review concerning EHR system (EHR-s) and the distinction between EHR and 
EHR-s is presented in section 2.6.
This section includes details concerning:
  Why an EHR system prototype is created, rather than re-using an existing 
product.
  An overview of the extensions to the existing standards, so as to include 
biological information.
  The processes require to integrate the ontology with a standards-based EHR 
application.
5.1 EHR system prototype overview
EHR-s in their various guises are popular tools in the clinical setting, as shown in 
section 2.6.2. These EHR-s are proprietary, and do not lend themselves to the extensions 
which were required; i.e. no system to the author's knowledge has been designed for the 
explicit purpose that we need. These additional requirements include the capability to 
integrate formal and structured biological and health information into EHR-s.
All computer-based systems and therefore all EHR-s are designed with specific user 
types in mind. For the purposes of this project the target users were non-specialist 
doctors, for example general practitioners. While it is true that similar techniques and 
general design principles would apply to other user types, the non-specialist has some 
specific requirements. The key element is that the specialist information (such as 
genetic information) could be linked to familiar information (i.e. health) by presenting 
the information together and providing correct interpretation of the specialist 
information. Furthermore, it is important to limit the amount of information to be 
managed by the user. This means that the EHR-s should present information in a 
context-sensitive manner, i.e. that appropriate information is displayed according to a
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patient's individual parameters. It should be noted that there has been little research thus 
far to bring biological information to the EHR (see section 2.6.2).
For this research, a limited number of resources have been brought together to create a 
knowledge base which could interface with a standard EHR-s. Most EHR-s, however, 
have evolved from a reducing number of suppliers (e.g. in UK general practice in 2009 
there are about 10 main systems 169 ' 170 , whereas in 1990 there were over 100 171 ). It is 
only recently that there has been a move towards standards-based systems, and the 
underlying design principles of most commercially available systems are not based on 
formal standards or specifications but are ad hoc and unique to a specific development. 
These systems are not open source and their architectures are proprietary and 
unobtainable for interfacing with research software.
The new CEN and ISO standards such as ISO EN 13606 are expected to be the basis for 
the record systems in the next 15-25 years, considering the standards development 
period9' 10 . These standards and others are in the public domain now and are candidates 
for this research. Three systems were considered, e.g., OpenEHR 108 , INDIVO 109 . and 
Healthframe" 1 and all of them have been reviewed in section 2.6.4. In the following 
material the major barriers to using them as the basis for the prototype will be 
introduced.
The OpenEHR utilises the CEN work, which is relatively mature, given that the original 
work began on the record architecture in 19929' 172 . There have been several 
developments and enhancements; the most recent undergoing balloting in ISO is in 
2009. The standards work has benefited from the involvement of the OpenEHR 
foundation and the development of tooling from Ocean Informatics9 ' 113 . However, at the 
time of this research there was not an available interface which could be used directly in 
OpenEHR.
The INDIVO system, formerly PING, developed separately from the standards 
organisations and also differed from many other initiatives as it was focused upon 
personal health records (PHR), designed to be created and operated by individual 
patients rather than institutions. INDIVO is open-source and is freely downloadable. 
However, implementation of INDIVO involves a wide range of third party tools which 
require considerable time if these resources are to interoperate without conflicts.
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Furthermore, the initial focus of this work is intended for non-specialist doctors rather 
than patients, and INDIVO is not likely to set a standard which other systems would 
follow.
Healthframe is a commercial PHR system. Unlike INDIVO, it is standards-based and 
developed on CCR. However, its proprietary nature meant that the source code and 
architecture of Healthframe are not easily adapted. Like INDIVO, Healthframe is a 
PHR system to be used by patients rather than by doctors.
If we had used an existing system and attempted to extend the functionality, then we 
would have been constrained by the system's programming language and its 
architecture, both of which were potential barriers. Considering the research objective 
and pragmatics we were not concerned with utilising the full functionality of such 
systems. Therefore, it was decided to use a subset, albeit based on a standard- CCR, to 
prove the concept, as this was a more realistic and time saving option. The reason for 
choosing CCR can be cross referenced to section 3.7.
5.2 Approach of connecting the EHR system prototype to OntoKBCF
To achieve the purpose of interfacing the bio-health information and to make it 
accessible via an EHR the following steps were used to create the connection between 
the EHR and the knowledge source- OntoKBCF. Figure 5-1 shows the general 
procedures used in this connection implementation. Basically there are five major parts:
1) To develop the EHR system prototype [5.3].
2) To connect the EHR system prototype with OntoKBCF [5.4].
3) To restructure the patient's record from published case reports [5.5].
4) To map the knowledge in OntoKBCF with CCR labels [5.6].
5) To test the connection [5.7].
5.3 Development of the EHR system prototype
5.3.1 Selection of labels from CCR
It was never the aim of this project to build a fully functioning GP EHR-s. As this 
research is to show proof of concept it is not necessary to include every aspect of CCR,
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and therefore I chose only those parts required in the EHR system prototype to achieve 
the specified aim. The analysis of the CCR was concerned with only the clinical and 
demographic parts, but not the administrative ones (management or financial 
information), although all three are covered in CCR 12 .
Restructured 
patients' records
Connection EHR 
and OntoKBCF
Figure 5- 1 Flow chart for EHR/OntoKBCF connection prototype construction
CCR uses labels (or CCR Attributes). As the aim was to connect OntoKBCF with the 
EHR system prototype, i.e., to make knowledge facts in OntoKBCF actively accessible 
through the EHR interface, it was critical to think of this application whilst building the 
EHR system prototype. Therefore the basic principle was to select labels which were 
applicable to the knowledge within OntoKBCF and to those found in patients' records.
There are three components in the CCR specification: the CCR header, the CCR body 
and the CCR footer respectively. The clinical labels are from the CCR body; the 
demographic data labels are from the CCR footer, patient's ID and consulting date/time 
are from the header.
Clinical labels are selected to organise the bio-health information, and demographic data 
is organised under demographic labels. Note: In this context clinical means medical 
related rather than administrative and demographic information. In this chapter this 
covers both medical and biological information. The specific labels will be introduced 
in detail in the next section.
5.3.2 Structure and functions of the EHR system prototype
Generally there are three major parts in the EHR system prototype:
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  Ontological data entry (to load different versions of OntoKBCF)
  The patients' entry (to choose the patient from a list with some basic 
demographic data)
  EHR system prototype interface (to display the selected patient's record)
The data contained in the system may be classified as demographic data and bio-health 
data.
5.3.3 Demographic data
Demographic data includes: 'Surname', 'Given name', 'Date of birth \ 'Sex', 'Ethnicity' 
and 'Age group'.
Certain demographic data items have particular prominence since they interact with the 
data held in the knowledge base and are required for the presentation of possible 
conditions/tests in a context-sensitive manner. These items are:
  Sex. Certain conditions are only relative to a particular sex.
  Age. Certain conditions are relative to a particular age group. This may also 
relate to sex, e.g. adolescent female cystic fibrosis patient.
  Ethnicity. Certain mutation types may be relatively highly prevalent among 
certain ethnic groups.
It is recognised that the latter two have certain flaws in that 'age groups' are not 
standardised. For example, the term baby may have different ranges in different 
contexts and ethnicity is even more contentious. However, previous research findings 
did utilise these terms and the precise standardisation and specification of these 
categories followed the definitions in UMLS.
5.3.4 Bio-health data
Bio-health data includes -Problems', 'Procedures* and 'Results'.
'Problems' include 'Conditions' and 'Symptoms'.
'Procedures' include 'Diagnostic Procedures' and 'Therapeutic Procedures'.
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'Results' include 'Diagnostic Results', 'Mutation Results' and 'Therapeutic Results'.
Except for 'Mutation Results', all other labels followed the CCR's definition and term 
selection. 'Mutation Results' was added to record and present the patient's specific 
sequence variations. 'Mutation Results' is a result of a laboratory test.
Figure 5-2 shows the major structure and functions of the EHR system prototype and 
also shows information flow in the EHR system prototype. The structure and function of 
the OntoKBCF related part, i.e. the connection part, will be introduced next.
Update i...
Edit
I Remove - - -
Display
Figure 5- 2 EHR system prototype interface-major structure and functions
(Note: solid line and rectangles are for structure; dashed line, arrows and callouts are for 
functions)
5.3.5 Candidate facts from OntoKBCF
This section displays case-sensitive candidate knowledge facts from OntoKBCF. All the 
contents from OntoKBCF had been organised into five specific subparts: 'Age/Sex 
related', 'Ethnic related', 'Mutation related', 'Diagnostic procedure related' and 
'Therapy related'.
The contents in the five specific subparts were originally represented in OntoKBCF. 
Only the content that is related to the patient's demographic data but not listed in the 
bio-health data would be displayed in these five boxes (the screenshots are in section 
5.7- Verification). This is because the current filters include patient's age, sex, ethnicity 
and specific bio-health data, for example symptom, mutation, condition etc. Each item 
in the boxes could be triggered to show the hierarchies in the tree view parts and if the 
item belonged to one of the bio-health data categories the item could be added to the
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patient's bio-health data part (after the user confirms it). 'Delta_F508', for example, (a 
type of mutation) is an item displayed in the 'ethnic related' box. The user can decide if 
'Delta_F508' should be added to the 'mutation result'.
5.3.6 Tree view
This is the part to display the hierarchies from OntoKBCF and the natural language 
interpretation of the representation. There are three subparts:
  The 'Original statement' is the original representation of knowledge fact from 
OntoKBCF;
  'Reference hierarchy for key concepts' displayed hierarchies of the key concepts 
(i.e. selected items from one of the OntoKBCF boxes, described in section 5.3.5) 
in the original statement from OntoKBCF and their relationships;
  'Interpretation of the original statement' was a natural language interpretation of 
the original statement in OntoKBCF.
Another important characteristic in 'Reference hierarchy for key concepts' is the 
hierarchies, which include not only the item of interest, but may also include some 
related concepts (i.e. supporting concepts) which are used in explaining that item. 
Currently only the location information for mutation concepts has been included as 
related concepts. The hierarchical view and the interpretation box are different methods 
to support users in understanding/interpreting the knowledge facts from OntoKBCF. 
The architecture of the EHR system prototype is summarised in Figure 5-3. The screen 
shots shown in section 5.7 give a detailed view of the EHR system prototype interface. 
Appendix M is a table with some main coding design decisions in building the EHR 
prototype for reference.
5.4 Connecting the EHR system prototype to OntoKBCF 
5.4.1 Context of the connection
The major focus of this research is to construct an ontology for cystic fibrosis 
containing formal, structured and associated bio-health information and to make this 
information accessible in a context sensitive manner to doctors through a
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standards-based EHR application. It was expected that the interface between the 
ontology and the EHR would involve the creation of queries within the EHR application 
and that such queries would be sent to the ontology. The returning 'information' would 
then be interpreted and presented to the user (Figure 5-4).
Surname
Given name
Date of birth
Ethnicity
Sex
Patient ID
Onto-related
Onto-explained
Age/sex related
Therapy related
Mutation related
Diagnostic related
Ethnic related
Original
Tree view
Interpretation
fl Clinic 
OntoKBCF
Figure 5- 3 EHR system prototype interface architecture
(The parts could be edited are in grey background; most bio-health labels and demographic labels from 
CCR; 'Clinic' under 'Full report' includes both demographic data and bio-health data.)
Unfortunately, when the available tools were investigated it was found that none were 
able to deal effectively with the types of queries that were necessary. When we tried
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different ways to query OntoKBCF or try to get the knowledge facts from OntoKBCF, 
we faced many different types of barriers. The barriers to the queries will be discussed 
in detail in Chapter 6. This lack of effective querying tools was brought to the attention 
and confirmed by Protege-OWL experts, the developers at Stanford University and 
Manchester University. The only available option was to effectively download the 
content of the ontology for rendering into more accessible representations.
Create query based 
on patient specific 
parameters
Send query
Interpret and present 
results
Collect and send 
results
Figure 5- 4 Ideal information flow between the EHR system and OntoKBCF
5.4.2 Possible options for the connection
The decision to move to a download configuration meant that at any given time we 
needed to take an image or 'snapshot' of the ontological representation of the 
knowledge. Downloading of the ontology content can be carried out in two ways:
  A function in the Protege-OWL tool may be used to extract content as an XML 
representation. It is understood that this is the preferred option of researchers at 
the Mayo Clinic in the US.
  A function in the protege-OWL tool is to download the 'raw' data from the 
ontology as a database format. This is the method adopted by this project since 
additional material which is placed in the ontology is allowed to be manupilated.
Whichever of the two methods is adopted there are serious losses of information. The 
two possible paths to information loss are described in Figure 5-5. These are not the 
only processes involved in information loss; all the possible processes related with 
information loss in this project will be discussed in Chapter 6.
5.4.3 Our solution
The raw data in the Figure 5-5 is converted from Protege-OWL to Microsoft's (MS)
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Access format; the knowledge facts in OntoKBCF are mapped to the CCR labels; and 
then data in the Access format is extracted into the bio-health tables and the OntoKBCF 
related tables used in the database for the EHR system prototype. The extracted 
knowledge facts from OntoKBCF are classes. The knowledge facts are related to 
specific characteristics, such as age, sex, ethnicity, diagnostic procedures, CFTR 
mutations and therapeutic procedures. The process has been done by a combination of 
manual and automatic means. In the manual process the content is analyzed in 
OntoKBCF directly and only the automatic process involves the converted table 
directly.
Loss of
information 
XML output     *• XML Schema
Relational database
Loss of 
information
Raw data output Query Response
Figure 5-5 Information loss between the EHR system and OntoKBCF by the two solutions 
The solution included:
1) To design what functionalities could be achieved in the connection, according to 
the contents in OntoKBCF, and the data included in the EHR system prototype 
interface.
2) To design the OntoKBCF related parts in the EHR system prototype interface.
3) Then to select the relevant knowledge facts from OntoKBCF according to the 
desired functionalities and to organise them into separate tables.
Figure 5-6 presents the general view of the connection. The major tables of the 
EHR/OntoKBCF connection prototype could be classified into three groups: patient 
related, bio-health related and OntoKBCF related tables. The data source for the first 
group is from the published case reports and details will be described in section 5.5; the 
data sources of the latter two are mapping results between OntoKBCF and the CCR
Chapter 5 Connection of a knowledge base prototype to a standardised EHR prototype -94-
labels, which will be described in section 5.6. This part of the work was conducted 
manually first and automatically later.
There are two major procedures in raw data processing: to convert the data from 
Protege-OWL format to MS Access table; to extract corresponding bio-health tables and 
OntoKBCF related tables from the converted Access table.
I
EHR model interface
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Patients' 
related 
tables
Bio-health O 
related rel 
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Restructured 
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// Extract from 
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Figure 5-6 General view of the EHR/OntoKBCF connection prototype 
5.4.4 Conversion table- from Protege-OWL to MS Access table
Based on help documents from the Protege community", the parameters were set to 
convert OntoKBCF from current format into a relational database format (a Microsoft 
Access table). The different bio-health and OntoKBCF related tables would be extracted 
from this converted table in the automation process.
There are several major characteristics in the data fields in this converted table (details 
in Appendix L). All these characteristics are critical clues for further automatic 
extracting. All the Asserted Hierarchies (i.e. 'classes' names), Annotations, Object 
properties, and Annotations for Property, were displayed in the original format in the 
table. However, the Asserted Conditions were displayed as an internal string in the form: 
"(a) -AO" or "@_:A632" etc. Note: Asserted Hierarchies, Annotations, Object 
properties, Annotations for Property, Asserted Conditions are all panel names on the 
Protege-OWL interface.
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5.4.5 Extraction from the converted Access table
The aim of this part of the work was to extract corresponding tables from OntoKBCF 
automatically, according to different requirements. The first step in the programming 
was to analyse the manually built tables and to decide which ones could be extracted 
automatically. Nothing could be done from OntoKBCF directly with respect to the 
patient-related tables; however, all other tables could be extracted partly or totally from 
the original converted table.
In addition to the connection of the two types of data, OntoKBCF could also be used as 
a data source for the EHR system prototype's bio-health data: all the candidate 
bio-health data lists are from OntoKBCF. The procedure for using OntoKBCF as the 
data sources for the EHR system prototype, and the data sources are mapping results 
between the two components, which will be introduced in section 5.6.
5.4.6 Automation of extraction
The manual method is a way to prove the concept; however, it is far from ideal, 
requiring much laborious work without the assistance of automation. The extraction part 
can be automated, and in Appendix N we list the major programming decisions 
involved with automation of the extraction. However, at this time, not all the results 
achieved by the manual method can be done automatically. Results from manual and 
automatic processes will be compared in section 5.8.
5.5 Test patient records
To test the functions of this OntoKBCF/EHR connection prototype it was necessary to 
load some test records. These records were anonymous. Given that the patient had 
cystic fibrosis, using the interface to the ontology, the possible indications and 
suggestions for further investigation could be displayed. This section will introduce how 
the test records were restructured.
5.5.1 Test record source
A major source of test records came from case reports in PubMed. Twenty four human 
cystic fibrosis genetics case reports with free full text were retrieved until Jan. 21st 2008. 
Case reports with mutation types which overlapped with the content in OntoKBCF were
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selected. If there were several case reports with the same mutation type, then the one 
with the most detailed clinical description was selected.
Finally three published case reports' 73 " 175 were selected, one of which included four 
separate cases. I chose three out of four from the same publication because the last case 
was almost the same as one of the previous selected three. In total, five test records 
were reconstructed using this method.
5.5.2 Test record restructuring
The above resources presented data in a textual manner, and in each case it was 
necessary to deconstruct the information into a number of factors. These factors were 
contained in the ontology, for example: age, sex, ethnicity, CFTR mutation type and 
other clinical description, i.e. symptom, diagnostic procedure and medication etc.
The method used was to restructure the test records from published case reports first, 
then to add several hypothetic parameters such as name, or date of birth. Normally in 
the published case reports patients' age, sex and ethnic origin would be indicated. A 
matrix was used to show the tested knowledge facts in OntoKBCF. According to the 
knowledge facts, some more hypothetical 'knowledge facts' (bio-health data) would be 
assigned to each test record to make sure most of the types of knowledge facts in 
OntoKBCF had been used in the test.
I used the following heuristics in constructing the test records: 1) use real parameters as 
much as possible, 2) use as few test records as possible, 3) represent as many different 
mutation types as possible and 4) cover the knowledge facts in OntoKBCF as wide as 
possible.
It should be pointed out that many descriptions were not sufficiently detailed to provide 
suitable entries for factors in the ontology. For example, "in a 21-year-old black woman 
with substantial pancreatic disease but only mild pulmonary involvement", "mild 
pulmonary involvement" is not a detailed clinical description for a record restructuring. 
For a doctor in practice maybe that the description would be enough to understand the 
patient's pulmonary status; however, if we want to record the case with clearer and 
specific detail, that description is far from useful. So the restructured test records are 
fragmental rather than a set of complete records, and hypothetical data is necessary.
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5.6 Mapping between OntoKBCF and the EHR system prototype
OntoKBCF contains basic concepts, combined concepts and final knowledge facts. 
Basic and combined concepts are used as components to construct and represent the 
final knowledge fact. All the basic and combined concepts are embodied as hierarchies 
in OntoKBCF. Final knowledge facts are embodied in their hierarchies (basic and 
combined concepts) and property descriptions (Asserted Conditions in Protege-OWL). 
The basic and combined concepts in OntoKBCF could be used as a data source for the 
EHR system prototype. The following section describes how mapping is used to make 
this work.
5.6.1 General introduction
Semantic mapping is carried out manually between OntoKBCF and the CCR labels, 
based on definitions of the labels in the CCR.
According to how the knowledge facts will be used, the concepts in OntoKBCF can be 
classified into basic concepts, combined concepts and final knowledge facts; the 
concepts can also be split into health and biological parts according to the topic. The 
classification of the knowledge facts in OntoKBCF helps the mapping.
5.6.2 Mapping procedures
These are the mapping procedures used. First the major selected labels are listed: 
Problems, Results, and Procedures. Secondly all the defined concepts in OntoKBCF are 
examined. Then specific labels, which are more specific than major labels, are selected 
according to the major labels' definitions and examples in the CCR specification (such 
as 'condition' and 'symptom which are both specific type of 'Problems') and within the 
scope of OntoKBCF. Thirdly all the defined concepts were reorganised under each 
specific label through both MS Access tables and structure in Protege-OWL. The 
procedures to choose labels from CCR and to map the contents in OntoKBCF to the 
CCR labels were interactive.
5.6.3 Mapping rules
When all the concepts are reviewed, for the health parts both basic and combined 
concepts and final knowledge facts were used in mapping; for the biological parts, only
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CFTR mutations were used as final knowledge facts. There are two reasons for this 
choice:
  First, the basic and combined concepts in health part act as a reference for users 
in EHR-s although they are not a necessary part of the EHR-s.
  Secondly there are many more detailed descriptions about health (clinical) 
concepts in the CCR specification. These descriptions provide many more 
mapping points for the health part between OntoKBCF and the EHR system 
prototype, compared with mapping points for the biological part between 
OntoKBCF and the EHR system prototype.
There is no specific section or label in the CCR specification to describe biological 
information. According to the label definition in the CCR specification the CFTR 
mutations are put under 'Results'. Although there is not any example of mutation 
(existing examples included haematology, chemistry, virology etc), literally, mutation 
can be seen as a type of laboratory result. So 'mutation result' was created as a specific 
label of 'Results' used to collect different CFTR sequence variations. Because there is 
no corresponding description for biological information in the CCR specification, there 
is no point in including too much detail biological basic and combined concepts in 
mapping. All the biological basic concepts, and part of the combined concepts in 
OntoKBCF are excluded in mapping, such as all the nucleotides, all the amino acids etc.
Some defined temporal, spatial and qualitative concepts and different CF patient groups 
have not been used in mapping, such as 'Prolonged_disease_course', 
'Long_arm_of_chromosomes_human_pair_7', and 'Adolescent_female_CF' etc. Some 
non self-defined health concepts are used in mapping, for example 'Atresia' is under 
 Conditions' which is under 'Problems'; 'Rash' is under 'Symptoms', which is a type of 
'Problems'; 'Cystic_fibrosis' is under 'Diagnostic_result' which is a type of 'Results' 
etc.
5.6.4 Mapping example
There are several mapping examples in the following context. 'Distended_abdomen' is a 
defined health concept, a description for one of manifestations for infant cystic flbrosis 
patient and also a combined concept. The concept is used as a property in describing 
final knowledge facts. In mapping, 'Distended_abdomen' was put under 'Symptoms'
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which was a type of 'Problems'.
'Delta_F508' is a CFTR mutation and also a combined concept in OntoKBCF. In 
mapping it was put under 'Mutation result', which was a type of 'Results'. However, 1 
did not map 'F508', which is another combined concept, to describe the amino acid 
location in the CFTR protein, nor The', which is a biological concept and a basic 
concept - Phenylalanine (the abbreviation is F).
'Bronchiectasis' is a basic concept of the health part in OntoKBCF. 'Bronchiectasis' was 
mapped under 'Diagnosis' which was a type of'Results'.
5.6.5 Mapping results
The mapping results are a set of tables, about mutational results, diagnostic procedures, 
conditions, symptoms etc.
The mapping between OntoKBCF and the CCR labels in the EHR system prototype is a 
test of the content of OntoKBCF. This is an extra use of OntoKBCF as a data source in 
the EHR system prototype. In an actual EHR system, data sources for EHR such as 
symptoms or conditions, diagnosis etc, should be provided separately from the EHR 
system, not necessarily from OntoKBCF.
Although mapping can be achieved in this way, there are some difficulties during this 
process.
5.6.6 Mapping difficulties
To select proper labels from CCR is not too difficult as there is a clear aim of how to 
use the EHR system prototype and a clear scope about the content in OntoKBCF. The 
really difficult part is in mapping, because in the CCR specification the definitions of 
the labels were not given in detail. There are many design decisions which need to be 
made, since there is a lack of consensus concerning the definitions of many concepts 
during mapping. This is easy for some concepts, such as 'coughing', which should be a 
member of symptoms; but it is more difficult for other concepts, such as: poor weight 
gain, weight loss. Should they belong to 'conditions*,  symptoms', or both? The 
decision heavily depends on the definition of the labels. The detailed discussion will be 
in section 5.9.2.
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5.7 Verification of the prototype components
The research seeks to show the feasibility of bringing biological information into a 
simulated clinical system by integrating a knowledge base prototype with an EHR 
system prototype. The research requires the development of two components, i.e. the 
substantive knowledge base- OntoKBCF and the EHR system prototype. In addition the 
means of connecting the two were investigated, i.e., how the connection shows the 
structure and relationships specified by the ontology and enable the knowledge base to 
be tested. Furthermore, the connection demonstrates the feasibility of bringing the two 
different types of information together within a prototype of an EHR system.
In this section we evaluate the research. The background introduction about evaluation 
has been presented in section 3.5. This evaluation does not include the evaluation of the 
EHR system prototype per se, which is simply a means of showing the knowledge 
base's structure and content. There are functional criteria for full EHR systems and 
some of those criteria have been used in building the prototype. However, the main 
purpose of the prototype is to embody the CCR specification to which the knowledge 
base attempts to map. In this section only connection-related parts of the EHR will be 
evaluated; for example, the biological information is made accessible through the EHR 
prototype, and filters are there to help to make the information relevant etc.
There are different types and levels of testing during the software development 
process 176 . Two terms are often used in software testing: verification and validation ' 
177 ; verification concerns the correctness of a specification whereas validation is 
checking a piece of software against the requirements, which is related to the process of 
executing test data in the software 177 . Evaluation in this thesis is concerned with 
verification. This is a functional verification rather than a usability evaluation. Screen 
shots are used to show the functional verification results and test records with scenarios 
are used to make the examples explicit. The method of defining the test records has 
already been described in section 5.5.2.
There are two major parts of verification in this section, i.e., OntoKBCF and the 
connection between OntoKBCF and the EHR prototype.
  Evaluation of OntoKBCF concerns structure and content of the knowledge base 
prototype. The objectives of OntoKBCF's evaluation are 1) to prove that the
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logical structure of OntoKBCF is consistent and correct; and 2) the content of 
OntoKBCF is useful and usable, by showing the mapping with CCR headings. 
This is dealt with in section 5.7.1.
  The functional verification of the connection part comprises 1) the means of 
access via the EHR prototype; 2) the use of filters to make the EHR system more 
active; 3) the presentation of the knowledge. This is dealt with in sections
5.7.2-5.7.4.
5.7.1 Evaluation of OntoKBCF
Evaluating ontologies is a complex task. However, because ontologies are logical 
specifications, much work has been done to provide automated tools to test the 
consistency and correctness of an ontology. These tools are called 'reasoners' A 
reasoner is "a piece of software able to infer logical consequences from a set of asserted 
facts", which can help to keep consistency and explicit hierarchy of the ontology8' 178 . 
RacerPro 17 is a description logic reasoner and is the appropriate tool for use here as this 
project uses the OWL-DL in OntoKBCF construction.
Two methods were then used to evaluate the ontology:
1) A formal reasoner, RacerPro 1.9.0, was used to:
V- check the consistency of OntoKBCF; OntoKBCF passed the reasoning 
process without fault in 5.789 seconds (there were 405 named classes and 
208 anonymous classes, and 112 named classes had been defined;);
> check the classification of OntoKBCF took 57.993 seconds to complete.
2) Another method used relates to the successful transfer of OntoKBCF across 
different tools, i.e., Protege-OWL (version 3.3.1) and TopBraid (test version 
2.3.1). This interchange also succeeded and provided further evidence for the 
consistency and validity of OntoKBCF's structure.
Mapping between the CCR labels and OntoKBCF was an evaluation related to the 
appropriateness of the contents in OntoKBCF. All the mapping between the CCR labels 
and OntoKBCF contributes to the bio-health candidate tables. Furthermore, all the 
bio-health data used in the testing of the connection was from these tables. This means 
that the content in OntoKBCF was suitable for our purpose. Other positives for the 
structure of OntoKBCF, such as reduced redundancy, and a robust and explicit structure
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were simply gained from direct experience in ontology restructuring, mapping, and 
modification during the construction process.
5.7.2 Means of access via the EHR Prototype
The bio-health information in OntoKBCF is made accessible through the EHR 
prototype. The following scenario is used to demonstrate this function.
Claude, male, 01/01/2005, French; he has cystic fibrosis.
In this scenario the candidate facts presented via the EHR's interface from OntoKBCF 
include: 'patient could have heat exhaustion', 'be underweight' and 'have bronchiectasis 
or lower respiratory tract infection and pancreatic insufficiency'; 'possible CFTR mutation 
type is G621+1T'. The tree view consists of hierarchies of G621+1T (Figure 5-7).
The means of access via the EHR prototype is embodied in five OntoKBCF candidate 
facts boxes and a tree view structure; both types of structure are from OntoKBCF (see 
hierarchy and candidate facts, Figure 5-7). G621+1T (candidate mutation) is a 
representative of biological information which is introduced into the EHR record.
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Figure 5-7 Screenshot for accessing bio-health information in OntoKBCF through the EHR
prototype
(Note- general EHR interface including demographic and bio-health data, candidate knowledge 
facts from OntoKBCF and tree structure of G621+1T)
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5.7.3 Use of filters to make the EHR-s more active
In the connection section the bio-health information in OntoKBCF can be customised 
according to individual patients' parameters, i.e. the EHR prototype could be set to 
display personalised bio-health information according to the filters, which include 
demographic data and bio-health data. The following scenario is used to show this 
function:
Jean, male, 12/11/1932, Italian; he has cystic fibrosis.
In this scenario the candidate facts on the EHR interface from OntoKBCF include: 'that 
patient might have bronchiectasis', 'deferred puberty', 'sterility'; and 'pancreatic 
insufficiency'; related mutations include Asnl303Lys, AA2183-G, G1717-1A (Figure 5-8).
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Figure 5- 8 A record for a male adult cystic fibrosis patient
(Note: the sex is related with the candidate facts displayed in the Age/Sex box -lower circle- and 
it can be compared with Figure 5-9, which is the female version of the same patient)
Figure 5-8 is the record for male Jean. Figure 5-9 is a record for female Jean (i.e. as a 
female version but all other parameters are the same with male version except for sex).
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The Age/Sex related box shows different candidate facts in Figure 5-8 from in Figure 
5-9 because of the different sex. This is to show 'sex' can be set as a filter. Sex is a 
representative of demographic data.
Figure 5-10 shows that if a patient's record has an AA2183-G then AA2183-G will not 
appear in the candidate fact box. This shows bio-health data as a filter. The mutation is a 
representative filter for bio-health data.
Demographic data
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BajBLfiE 112/11/1932 
I birth I
Given 
Name
Lear,
Age 
group
[Adult \ fthnidty Italian
Bio health data
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I Results
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Figure 5- 9 A record for a female adult cystic fibrosis patient
(Note: except for sex- this is a female, other parameters are the same as the patient in Figure 5- 
and correspondingly the candidate facts in the Age/Sex box are different - lower circle)
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Demographic data
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Figure 5- 10 A record of a cystic fibrosis patient with CFTR AA2183_minus_G mutation
(Note: this is the same patient as in Figure 5-8 except that this patient has CFTR 
AA2183_minus_G already- upper circle-, so AA2183_minus_G would not display in the 
candidate facts- middle circle- and this mutation may relate to an Italian patient- lower circle)
5.7.4 Presentation of knowledge
This section shows how the connection part can present bio-health knowledge through 
the EHR prototype. In this section we include the test patient record interface with 1) 
tree view (Figure 5-11, for 'G1717_minus_l_A' mutation); 2) extended tree view and 3) 
natural language interpretation with a confirmation dialogue before the candidate fact is 
added to the existing bio-health data (Figure 5-12, for 'G1717_minus_l_A' mutation to 
be added to 'mutation results').
Two different ways of presenting the knowledge are shown as examples. Eventually
Chapter 5 Connection of a knowledge base prototype to a standardised EHR prototype -106-
users will be able to decide which way they would prefer to see the knowledge so as to 
give them the most support. Knowledge is presented through 1) a tree view (knowledge 
hierarchy from OntoKBCF); 2) an extended tree view (knowledge hierarchies including 
supporting concepts, which can be used in explaining complex concepts). The tree view 
may help users to understand the domain knowledge hierarchy, whereas the extended 
tree view may help the user to understand the complex concept.
Tree view and the extended tree view can be used as general or more specific references 
to help users decide whether the candidate facts from OntoKBCF should be added into 
the patient's record (the bio-health data). The scenario for this example is:
Maria, female, 08/08/2003, has cystic fibrosis, meconium ileus and receives physiotherapy.
Candidate facts include: patient might have Asnl303Lys, AA2183-G or G1717-1A; patient 
also might have heat exhaustion, underweight, bronchiectasis or lower respiratory tract 
infection and pancreatic insufficiency (Figure 5-11, 5-12).
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group |
ISi f Mint Hit | Update |
BMotr Fsiiar'
Res* | plates ] Problems | Full Report
hterapeufc 
Results
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Figure 5-11 A record of a cystic fibrosis patient with basic tree view of CFTR G1717-1A 
(Note: basic tree view can provide knowledge hierarchies of CFTR Gl 717-1 A)
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Figure 5-12 A record of a cystic fibrosis patient with extended tree view of CFTR 
G1717_minus_l A and interpretation
(Note: extended tree view including hierarchies of Patient_CF_with_G1717_minus_l_A, 
G1717_minus_l_A, G1717_minus_l; Interpretation of the original statement "nucleotide 
mutation, located in human CFTR gene intron 10, in G1717_minus_l it is a transition from G to 
A". The user may use the confirm dialog before the mutation is added to mutation results)
In this section we have shown how the knowledge base delivers candidate facts; a small 
subset of the many stored facts within the knowledgebase. The candidate facts are 
retrieved by using filters, and the existing patient health information stored within the 
health record. Retrieval and presentation are triggered automatically according to 
submitted patient details, making the record system more of an active rather than a 
passive system.
Although the research aims have been achieved, there are limitations and there are also 
future directions that need to be explored; these will be summarised in section 5.9.
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5.8 Results
The EHR system prototype was built based on CCR and the bio-health information in 
OntoKBCF made accessible. The process has been achieved manually and partly by 
automatic means; both methods were successful. The bio-health information in 
OntoKBCF can be personalised according to individual patients' parameters and the 
hierarchies of concepts in OntoKBCF can be presented through the EHR interface; the 
accessible personalised bio-health information has been tested by several test records 
through the EHR system prototype. At the beginning it was unclear as to how the two 
types of information could be brought together. To close this results section I include the 
process and steps that I found to be useful, which may help others to produce a formal 
development method.
Currently filters for bio-health information in OntoKBCF include: age, sex, ethnicity, 
CFTR mutation type, diagnostic procedure and therapy related data. Figure 5-13 shows 
the information flow through the connection prototype interface.
Entry page I
Patient list entry
EHR interface
I
According to demographic and bio-health data
Active display
Full report OntoKBCF
Figure 5-13 Information flow diagram for the EHR/OntoKBCF connection prototype 
(Note: double direction arrow means read and write, which allows edit function) 
The results of the automatically derived part are a set of MS Access tables, which
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correspond to the Access tables produced manually; however, the two sets are not 
identical. The tables or part of the tables involved with hierarchies of OntoKBCF could 
be created totally automatically; the tables or part of the tables involved with property 
description or logic representation could not be created automatically, because these 
parts of content in OntoKBCF could not be displayed correctly in the original converted 
table from Protege-OWL. More details are given in section 5.9.3.
This research has been a "learning through making" process. On reflection, the process 
and steps that I used to connect a knowledge base prototype with an EHR system 
prototype were:
1) To decide what to offer and how to offer it from the knowledge base prototype 
through the EHR prototype interface.
2) To construct a compatible EHR structure in the knowledge base prototype 
according to the requirements set in the first step. There were several specific 
points to be considered:
a) What structure in the knowledge base prototype need to be displayed or 
accessed through the EHR prototype: hierarchy only, or both hierarchy and 
property?
b) If hierarchy only, then should the original hierarchy only be used or the 
classes organised in a different way?
c) The EHR structure in knowledge base prototype need to be compatible 
with the EHR prototype architecture.
3) To make a technical choice, which type of knowledge base prototype file should 
be used: converted table, XML, or RDF file?
4) To organise the interpreted content from the knowledge base prototype manually 
or automatically according to what would be offered through the EHR prototype.
5) To program for both EHR prototype and the knowledge base prototype file to 
make the connection work.
5.9 Discussion
Although as a proof of concept research, the research objectives were achieved
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successfully: i.e., to make the formal and structured bio-health information accessible 
and personalised through a CCR-based EHR system prototype. There were, however, 
many limitations and problems with the connection process pointing to future directions 
that remain to be explored.
5.9.1 CCR limitations
CCR was used in building the EHR system prototype; however there is no biological 
specification in CCR. The clinical specifications are not detailed in CCR, so many 
design decisions had to be made in choosing labels and in the mapping process. In the 
following context several examples will be used to describe the problems faced in using 
CCR.
'Laboratory results' and 'therapeutic results' are two examples in the definition of 
'Results' (i.e. one of the CCR attributes). However, there is no further explanation about 
how to distinguish the two labels. Semantically, therapeutic results and laboratory 
results can overlap with each other since therapeutic results can be indicated by 
laboratory results. It would be very difficult to decide which label should be chosen 
without detailed differentiation between the two labels. For example 
'Increased_value_of_mucus_clearance', 'Bone_density_increased', 
'Nutritional_status_improved': should these belong to 'laboratory results', 'therapeutic 
results', or both? If there is an exact value for bone density, then the specific value of 
the bone density should be collected under the laboratory result. However, in most 
reviews of patient's records, or extracted patient's records, there is a lack of detail about 
the examination that the patient has taken. Currently all the three examples above are 
collected under "therapeutic results", however, this has been a design decision only.
'Conditions' and 'diagnoses' are two examples for 'Problems' (a CCR attribute) while 
'diagnostic results' is an example for 'Results' (another CCR attribute). How should the 
three labels be distinguished? What types of relationships are there among the three 
labels? This is unclear. Under 'Problems' I did not include 'diagnoses', but I did use 
'diagnostic results' under 'Results'.
In the current EHR system prototype we have not included different mutation test 
methods. According to the CCR specification, different mutation test methods can be 
included in 'diagnostic procedure'. However, the mutation results will be in 'laboratory
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results'. Considering there is a heading- 'diagnostic results' in CCR, this would be 
inconsistent if details of different mutation test methods were included. Which should 
be the heading for mutation results: 'laboratory results' or 'diagnostic results'? It is not 
the intention of this research to provide an exclusive CFTR mutation, but rather a 
representative of CFTR mutation.
Generally, there is a lack of biological labels and a lack of sufficiently detailed 
difference/explanation/differentiation among the various labels in CCR.
5.9.2 Mapping limitations and merits
Mapping between OntoKBCF and the CCR labels manually can work well. However, in 
the automation part, there are some limitations.
How to keep the mapping reasonable without sacrificing simplicity in the coding was a 
major challenge. Logically 'reasonable' means placing both parents and children under 
the same CCR label as parents and children. For example: 'Nasal_polyps', and 
'Recurrent_nasal_polyps': semantically both of the concepts should be collected under 
'Symptoms' The actual hierarchy in the domain (KBCF) part of OntoKBCF is that 
'Recurrent_nasal_polyps' is a child (subclass) of 'Nasal_polyps. However, the class and 
subclass relationship will be too complex for coding should we want to make the 
procedure automatic. To define the two concepts as siblings under the concept 
'Symptoms' would be much easier for coding, but it would be a logical conflict. The 
hierarchical relationship in the domain part is parent and child and they cannot be 
siblings in the EHR part within the same knowledge base. Only one of the concepts was 
kept in the EHR part in the real practice. This was a pragmatic decision.
In the current version mapping focuses mainly on hierarchies of concepts, without 
considering the 'property' descriptor. Mapping simply based on the hierarchy only is not 
sufficiently detailed to represent the exact meaning, and hence there will be some 
information loss. 'Recombinant_human_deoxyribonuclease' is a subclass of 
"substance" in the domain hierarchy; 'treated_by' (property) is used to represent the 
therapy using this substance in OntoKBCF. There is not a method listed as a separate 
subclass of therapy in OntoKBCF. The hierarchy-only method cannot express the 
original meaning completely and precisely.
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Although there are some limitations in mapping, the mapping structure in OntoKBCF 
brought some advantages for knowledge representation in the domain part as well. The 
EHR mapping structure provided help to OntoKBCF with more constraints in 
knowledge representation. For example, in the property 'has_manifestation_of, with 
EHR structure in OntoKBCF, we can restrict the property in 'symptoms' and 
'conditions' classes. Before the EHR structure was added into OntoKBCF, the 
subclasses of the two classes were distributed in every corner of OntoKBCF; it was not 
realistic to restrict the property in every single class.
5.9.3 Automation limitations
It would be ideal to make the connection part completely automatic, which is critical for 
future updating; however there are still limitations to this process.
The tables or the part of the tables in the Access database could not be extracted 
automatically if the required fields were related to the property description, for example 
"has_manifestation some Pancreatic_insufficiency", or "occur_in_ age_group some 
Adolescent_age_group", because the representation could not be displayed correctly in 
the converted table. The content would be displayed as an internal string, such as 
"@_:A98". So the tables used in the EHR prototype could not be created completely 
automatically from the converted table.
5.9.4 Nomenclature of the titles in the EHR interface
The titles of the five OntoKBCF-related boxes in the EHR interface are related to their 
origin, not necessarily related to the contents/items themselves listed in the boxes. For 
example, in the ethnic related box, any knowledge fact related to particular ethnicity 
(such as the most possible CFTR mutation related to Swiss or Italian patients) will be 
listed, however, the knowledge facts themselves are not about ethnicity (in this case 
they were caused by CFTR mutations).
In one of OntoKBCF-related boxes' titles in the EHR system prototype interface, 
Therapy related' is used instead of 'Therapeutic procedures related' or Therapeutic 
results related' This is because the knowledge facts themselves, which are listed in the 
box are therapeutic results, which result from the corresponding therapeutic procedures. 
This means the facts in this box are related to both 'Therapeutic procedures' and
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Therapeutic results'. So 'Therapy related' was therefore chosen as the box title. 
5.10 Summary
In this chapter I have presented the EHR system prototype interface, its construction 
and its connection with OntoKBCF; what function the EHR system prototype and the 
connection part have; how to automate the connection; how to map OntoKBCF and the 
CCR labels; what are the current results; and what are the known limitations and 
difficulties. Generally I have answered questions about "what", "how", and "why" for 
the connection between OntoKBCF and the EHR system prototype in this chapter. This 
is an extension for OntoKBCF in both content structure and application. This is also an 
exploration towards a more active future EHR system prototype.
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The ability to deliver formal and structured bio-health information in a clinical setting 
has huge potential. It is key to personalised health care services, since biological 
information is fundamental to understanding more of the unique traits of an individual 
and also plays a critical role in the determination and explanation of disease. In this 
research such personalised information has been presented via a CCR-based EHR 
interface and tested by a number of test records. This chapter will restate the research 
results and interpret them, then compare this research with other research, to present the 
significance, limitations, experiences and future directions of this research.
6.1 Restatement of results
The major results of this research have been to show:
1) How biological information associated with health information can be organised in a 
formal, structured way in an ontology-based knowledge base.
2) How the bio-health information can be made accessible through a CCR-based EHR 
prototype, which not only reveals the content and structure of the underlying 
knowledge base but presents the personalised bio-health information via the 
interface.
It is a step towards seamlessly linking the two types of information, which presently 
remain largely unconnected, but which will inevitably come closer together.
6.2 Interpretation of results
The primary results of this research can be divided into three parts, results of the 
ontology work - OntoKBCF, the EHR prototype, and the connection between the two. 
The three parts will be interpreted in turn.
6.2.1 Findings related to OntoKBCF
OntoKBCF has three characteristics:
1) The bio-health information is organised in a formal and structured way.
2) It has both basic concepts and final knowledge facts.
3) It can be used not only as a knowledge management tool but also an
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application of semantic web technology.
The bio-health information is organised according to accepted ontological principles 
found in the literature. The proposed organisation should ideally be capable of 
improving how such information can be used, reused, shared, and communicated. At the 
same time the organisation should attempt to decrease information overload to the body 
of users who already complain of being overwhelmed. In such a short study it is not 
possible to directly prove all these sub-goals. Therefore part of the strategy was to 
deploy technologies and develop tools that are already recognised as having some of 
these benefits. For example, 'reuse', 'sharing' and 'communication' are promises or 
realisations of existing semantic web technology, and consequently these are also found 
in OntoKBCF.
Decreasing information overload is one sub-goal that is more difficult to show in a 
study like this, because 'overload' might be considered to be a subjective concept, 
depending on the user and their context at any one point in time, and user-testing is 
beyond the scope of this study. However, it is possible to organise the knowledge base 
model in a principled way that should make the sub-goals achievable:
1) The fact that the bio-health information in OntoKBCF is based on an ontology 
permits a more systematic organisation, and better structure with less 
redundancy.
2) The explicit relationships within the knowledge base permit information to be 
tailored to a defined context rather than delivering the whole set of information 
in one go. The association of biological and health information in OntoKBCF 
makes it feasible for further mapping and information customization via the 
EHR prototype interface.
3) It provides basic concepts and final knowledge facts from the same source.
There is an argument that by bringing bio and health information together automatically 
an increased volume of information will be created and therefore 'overload' is inevitable. 
However, the inescapable fact that these types of information are required and will be 
brought together means that tools such as OntoKBCF and the approach used here may 
be used in the future to either minimise the excess potential or perhaps through 
;ophisticated filters and tailoring to avoid deluge. This research has started this work.
s
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An original aspect of this research is to attempt to avoid knowledge overload by precise 
knowledge extraction because of clinically-driven queries.
From the structural point of view of OntoKBCF, there are basic concepts (including 
both biological and health concepts, for example 'Gly', which is Glycine), combined 
concepts (i.e., more specific classes based on existing classes from UMLS or GO, for 
example "Gly542X\ which is an amino acid substitution), and final knowledge facts 
(i.e., concepts with associated OWL conditions, for example the properties related to 
'Patient_CF_with_Gly542X). This structure has provided a stable foundation 
throughout the project. It permits restructuring and revision without compromising the 
overall integrity of the ontology. It also proves useful in establishing connections 
between the knowledge base prototype and the EHR prototype.
OntoKBCF uses different cystic fibrosis patient groups (such as patients in different age 
and patients with different CFTR mutations etc) as subjects to organise the related 
properties together. The knowledge facts organised by this method can be properly 
accessed through the EHR prototype (although only by manual processes at this time).
The structure provides a useful way of navigating content. For example, a combined 
concept can be traced down to the appropriate more basic concepts. Although this may 
not be revealed to doctors completely via the EHR prototype, it is an inexpensive way 
of showing the relationships between concepts and this might help a user in 
understanding or interpreting the complex combined concepts. For biological 
information, the hierarchies of supporting concepts (both basic concepts and combined 
concepts) for cystic fibrosis patients with different mutations can be made accessible 
through the EHR prototype. At present supporting concepts for mutations within the 
knowledge base include the position and mutation type of amino acids or nucleotides; 
these concepts can be traced by hierarchies.
OntoKBCF is also an application of semantic web technology. It is quite common to use 
ontological principle in knowledge management, for example in biomedical 
vocabularies e.g. UMLS and GO, and in knowledge resources e.g. the Foundational 
Model of Anatomy (FMA). From a functional point of view 180 OntoKBCF can be used 
as an encyclopaedic knowledge resource for bio-health aspects of cystic fibrosis. The 
structure and content are accessible through the EHR interface. To use OntoKBCF
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through such an EHR interface is a step forward in exploring ontology application in a 
clinical setting.
There are many aspects that could be used to describe a mutation, for example mutation 
locations (amino acid location, nucleotide location, chromosome location, affected 
codons etc), mutation types (deletion, insertion, substitution, transition, transversion, 
complex mutation etc), exact nucleotide or amino acid change, related phenotype 
(molecular, tissue or organism level). Considering this research targets the 
non-specialist doctor, such as a GP, who is not a molecular geneticist, only the most 
basic characteristics of mutation have been included rather than the comprehensive set 
of characteristics of mutation and interpretation recommendations71 .
6.2.2 Comparison of OntoKBCF with similar research
Existing research is reviewed in Chapter 2 but here I will focus more on the differences 
between the published research and my solution in OntoKBCF.
PharmGKB 181 and PheGe53 involved both genotype and phenotype data. In both cases 
the development work provided a more comprehensive representation at a specific level 
of hierarchy, i.e. horizontally (Figure 6-1). Compared with those two studies, 
OntoKBCF provides a representation of bio-health information, starting from basic 
concepts to final knowledge facts, including both sequence variations information and 
clinical symptoms that move between levels of the hierarchy, i.e. vertically (Figure 6-1). 
Full information at any level has not been represented completely in OntoKBCF (Figure 
6-1), for example sequence variations information has included some CFTR mutation 
types without exhaustive CFTR gene mutations or mutation types. Whereas in 
OntoKBCF both biological and health information is defined in a formal and structured 
way using ontological principles. By contrast, PharmGKB developed only an XML 
format for genotype data. OntoKBCF also extends the application to a CCR-based EHR 
prototype whereas PharmGKB is a stand-alone knowledge base and PheGe is a platform 
rather than an end-user application for specific content.
CBO51 was an ontology for describing clinically significant genomics concepts, which 
involved more detailed vocabulary related to molecular diagnosis and cytogenetics. 
However, this was confined to the horizontal level and it was very comprehensive. If the 
content represented in CBO can be described as a surface, then the content represented
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in OntoKBCF would represent a line which goes through the CBO surface. OntoKBCF 
provides vocabulary, semantic hierarchies and final knowledge facts. Most of the 
content in OntoKBCF can be presented in response to patient's parameters being 
entered through the EHR interface.
Unlike Kumar's research52 , OntoKBCF includes the concepts from nucleotides to 
disease phenotypes. The content in OntoKBCF is organised on two axes: time-oriented 
and problem-oriented, and the knowledge scope is established at the outset. However, 
that constructing a knowledge base is only the first part of this research.
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Figure 6-1 The EHR as container of diverse and complex data
Compared with GO and UMLS56' 182 , OntoKBCF includes both basic concepts and 
representation of final knowledge facts. Both of these tools have been used in 
OntoKBCF's construction.
Unlike LSDB73 ' l83 , OntoKBCF is based on semantic web technology whereas most 
LSDB are based on database technology and are stand-alone, for example CFMDB. The 
formal and structured bio-health information in OntoKBCF can be made accessible 
through the EHR prototype, which provides a simulated clinical system for 
OntoKBCF's clinical application.
6.2.3 Findings related to the EHR prototype
The EHR system prototype has several characteristics:
1) Formal and structured biological information can be made accessible.
2) The EHR system prototype is based on an international standard -CCR.
3) Accessible information from OntoKBCF can be filtered according to a patient's
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parameters.
4) The hierarchies within the knowledgebase provide a descriptive model of the 
domain, making explicit and clear the meaning and interrelationships between 
concepts at the interface.
Currently the biological information included for access via the EHR prototype is gene 
and protein sequence variations information. There is no exact corresponding heading in 
the CCR specification which can be used explicitly to include these sequence variations. 
The mutation information could, however, fit in the 'Results' as one type of'Laboratory 
results', which is a heading in CCR. Different mutation detection methods could also be 
fitted into 'Diagnostic procedures'.
Building a standards-based EHR system prototype to simulate the clinical system 
provides several advantages: First, it means that the underlying standard provides a base 
for many implementations. This avoids the need to examine each implementation 
separately, and makes the testing easier and the study more manageable. Secondly, any 
findings related to the standards-based EHR system prototype will contribute more to 
the domain. When the standard is modified to accommodate genetic information, 
existing implementations will have to be brought up to date if they are to comply with 
the standard, and new implementations will automatically conform. Furthermore, a 
standards-based EHR prototype provides potential for future communication, reuse and 
underpinning of a consistent data model.
The content and structure of OntoKBCF is accessible via the EHR interface and 
bio-health information can be personalised according to patients' parameters. Currently 
in this prototype patients' parameters include age, sex, ethnicity, and existing bio-health 
status, for example: patient's symptoms or diagnostic procedures. The structure of 
OntoKBCF can be used as a single explanation of semantic relationship for simple 
concept (for example hierarchy of coughing) and also can be used as a group 
explanation for a complex concept, for example: Patient_CF_with_Gly542X includes 
hierarchies of Patient_CF_with_Gly542X, Gly542Xand Gly542.
Explanation in OntoKBCF is more comprehensive compared with what is accessible via 
the EHR prototype interface: e.g. the affected gene or protein name, affected codon, 
mutation type. There are two reasons why not all of these explanations have been
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transferred through the EHR system prototype interface: 1) we have not transferred 
explanations that would either repeat existing ones or ones which are too similar; 2) 
property descriptions from the Protege-OWL environment can currently only be used 
automatically to a very limited extent. Explanations that utilise properties can only be 
transferred manually.
6.2.4 Comparison of the EHR prototype with similar research
Hoffman recommended incorporating clinically significant genomic information into 
the Electronic Medical Record (EMR). However, in that paper he did not describe how 
to fit specific genomic information into an EMR. He described more what was available 
and what the problems were but did not provide a concrete solution. The current 
research has not solved all the problems of bringing genetic information into a clinical 
setting, however. This research has, rather, explored how to organise biological 
information (mainly sequence variations) and health information in a formal, structured 
way and how to fit the content and structure in the knowledge base into an EHR 
prototype.
Hoffman, in another study51 , provided a clinical bioinformatics term/vocabulary support 
for Hospital Information System (HIS). In this research a bio-health knowledge base 
works as an active support for the EHR system prototype. In Hoffman's research rich 
terms are listed to describe findings by molecular diagnostic procedures and then 
imported into a commercial HIS system: his work can therefore be considered to be 
more horizontal; whereas OntoKBCF is on a vertical level, connecting the elementary 
concepts in biological and health fields, and it plays an active role after being embedded 
into an EHR system prototype.
Tange's 184 review of electronic medical record systems, was concerned with medical 
narrative data. This type of content has been involved in the research; however, it is not 
the focus. Most of the systems mentioned in the review used coded terms, controlled 
vocabularies or free text for medical narrative data; whereas both controlled 
vocabularies and structured concepts have been used in this research: these are in formal 
format to help in computer processing.
The Infobuttons44 49 research and this research share some characteristics, are reviewed 
in Chapter 2. My solution has been to construct a knowledge base prototype, from
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which knowledge facts have been organised formally and structurally and are 
personalised according to patients' parameters (such as age, sex, ethnicity and existing 
bio-health status) within an EHR system prototype. However, Infobuttons works by 
building an HTTP request according to specific clinical context and generating different 
URL hyperlinks for different knowledge sources. Their solution is more of a "portal" to 
relevant links rather than a final stop. The results of this research include hierarchies of 
concepts, and final candidate information related to a particular patient. Infobuttons 
researchers were trying to develop HL-7 based HTTP requests to tackle the 
communication problem 185 . Whereas one of the important characteristics of the solution 
in this research is the data sharing ability which was introduced through the semantic 
web technology. However, to update the knowledge base in this research is a challenge, 
and it would require sophisticated means to automatically keep the bio-information 
relevant. Infobuttons has the advantage of retrieving information from third party 
knowledge resources and relies upon their maintenance. Moreover, this research is a 
"lab product" compared with "Infobuttons", which has been integrated into real CIS.
6.2.5 Findings related to the connection between the knowledge base and the EHR
In this research the connection between the knowledge base prototype and the record 
prototype is also important, i.e., to make the formal and structured information 
accessible via the interface of the EHR system prototype is almost an application and 
research project in itself. Through the connection work it was realised that it is not 
currently realistic to connect the two parts by using simple query results, which would 
have made a clean interface between the two major components. Therefore an EHR 
related structure had to be constructed in OntoKBCF. This structure works as another 
axis in OntoKBCF with which to organise the major concepts. This structure is vital for 
establishing an automatic connection and making the hierarchy and content of 
OntoKBCF accessible through the EHR interface.
Through the EHR prototype interface, the hierarchy of basic concepts and combined 
concepts in OntoKBCF can be made accessible. This can be done both manually and 
automatically; however most of the knowledge facts in OntoKBCF at this time can only 
be used manually through the EHR. The reason for this is that the property descriptions 
and logic representations, whilst easily understood by human users, cannot be 
terpreted by the machine (i.e. the software) as it is not yet sufficiently developed toin
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permit automatic processing. 
6.3 Research significance
This research is a starting point for including bio-health information in the clinical 
system. The sequence variation data can be represented and organised and also can be 
used in this way. Explanation of mutation position, amino acid or nucleotide may be 
used to support non-specialist doctors in interpreting mutation in their consultation with 
patients. The degree to which this helps in clinical practice will need to be formally 
tested in future work.
This research is also a preliminary exploration of an active EHR system. To offer 
customised information automatically is one characteristic of what might be called an 
active EHR system, moving beyond a passive repository of clinical data. The biological 
and health information can be customised according to patient's parameters. It is 
consistent with the direction of EHR system's development: from management system 
to clinical system, from passive service to active service. The customisation of 
bio-health information is a potential help for doctor's information overload as it filters 
out what may be irrelevant.
This is also a starting point to connect a knowledge base with an EHR prototype. 
Although this research uses cystic fibrosis as an exemplar, the structure and organisation 
of the bio-health information and the way it is used in the EHR prototype may be 
generalised to other diseases, which have a clear cause of gene mutation and available 
associated health information. This is a good foundation for future automatic connection 
between complex knowledge bases and the EHR system.
This research explores the organisation of a range of knowledge: from nucleotide to 
organismal phenotype, from basic bio-health concepts to final knowledge facts in the 
same knowledge base. OntoKBCF plays an active (offer personalised information) and 
supporting (display hierarchies of concepts) role via the EHR prototype. The way 
bio-health information is organised in OntoKBCF and the way the content of the 
knowledge base is mapped to the EHR prototype are feasible.
Although there is a lack of solid foundation for plotting the precise pathway between 
biological base and pathologic status, even for cystic fibrosis, the two ends are loosely
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coupled in OntoKBCF. This research provides a foundation for creating a way to 
explore the relationships between biological information and disease status by bringing 
biological information into a clinical setting, which could be a platform for relationships 
study. This way is complementary to experimental validation, mathematics or statistics 
computing and modeling etc. and permits the same question to be seen from a different 
perspective.
6.4 Potential benefit
In this section the potential benefit for carrying out this research is explained. It should 
be noted that most of the benefit would be long term, which is not direct benefit from 
this research. Currently the research is a starting point.
To integrate biological information into clinical systems would benefit doctors, 
biomedical researchers, clinical system suppliers and standards development 
organisations in long term. Doctors would get more support in interpreting genetic tests 
results which in future might also influence treatment or prognosis guidance for patients, 
which depend on the domain research findings. Apart from that the prototype could be a 
tool for training and educating doctors who have to manage cystic fibrosis. For example, 
the tool may help to interpret the genetic test result correctly.
Biomedical researchers would get new perspectives in understanding relationships 
between biological information and disease status. The clinical system could be a 
platform for new precise evidences for connection research between biological 
information and disease status. For relationship research between biological information 
and disease status, this is also a complementary method.
Clinical system suppliers would benefit from the research for future systems integrating 
biological information. With the importance and huge amount of the biological 
information available revealed, biological information will inevitably be included in 
health records. This research is a preliminary exploration in this direction.
The research may benefit standards development organisations in integrating biological 
information into the new electronic record standard. Currently, at least for CCR, there is 
no explicit heading/structure for biological information. This research provides a 
starting point to do systematic research on how to integrate biological information into
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the new generation of record standards. 
6.5 Research limitations 
6.5.1 End user evaluation
The current research lacks formal end user evaluation of usability for the connection 
prototype. This will be required in any future work, but the focus of this early research 
has been on the feasibility of bringing the two types of information together and the 
functionality has been tested through the use of hypothetical records at this stage. 
Compared with the typical usability evaluation for clinical information systems 186, the 
future user usability evaluation for this research should focus on the content provided 
from OntoKBCF and the way the content is presented through the EHR interface, rather 
than being concerned with the efficiency of the EHR per se. Generally such evaluation 
will include answers to the following questions: 1) Is the content useful for a specific 
purpose? 2) Is the presentation method of the content, e.g. items in the OntoKBCF 
related boxes, tree view and extended tree view, helpful or are there better ways of 
presenting the same information? 3) How accurate is the presentation of the content and 
to what extent is information lost in different presentation styles? 4) How easy can the 
full content be displayed in front of a user and to what degree summarization and 
further explanations are required?
For question 3 for example, a major issue related with user's evaluation relates to the 
presentation method of the content from OntoKBCF which might not be sufficiently 
accurate or clear:
a) For example: CFTR AA2183_minus_G (a CFTR mutation) is a mutation which 
has relatively high prevalence in Italian CF patients. This connection has been 
used as a filter in the connection prototype (see Figure 5-10). If a patient has 
this mutation, then in the 'mutation related' box 'Italian' will be displayed. It 
suggests that the patient might (but not necessarily) be an Italian. However if a 
user is not familiar with the interface and/or the mechanism behind it, there is 
likely to be a misunderstanding. This might be corrected by training users to 
use the tool appropriately but changing the interface and the interaction might 
provide a clearer presentation of the original statement of knowledge to remove 
potential confusion;
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b) Another example relates to the knowledge editor tool and to the extent it can 
represent uncertain knowledge.
The other major issue is essentially to do with the working context. In this research we 
have not yet tested the interaction between the display of the content from OntoKBCF 
and a user. The current preliminary method assumes a non-specialist user who would 
get the required support by providing knowledge hierarchies and showing location 
explanation for sequence variations; however the real users' requirements are likely to 
be much more complex and diverse depending on the context. The type of support 
required will vary from user to user. To test this would require the prototype to be much 
more comprehensive so as to permit meaningful usability evaluation. Full scale 
usability evaluation, looking at the cognitive and contextual issues, will be necessary to 
make a full implementation useful and usable for clinicians during the consultation.
6.5.2 Filters
The patient's demographic data was used as filters to customise the whole related set of 
information from OntoKBCF. At the moment the filters include age, sex, ethnicity and 
existing descriptions of individual patients' bio-health status. The filters rely on both the 
headings of the EHR system and the knowledge source of the exemplar disease. Age, 
sex and ethnicity are basic factors for medical records.
Originally some queries related to smoking (lifestyle) were tried by using Nucleotide, 
DDBJ, EMBL, OMIM and CFMDB, Genetic Home Reference, the Cystic Fibrosis 
Foundation 131 , Mayo Clinic 134 , and two text books" 9' I2° and PubMed. The reason for 
making these queries was to see whether there was any biological information related to 
smoking in cystic fibrosis patients; if there was any result then the result could be 
included into OntoKBCF and smoking could become another filter. However, the lack 
of proof is symptomatic of the current gaps in domain knowledge, and as the knowledge 
matures then more filters can be introduced. The customised information has been 
proved by realistic but hypothetical test records; a more generalised conclusion will 
need an extensive evaluation.
6.5.3 Query of ontology
Given that OntoKBCF construction used a mature knowledge base development
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environment, it was presumed that it would be a straightforward step to query the 
content. Consequently, attempts were made to use Protege-OWL 3.3.1, Sesame2.0 187 
and TopBraid Composer 2.3.1 188 for this purpose, but, surprisingly, all failed to produce 
the required results or to deliver acceptable file export formats.
Because the direct query did not deliver the desired results, the idea of getting proper 
query results and to using the result in an EHR system was aborted. Ideal query results 
cannot be achieved by SPARQL either through Protege-OWL or TopBraid Composer or 
SeRQL through Sesame, at the time of this research.
6.5.4 Information loss
Moving information between the loosely-coupled components of the overall system 
resulted in loss of information. From knowledge representation to knowledge 
presentation via the EHR interface some information loss occurs at each step. For 
example, in the knowledge representation part, imprecise content (such as "mostly" or 
"especially") cannot be represented precisely through Protege-OWL.
Not all information within OntoKBCF could be mapped directly onto headings of CCR. 
For example: 'recurrent_coughing' is a subclass of 'coughing' in OntoKBCF domain 
part, both of which can be mapped to the CCR heading  symptoms'. However, in the 
EHR part of OntoKBCF, 'recurrent_coughing' and 'coughing' cannot retain a 
hierarchical relationship if they are both under 'symptoms'. This conflicts with the 
domain part in OntoKBCF. The solution in this research is to keep the specific one, 
"recurrent_coughing\ which is a pragmatic choice. However, this choice leads to 
information loss.
Not all the information in OntoKBCF can be transferred through the EHR interface 
without loss. For example, in OntoKBCF there is a final knowledge fact about the child 
cystic fibrosis patients: "hasjnanifestation some Heat_exhaustion". This means in child 
cystic fibrosis patients, patients will have heat exhaustion as a manifestation and may 
also have other manifestations. However, in the EHR system prototype interface 
'Heat exhaustion' will be displayed under the 'Age/Sex related' box as a possible 
candidate fact for child cystic fibrosis patients. This display does not provide a clear 
statement of the manifestation, i.e. an "all values from" (only have manifestation of heat 
exhaustion) or a "some values from" situation (may have other manifestations apart
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from heat exhaustion). It would be part of the user testing to determine the balance 
between full context being provided and minimising load through the EHR. In future, 
maybe, the presentation of candidate information from OntoKBCF through the EHR 
interface could include more detail, adding specific explanation or original description 
from the knowledge resources.
6.5.5 Knowledge sources
When OntoKBCF was constructed only sufficient knowledge sources were included to 
prove the concept rather than attempting to collect all comprehensive knowledge 
resources. Figure 6-1 provides a schematic overview of the layered knowledge base 
exploiting the metaphor of an EHR as a container and drawing from clinical and 
bio-information. The content produced for the knowledge base prototype, depicted by 
the horizontal levels in Figure 6-1, is sufficient to organise the relationships between the 
vertical levels for this research but not exhaustive. Other high quality knowledge 
sources which have not been included in current prototype are: for example, UpToDate, 
Clinical Evidence, Best Evidence and so on' 52(p441).
There are many different approaches to achieving the research aim and even for the 
same approach there are still many different tools available. A pragmatic selection to 
accomplish the research aim was made; other possibilities are considered in the section 
on future research.
6.5.6 Biological research
Although significant progress has been made in explaining the biological essence of 
pathologic status, this is put into perspective when we consider the individual's lifestyle 
or the contextual environmental factors. The whole picture is then far from clear or 
complete even for monogenetic disease, not to mention polygenetic diseases. The 
science and technology have not yet reached the necessary level to explain all the 
mechanisms involved clearly, and it is doubtful they ever will. However, the recent 
discovery that diabetes may be due to a virus which attacks those with a genetic 
susceptibility only underlines the importance of understanding the relationships between 
the two types of knowledge. All of these factors make it far more difficult to decide 
what biological information should be included in clinical applications.
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It is clear that although genetics has an important role to play, environmental and 
lifestyle factors are also very important given the complex, multi-facetted nature of 
health. Genetics, although fundamental, is also relatively stable and therefore long term: 
'quick' and observable changes in conditions such as increases in diabetes or obesity 
will probably never be fully explained just by genetics.
Although not a limitation per se, one lesson learned was that it would appear prudent to 
do the connection work manually before considering automation. The manual process 
can give a clearer picture about the requirements for the connection and automation.
6.6 Future directions
In future user usability evaluation should include hierarchies and final knowledge facts 
evaluation by using credible numbers of users under a strict design. The tree view part 
provides a reference box for the user before the concept is added into a patient's EHR 
record. In the future full usability evaluation of this supportive role will be necessary in 
order to give feedback about the usability of knowledge structure and knowledge 
representation. Currently only the location information for mutation is included as a 
reference in the tree view box. In future it might be possible to add more types of 
information (apart from sequence location) so as to give the user a more comprehensive 
picture of the targeted item. Another related study would be to conduct a semantic check 
before an item is added from tree view to a patient's record in order to prevent mistakes.
A further task might include surveying the biological information needs of GPs, genetic 
specialists and other stakeholders, including patients. There is no direct biological 
information requirement from doctors available at the moment. There are many surveys 
of doctors' information needs, however, none have been found which focus on detailed 
classification of the contents that doctors need in their information seeking behaviour.
-> jo
All evidence is indirect '
Currently the filters which were used in customising bio-health information in the EHR 
system prototype are static. Some of the filters will never change e.g., date of birth, sex, 
and ethnicity. Other characteristics such as blood group, iris and the immunisation status 
might be other types of filters that could be considered subject to availability. The 
systematic research of all the possible filters for genetic disease or other diseases might 
also be a future research topic.
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Another future research direction related to CCR extension involves how different types 
of biological information could fit into the CCR structure; what new headings and new 
structures should be added; and what the detailed attributes and value ranges of these 
new pieces of information are.
Currently classes/concepts/hierarchies of the knowledge base are accessible through the 
EHR prototype. The parts related to property description and logic representation in 
ontology ("Asserted condition" part in Protege-OWL interface) cannot be currently used 
directly, and this provides one area for further work.
There are two directions which can be explored on the technical level: how to use 
OntoKBCF output XML file and how to improve the ontology query results. In the 
current study the converted database table file from OntoKBCF was used for connection. 
There are many characteristics in the ontology which cannot be reached by present 
query, for example the properties description cannot be queried. This leaves space for 
future exploration.
Other directions need to be explored, for example the possibility of generalising to other 
genetic diseases by following the structure of OntoKBCF, the comparison with other 
EHR standards for the EHR-s prototype, and different knowledge structures or 
representation in OntoKBCF.
6.7 Summary
In this chapter the research results have been restated, interpreted and compared with 
other studies. Afterwards the research significance, limitations and future directions 
were discussed. This research has provided a useful starting point for including 
biological information directly into clinical applications. This is an explorative step 
towards an active EHR system; some of the present structure in OntoKBCF can be used 
automatically through the EHR system prototype, while certain parts can only be used 
manually. As a proof of concept the research achieved its aim. However, more research 
is required before the integration between the two types of knowledge becomes 
seamless and fully automated.
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7.1 Summary of the thesis
The aim of this research was to make formal and structured bio-health information 
accessible through a standards-based EHR system. A prototype was successfully 
constructed to prove the concept. Here I will give a brief review of what has been 
included in this thesis.
The first chapter gives the general context and background of this research and the 
motivations behind it: i.e., essentially the importance and rapid increase of biological 
information and the need to link it with health information in a formal and structured 
way such that it can be delivered in manageable quantities at the point of care. The 
increasing numbers of Electronic Health Record systems being used at the point of care 
suggested that this would be the tool used by doctors to filter the information and make 
it accessible. Furthermore, the recent emphasis on technical standards or specifications 
to underpin such systems suggested that the EHR and EHR-s should be standards-based. 
Although an area of increasing research, little could be found in the literature that 
combined these areas. The research aim and general solution follow from the motivation 
to explore the feasibility of accessing formal and structured biological information and 
associated health information by an ontology-based knowledge base prototype via a 
standards-based EHR system prototype. The major contributions of this research were 
presented.
The second chapter presents the literature review. Three primary parts include:
1) The rationale for this research and its position amongst existing similar work: e.g. 
because biological information is critical in understanding disease and the precise 
route between biological information and disease status is not completely clear; to 
bring biological information into simulated clinical setting provides a 
complementary method for relationship research between biological information 
and disease; there is no published research to the author's knowledge to bring 
ontology-based bio-health information, more precisely nucleotide sequence and 
amino acid sequence, to EHR systems;
2) The technical approach of this research: i.e. the reasons for selecting the technology 
used (i.e., ontology-based knowledge base and EHR system prototype) e.g., 
ontology makes the bio-health information reusable, sharable and extensible,
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whereas EHR systems are one of most popular tools used in the clinical setting;
3) The choice of test domain, i.e., the candidate biological information resources, tools 
and exemplar disease-cystic fibrosis.
The third chapter is about research methodology. The research question, conceptual 
framework, research strategy, general procedures, research evaluation, requirements and 
functions of the knowledge base and the EHR prototype, reasons for choosing CCR as 
the standard and development environment introduction are included. This is an 
overview chapter about what was to be done. An ontology-based knowledge base 
prototype of cystic fibrosis was used to organise formal and structured bio-health 
information and a CCR-based EHR system prototype was built to interface with the 
knowledge base prototype.
The fourth chapter is one of two substantive content chapters, specifically about the 
construction of the ontology-based knowledge base prototype, named OntoKBCF. The 
detailed prototype construction work is included: i.e., OntoKBCF's scope, granularity, 
major axes, structures and specific construction procedures. Three examples are used to 
explain how knowledge facts have been organised in OntoKBCF. A summary of 
OntoKBCF, the rationale of the construction approach, design decisions and the 
limitations of OntoKBCF are also presented.
The fifth chapter is the other major substantive content chapter, specifically about the 
development of the EHR system prototype and its connection with OntoKBCF. 
Motivation for using the EHR system prototype is explained. Included here are the 
detailed procedures for building the EHR prototype; the connection with OntoKBCF; 
the mapping between CCR labels and OntoKBCF; and the degree to which the process 
can be automated. Following this, verification of the connection are shown through 
screenshots. OntoKBCF is shown to be actively accessible through the CCR-based EHR 
system prototype. The limitations of the EHR prototype and connection part are 
discussed.
The sixth chapter brings the parts together. The research results are shown and 
interpreted; research significance, implications, limitations and future directions are 
reviewed. As a proof of concept research study, the research aims have been achieved 
successfully in this study. It is nothing more, but nothing less than a good starting point 
to integrate formal and structured sequence variation information into the CCR-based
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EHR system prototype and to present the customised bio-health information via the 
standards-based EHR prototype interface. The way to organise bio-health information in 
the ontology has been proved to be usable through the EHR prototype. The 
standards-based approach has the potential to provide a common underlying model for 
many EHR systems, irrespective of implementation. Basic concepts and combined 
concepts in OntoKBCF can be used automatically through the EHR prototype; the final 
knowledge facts in OntoKBCF can, to some extent, be used automatically. The 
knowledge base prototype can be connected with the standards-based EHR system 
prototype as perhaps one of many knowledge bases.
7.2 Restatement of aims
The general research goal of this research is to explore how to integrate different types 
of knowledge seamlessly into a clinical setting. The research aim is to explore the 
feasibility of offering formal, structured biological information and associated health 
information via a standards-based EHR system prototype.
7.3 Contributions of the research
The major contributions claimed for this research include:
  The bringing together of sequence variations information with health 
information using a standards-based EHR.
  The construction of an ontology-based cystic fibrosis bio-health model (the 
first of its kind) and knowledge base prototype.
7.4 Recommendation for future work
This research has raised the prospect of many future directions in need of further 
investigation. There are two directions in particular that I believe should be considered: 
1) how to further personalise bio-health information through an EHR and 2) how to 
connect a stand-alone knowledge base into an EHR system.
7.4.1 Personalise bio-health information in the EHR
Personalised information is clearly beneficial for the patient, but it is also useful for 
doctors in relieving them from the burden of information overload caused by
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irrelevance. This research is a starting point in personalising bio-health information in 
the EHR prototype by filters. A method that might be used in future in personalising 
bio-health information through EHR would be to systematically investigate the 
suitability of other candidate filters, which may include headings from the EHR-s 
demographic data (apart from age, sex, ethnicity which are used in this research), 
epidemiologic data (such as life style and environmental factors), lab data (i.e. more 
biological genetic test results apart from just sequence variations) and clinical data (i.e. 
more types of diagnostic and therapeutic procedures etc.).
The filters are fundamental in providing personalised bio-health information. A method 
to carry out a systematic investigation of filters may include the following steps (using 
cystic fibrosis as an example): 1) to select all the factors closely related with cystic 
fibrosis that also can be found in an EHR, such as smoking, lung function test values, 
family history etc; 2) to consult with domain experts about what factors may correlate 
with a patient's molecular genetics change; 3) to retrieve literature to look for available 
evidence from both health and biological aspects according to suggestions from step 2; 
4) review the retrieved literature and revise the filters to satisfy the available evidence. 
This method may also help to draw a clear domain map to indicate the current research 
gaps, to help experimental design and to choose domain research topics.
7,4.2 Stand-alone knowledge bases connection with EHR-s
My research has not done this. The constructed prototype has relied on two specifically 
custom built components being connected, albeit that the software tools (Protege-OWL 
etc.) and specification (i.e. CCR) are independent artefacts. The same person has 
constructed both sides of the connection in this research. This would not happen in 
practice. Full semantic interoperability would be required to permit stand-alone 
knowledge bases to interchange effectively with other systems such as EHR-s, and this 
is still a challenge requiring formal agreements and standards as well as further research 
into semantic, structural and content representation.
The long term goal of harvesting appropriate knowledge and making it available at the 
point of care is a long journey. Although it will be important to make diverse knowledge 
bases plug-playable into an EHR system, there are still some critical barriers: 1) how to 
map and integrate knowledge in the knowledge bases with the many possible EHR 
structures automatically; 2) how to populate and present the knowledge through the
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EHR interface without information loss. In this research semantic mapping has been 
achieved manually and in some extent automatically by using a database file format. 
Further investigation may consider XML format or message, for semantic 
interoperability between the knowledge bases and the EHR-s structure. Controlled 
vocabulary for both systems and knowledge bases, generic system structures, and 
detailed and scientific indexes for knowledge bases, are all important at the technique 
level. Meanwhile, to get clear and detailed user and information requirements will be 
equally important for connection. Figure 7-1 is a description of this recommendation.
Knowledge bases
System users
Figure 7- 1 Description of the EHR system with multi-knowledge bases
(Note: the knowledge base could be a cystic fibrosis knowledge base or a Huntington disease 
knowledge base etc; system user can be a doctor or other clinician)
7.5 Conclusions
The thesis has explored how to integrate formal and structured bio-health information 
into a simulated clinical setting. Sequence variations information and associated health 
information related to cystic fibrosis have been organised in an ontology-based 
knowledge base prototype- OntoKBCF. There are basic concepts, combined concepts 
and final knowledge facts in OntoKBCF. The hierarchy for basic and combined 
concepts in OntoKBCF can be made accessible manually and automatically through the 
CCR-based EHR system prototype. The representation of final knowledge facts 
(involving concept, property and description logic representation) can also be made 
accessible, although this is mostly manual with some automatic functionality. This work 
provides a way of delivering formal and structured bio-health information from
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OntoKBCF via the CCR-based EHR system prototype.
This research has shown the feasibility of integrating sequence variation information 
into an EHR system prototype; usability tests in future research should concentrate on 
the relevance and most usable presentation of complex data. The integration of a wider 
range of biological information (currently the sequence variations knowledge supports 
include hierarchies for nucleotide mutation, amino acid change and corresponding 
nucleotide or amino acid position) will need further study. This is an exploration in 
integrating biological information into the EHR, but one has important potential in 
providing personalised health care service in future. In the long term view, such 
research should benefit doctors, biological researchers and patients.
The research suggests a need to expand the current CCR structure to include sequence 
variations. In CCR there is no specific label or example for biological information. The 
standards-based EHR prototype provides the common underlying data model for many 
implementations. This is also a starting point to present customised bio-health 
information via the CCR-based EHR. Sequence variations information has been 
included under the 'lab results' label in the EHR prototype. The procedures to connect a 
knowledge base with the EHR system prototype have been summarised. The bio-health 
information from OntoKBCF can be made accessible through the EHR system 
prototype interface and customised according to patient parameters. Filters include age, 
sex, ethnicity, existing bio-health description and diagnostic and treatment procedures. 
The customised information has been proved through the use of test records. It can be 
argued that to connect the knowledge base prototype with a standards-based EHR 
system prototype it is critical for further communication and standardisation. Much 
more work is required before plug-in stand-alone knowledge bases can be used within 
EHR-s without extensive manual intervention. This research should benefit standards 
development and EHR-s suppliers.
This work potentially lengthens the life of an ontology and has showed limitations in 
semantic web technology application and in previous ontology development: such as 
query limitation, limitation in using property description and logic symbols, semantic 
and logic conflicts between the domain knowledge and EHR structure etc. The way to 
organise the domain knowledge and EHR structure has been shown to work through the 
EHR system prototype. Both content and structure of the ontology are made accessible
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through the EHR prototype. Cystic fibrosis is used as an exemplar condition, however, 
the construction idea in ontology and connection method can be used for any other 
disease as long as there is a definite sequence variation and associated health 
information available. In this research, ontology has been used not only as a knowledge 
management tool, but also as an active knowledge resource in an EHR prototype. This 
research widens the semantic web application within the health care field.
In conclusion, this research has explored how to integrate formal and structured 
bio-health information into a simulated clinical setting, and in answering the research 
question it has raised a number of important others that need further research. The idea 
had certainly come of age and the direction of travel seems to be the right one. Even so, 
there is still much more research required before full implementations can deliver such 
information effectively at the point of care.
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Appendix A: Introduction to RDF and OWL
RDF is a type of structure for representing information on the web 189 . It is metadata (i.e. 
data about data) used to represent machine processable information on the web 189 A 
recommended XML-based syntax from W3C RDF/XML- is used for exchange of 
information between applications (such as software agents) 189 . The structural unit for 
the RDF expression is an RDF triple: i.e., a subject, a predicate and an object, in that
1 RQ
order . Each RDF triple represents a statement between a subject and an object, 
connected by the predicate 189 . A set of RDF triples comprise an RDF graph, whose 
meaning contains the conjunction of all the triples' statement 189 . URI references and 
fragment identifiers are used in RDF naming 189 .
The OWL ontology is an example of an RDF graph92 . Although there are many forms in 
writing OWL ontology, it is the RDF graph that solely decides the meaning of an 
ontology92 . This is that for the same OWL ontology, different syntactic forms share the 
same underlying set of RDF triples "
OWL Lite is an ontology language support only subset of OWL language constructs and 
specially designed to develop tool support for OWL, OWL DL and OWL Full support 
the same set of OWL language constructs, however the former has desirable functions 
for a reasoning system with more restrictive constraints92 OWL Lite supports primarily 
a classification hierarchy and simpler constraints; OWL DL supports the maximum 
expressiveness and retains computational ability; OWL Full has maximum 
expressiveness and the syntactic freedom of RDF, with no computational guarantees83 .
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Appendix B: Gene therapy of cystic fibrosis
The following text is from the publications 143 ' 146 :
> Alton EWFW. Use of nonviral vectors for cystic fibrosis gene therapy. Proc Am Thorac
Soc. 2004; 1:296-301. 
> Flotte TR, Laube BL. Gene therapy in cystic fibrosis. CHEST. 2001; 120:124S-131S.
  Non_viral_vector_gene_therapy
["Annotation comments: This method appears more suitable for repeat dosing, but has been less 
effective. The transfer efficiency of non-viral vectors is currently low. Desirable properties of 
non-viral gene delivery systems, including biocompatibility (low toxicity and low 
immunogenicity), large adaptability with efficient nucleic delivery, ease of manufacturing (large 
quantities, high reproducibility, acceptable cost and simple storage conditions) and ease of 
clinical administration."]
o Lipoplexes_vector_gene_therapy
['Annotation comments: Synthetic non-viral vectors can be formed by associating the nucleic 
acid sequences with cationic lipids to form lipoplexes. Cationic liposomes are lipid-DNA 
complexes, less efficient, do not stimulate inflammatory and immunologic responses."]
o Lipopolyplexes_vector_gene_therapy
["Annotation comments: Synthetic non-viral vectors can be formed by associating the nucleic 
acid sequences with cationic lipids to form lipoplexes, with cationic polymers to form 
polyplexes, or with both cationic lipids and polymers to form lipopolyplexes."]
o Polyplexes_vector_gene_therapy
["Annotation comments: Synthetic non-viral vectors can be formed by associating the nucleic 
acid sequences with cationic lipids to form lipoplexes, with cationic polymers to form 
polyplexes."]
  Viral_vector_gene therapy
['Annotation comments: Unsuitable for repeat dosing, as immune response reduces the 
effectiveness of each subsequent dose. Fail to overcome host immune response to allow 
multiple readministration."]
o Adeno_associated_virus_vector_gene_therapy
["Annotation comments: AAV vectors, they do not appear to induce inflammatory changes over 
a wide range of doses. The level of CFTR messenger RNA expression is difficult to ascertain 
with AAV vectors. AAV vectors appear to be safe and have superior duration profiles. AAV 
vectors establish latency in cells without inducing inflammation."]
o Adenovirus_vector_gene_therapy
["Annotation comments: Ad vectors cause transient infection associated with acute 
inflammation."]
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Appendix C: A brief summary of how cystic fibrosis may announce itself at
different ages
The following text is from the book" 9(p26):
> Harris A, Super M. Cystic fibrosis: the facts. 3rd ed. Oxford: Oxford University Press, 1995
• In the new born:
"Intestinal obstruction caused by meconium ileus or atresia; prolonged jaundice"
• Infants:
"Rectal prolapse; recurrent loose stools; distended abdomen; 'milky allergy'; recurrent
chestiness, coughing, or wheezing; a salty taste to the sweat; poor weight gain, often associated
with a ravenous appetite; unexplained dehydration
(Such symptoms are very common and may sometimes be mild, the diagnosis can be
overlooked in infancy.)"
• In older children:
"After the diagnosis of CF in a brother or sister; incomplete intestinal obstruction; nasal polyps,
especially if recurrent; bronchiectasis or recurrent chest infections; heat prostration;
underweight child
(Occasionally the diagnosis may be missed for many years.)"
• In adolescents or adults:
"Delayed onset of puberty; sterile or azospermic males; infertile females with scanty cervical
mucus; bronchiectasis"
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Appendix D: Cochrane review conclusion about cystic fibrosis
The following text is from The Cochrane Library 129 :
> The Cocharane Collaboration. Cochrane review topics: cystic fibrosis. [cited 2006 July 
7]; Available from: http://wvvw.cochrane.org/reviews/en/topics/55.html
1   "Bisphosphonates for osteoporosis in people with cystic fibrosis: Intravenous pamidronate 
increases BMD at axial sites in people with CF, although it can cause severe bone pain in 
participants not receiving corticosteroids."
2. "Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis: Airway 
clearance techniques have short-term effects in terms of increasing mucus transport."
3. "Macrolide antibiotics for cystic fibrosis: There is clear evidence from these studies of a 
small but significant improvement in respiratory function following treatment with 
azithromycin. The largest study employed a three times a week dose and, in this study, 
treatment with azithromycin was associated with a significant increase in mild adverse 
events."
4. "Newborn screening for cystic fibrosis: Nutritional benefits are apparent. Screening 
provides a potential opportunity for better pulmonary outcomes. Confounding factors such 
as severe genotype, pancreatic status and early acquisition with Pseudomonas aeruginosa 
have influenced long term pulmonary prognosis of people with CF in this study. Diagnosis 
through screening seems less expensive than a traditional diagnosis.''
5. "Non-invasive ventilation for cystic fibrosis: Non-invasive ventilation may be a useful 
adjunct to other airway clearance techniques, particularly in people with CF who have 
difficulty expectorating sputum."
6. "Prophylactic antibiotics for cystic fibrosis: Anti-staphylococcal antibiotic prophylaxis 
leads to fewer children having isolates of Staphylococcus aureus, when commenced early 
in infancy and continued up to six years of age."
7. "Recombinant human deoxyribonuclease for cystic fibrosis: Therapy with rhDNase over a 
one-month period is associated with an improvement in lung function in CF. Results from a 
trial lasting six months also showed the same effect. Therapy over a two-year period (based 
on one trial) significantly improved FEV1 in children and there was a non-significant 
reduction in the risk of infective exacerbations. Voice alteration and rash appear to be the 
only adverse events reported with increased frequency in randomised controlled trials."
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Appendix E: Most common CFTR mutations
The table is from the publication:
> Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Anu Rev 
Genetics. 1995;29:777-807
Name of Mutation
[[Delta]]F508
G542X
G551D
N1303K
W1282X
R553X
621+1G->T
1717-1G->A
R117H
R1162X
R347P
3849+10kbC->T
[[Delta]]I507
394delTT
G85E
R560T
A455E
1078delT
2789+5G->A
3659delC
R334W
1898+1G->T
711 + 1G->T
2183AA->G
3905insT
S549N
2184delA
Q359K/T360K
M1101K
Y122X
1898+5G->T
3120+1G->A
I148T
Frequency
28,948
1,062
717
589
536
322
315
284
133
125
106
104
93
78
67
67
62
57
54
54
53
53
49
40
38
30
29
(%)
-66
-2.4
-1.6
-1.3
-1.2
-0.7
-0.7
-0.6
-0.3
-0.3
-0.2
-0.2
-0.2
10-30%*
6-17% ! "
87.5%';:
69%*
48%*
30%
11%
9.10%
Population with the highest 
prevalence
Spanish
English
Italian
Jewish-Askhenazi
German
French-Canadian
Italian
Italian
Nordic, Finnish
Dutch
Celtic
Spanish
French-Canadian
Italian
Swiss; Amish; Acadian
Jewish-Georgian
Hutterite
French, Reunion Island
Chinese, Taiwan
African-American
French-Canadian
 :  /^««^^rf,',,m MOO/n Tho fronnor,/-!, Ics based 
"ine source 01 uaia is uuiamvu 1.^.1. «.~ ~- _-...-- •-   .-
on the screening of 43 849 CF chromosomes, although not all of them have been tested for the indicated 
mutations The mutations are found in patients of Caucasian origin, except indicated otherwise. The 
geographic location (or ethnic group) with the highest prevalence is indicated for some of the mutations 
A rough relative frequency (expressed in %,*)js given for those mutations studied m relatively small-si: 
samples or in the indicated populations only '"-"
ize
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Appendix F: Characteristics of the most common cystic fibrosis mutations
The table is from the book 120(pll):
> Orenstein DM, Rosenstein BJ, Stern RC. Cystic fibrosis: medical care. Philadelphia: 
Lippincott Williams & Wilkins, 2000.
Mutations
[[DeltallFSOS
G542X[1]
G551D[1]
W1282X[1]
R553X[1]
621+1G->T[1]
1717-1G->A[1]
R117H[1]
R347P[1]
3849+10kbC->T[l]
A455E[11
R334W[11
3905insT[ll
P574H[1]
Y563N[11
Geographic/ethnic 
incidence
70-75% in North 
America
3.4% world wide
2.4%worldwide
50-60% in Ashkenazi 
Jews; 2.1% 
worldwide
1.3% worldwide
1 .3% worldwide
1.3% worldwide
0.8% worldwide
1.4% worldwide; 4% 
in Isreal
3-7% in Netherlands; 
0-0.2% in North 
America
2.1% worldwide
Other characteristics
Pancreatic insufficiency
Pancreatic insufficiency; more meconium 
ileus
Pancreatic insufficiency
Pancreatic insufficiency
Pancreatic insufficiency
Pancreatic insufficiency
Pancreatic insufficiency
Pancreatic sufficiency[2]; slightly 
sweat chloride; older age at diagnosis
lower
Pancreatic sufficiency[2];
Pancreatic sufficiency[2]; normal 
chloride; most males not sterile 
disease varies from mild to severe
sweat 
; lung
Pancreatic sufficiency[2]; mild lung disease
Pancreatic sufficiency[2]; older 
diagnosis
age at
Pancreatic insufficiency
Pancreatic sufficiency[2];
Pancreatic sufficiency[2];
"[!]: Compound heterozygotes, in most cases, meaning these patients had one copy ot the mutation 
noted and one other CF mutation (usually |TDeltal]F508)
\2\ Pancreatic sufficiency in most, but not all, cases."
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Appendix G: Nomenclature of nucleotides and amino acids in OntoKBCF
Nucleotides are units of nucleic acid64 . According to their chemical structure, 
nucleotides can be broken down into nucleosides and phosphate 190 ' l91 . The nucleosides 
can he further broken down into nitrogenous bases and ribose (as in RNA) or 
deoxyribose (as in DNA) 19(X 19! . It is the nitrogenous base (Adenine, Thymine, Cytosine, 
Guanine, or Uracil) that decides the nucleotide type. "The one letter abbreviation can be 
used for either the bases alone or for the nucleotides containing them"64 (pi 85). In 
OntoKBCF the one letter abbreviation name is used for nucleotide, which helps to 
provide compatibility with the mutation name used in the knowledge resources. When 
mutation occurs in the DNA or RNA chain, this is in the nitrogenous base, also named 
the nucleobase 192 ; however, nucleotide also changes.
The International Union of Pure and Applied Chemistry (IUPAC) permits the naming of 
arnino acids according to both a three letter abbreviation (e.g. Gly for Glycine) and a 
single letter abbreviation (e.g. G for Glycine). Naming within the ontology follows the 
three letter abbreviation name in order to avoid any confusion with the nucleotide name, 
which is a one letter abbreviation. The sub-hierarchy of amino acids uses the three letter 
naming convention (e.g. Gly) - both the full name and the single letter abbreviation are 
maintained as annotations. The sub-hierarchy of amino acid changes uses the three letter 
abbreviation name (e.g. GlySSlAsp) as does the sub-hierarchy of amino acid change 
location (e.g. Gly542). Some mutation names which are from knowledge resources 
(reviewed academic publications in this study), such as G542X, are kept in the 
annotation.
In OntoKBCF nucleotide uses a one letter abbreviation name. Table G-l lists the 
meaning of the abbreviations used in OntoKBCF .
Table G- 1 Full names list for nucleotides used in OntoKBCF
DNA
RNA
A
G
c
T
a
g
c
u
dAMP
dGMP
dCMP
dTMP
AMP
GMP
CMP
UMP
Deoxyadenosine monophosphate
Deoxyguanosine monophosphate
Deoxycytidine monophosphate
Thymidine monophosphate
Adenosine monophosphate
Guanosine monophosphate
Cytidine monophosphate
Uridine monophosphate
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According to the IUPAC recommendation, 'X' can refer to any amino acid. However, 
according to the recommendation of protein sequence variants, 'X' should be used to 
designate a translation termination codon 163 . In the prototype, I followed the later 
recommendation to use 'X' to represent stop codon. As all of the 22 amino acids were 
listed already, the specific name (rather than 'X') could be used if any of them were 
needed.
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Appendix H: Construction example: CFTR Gly542X
This example is about the description of one of most common CFTR mutations- 
Gly542X. CFTR mutations are related to ethnicity, which is another important filter 
used in individualising information. This example concerns the CFTR mutation 
Gly542X, which is located in exon 11 of CFTR gene. It has a higher prevalence in 
Spanish cystic fibrosis patients. There are 24 exons in the CFTR gene; a definition of 
exon is given in Appendix J. Cystic fibrosis patients with Gly542X may have pancreatic 
insufficiency, and many of them may have meconium ileus.
Hl.l Analyzing and dissecting the knowledge fact into basic concepts
This example is concerned with cystic fibrosis patients with a specific mutation 
(GIy542X), together with a high level explanation of the mutation, its relationship to 
ethnic characteristics and clinical manifestations.
Basic concepts include:
  cystic fibrosis patient: patient with Gly542X;
  amino acid substitution: Gly542X;
  exon: human CFTR gene exon 11;
  gene: human CFTR gene;
  ethnic population group: Spaniards;
  disease or syndrome: pancreatic insufficiency;
  disease: meconium ileus
HI.2 Selecting concepts/terms from UMLS and GO
According to the concepts/terms' definitions, we selected the concepts/terms and their 
superclasses for this piece of knowledge fact (Table H-l to H-4).
Table H- 1 Amino acid and nucleotide related concepts from UMLS
Physical_object
Substance
Chemical
Amino_acid_peptide_or_protein
Amino acids
Glycine
Nucleic_acid_nucleoside_or_nucleotide
DNA
Exon
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Table H- 2 Conceptual related concepts from UMLS
-148-
Conceptual_entity
Idea_or_concept
Spatial_concept
Group
Population_group
Ethnic_group
Spaniards
Table H- 3 Diseases related concepts from UMLS
Phenomenon_or_process
Pathologic_function
Disease_or_syndrome
Diseases
Digestive_system_diseases
Gastrointestinal diseases
Intestinal diseases
Ileus
Pancreatic_insufficiency
Table H- 4 CFTR gene related concepts from UMLS
Physical_object
Anatomical structure
Gene_or_genome
Human CFTR_gene
HI.3 Creating and organising concepts
There are fewer molecular genetic concepts in UMLS than clinical concepts. Also, 
because GO has a focus which is totally different from OntoKBCF's, very few reference 
terms could be retrieved from it. While several classes were created to represent missing 
knowledge facts, the original identities and alternative vocabularies from UMLS were 
kept when available.
'Patient_CF_with_amino_acid_change' was created as a subclass of 'Patient_CF' It 
is also an interim and abstract class to associate cystic fibrosis patients with different 
amino acid changes.
iPatient_CF_wlth_Gly542X was a subclass of
'Patient CF with_amino_acid_change' as shown in the Table H-5. Other sibling
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classes of lPatient_CF_with_Gly542X" included iPatient_CF_with_Delta_Phe508\ 
'Patient_CF_with_Asnl303Lys' etc.
Table H- 5 Hierarchy of Patient CF with Gly542X in OntoKBCF 
Physical_object
Human being 
Patient CF
Patient_CF_with_amino_acid_change 
Patient_ CF with_ Gly542X
'Patient_CF_with_Gly542X" was defined as an intersection of (1) 
Patient_CF_with_amino_acid_change, (2) has mutational property some Glv542X.
'hasjnutationalproperty' is a property used to describe nucleotide mutation or amino 
acid change. There are 4 sub-properties: l has_transversion_property\ 
'has transition _property\ i has_deletion_property', l has_insertion_property . The 
former two are used specially for nucleotide mutations and the latter two can be used for 
both nucleotide mutation and amino acid change. For amino acid change, there is 
another type of change - substitution. We created 'substitute Jrom' and ' substitute_with' 
as sub properties of'mutate' to describe amino acid substitution.
The hierarchy of the "Gly542X" has been shown in Table H-6.
Table H- 6 Hierarchy ofGly542X'm OntoKBCF
Phenomenon_or_process
Amino_acid_change
Amino acid substitution
Amino_acid_substitution_in_human_CFTR_protein
Gly542X
We defined ^Gly542X as an intersection of (1) locateJn some Gly542; (2) locate_in
some ffuman_CFTR_gene_exon_ll; (3) substitute Jrom some Glycine; (4)
substitute_with some Nonsense_codon. The screenshot for representation of 'Gly542X'
is in Figure H-l with necessary and inherited conditions.
The l Gly542' was defined as a spatial concept first, and then it was used in definition of
>Gly542X'.
Table H-7 shows hierarchy of'Gly542' in OntoKBCF.
'locate in is a property for location (number of nucleotide or amino acid).
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Asserted Conditions
D locatejn some Gly542
D locatejn some Human_CFTR_gene_exon_11
It substitute Jrom some Gly
© substitute_with some Nonsense_codon
Amino_ac!d_substitutlonJn_human_CFTRjrotein
• Mutation.result
• Related_Gly542X
0 occur some Human_CFTR_proteln
•5 subs«ute_with some (Amino_acids or Monsense_codon)
NECESSARY 8 SUFFICIENT
(from Ammo_acid_substitutionJn_human_CFTR_protein] E 
[trotn Amino_acid_substftution]
Figure H-1 Representation ofGly542X
The mutation 'Gly542X is located in exon 11 of CFTR gene. The exon 11 class 
hierarchy was created in OntoKBCF (Table H-8).
Table H- 7 Hierarchy ofG542 in OntoKBCF
Conceptual_entity
Idea_or_concept
Spatial_concept
Amino_acid_location_in_human_CFTR_protein
Gly542
Table H- 8 Hierarchy of Human_CFTR_gene_exon_ll in OntoKBCF
Conceptual_entity
Idea_or_concept
Spatial_concept
Location_in_human_ CFTR_gene
Human_CFTR_gene_exon
Human_ CFTR^gene_exon_ 11
'Nonsense_codon' was used as one of subclasses of 
'Nucleic_acid_nucleoside_or_nucleotide' and with subclasses: 
"DNA_nonsense_codori> and ' mRNA_nonsense_codon' (Table H-9). There is an 
equivalent class for 'Nonsense_codon': 'A"'. Both of the classes are used to represent 
stop codon of amino acid in translation.
H1.4 Representing the knowledge fact
By combination of the classes and properties with logic symbols the final knowledge 
fact was represented under the 'Patient_CF_with_Gly542X' with necessary conditions: 
(1) has_ethinic_origin some Spaniards; (2) hasjnanifestation some 
Pancreatic_insufficiency; (3) hasjnanifestation some Meconium_ileus. Figure H-2
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shows the final representation and the hierarchical organisation of the 
Patient CF_with_Gly542X.
Table H- 9 Hierarchy and subclasses of Nonsense_codon in OntoKBCF
Substance
Chemical
Nucleic_acid_nucleoside or_nucleotide
Nonsense_codon
DNA_nonsense_codon
TAA
TAG
TGA
mRNA_nonsense_codon
uaa
uag
uga
X
Qi^«^i^titi2£Lk£flBHHHIIi^l^HHHBiI
Far Project: • CF0907
Asserted Hierarchy " t« ^
owtTHng
*• • EHRJXR 
T • KBCF
ft- • Activty 
ft- • Conceptual_entrty 
ft- 0 Phenomenon or_process
T • Physic^_ob)ect
T • Hurran_being
T ©pgtient_CF
T 0 Petiert_CF_w4h_6mro_acid_change 
O Padent_CF_wlh_Arg553X 
© Padent_CF_wlh_Asn1303Lys 
O Peflent_CF_wth_De«8 J>heS08
|©P*lent_CF_wlh_GlyS42X 
O Patient]CT_w»i_Gly551Asp 
O Patient_CF_wlh_Trp1282X
@ Ptfient_CF_wlh_neonetaJ_screening_forj 
K •Pafient-CF_wlh_nucleoticle_mutatlon
^ • Patiefi^CF._wihJherapv 
>- •Siiistance 
ft- •Therapy
For Class: © |pafient_CF_wth_Gly542X | (Inrfance o( owtdass) Q Inferred Vtev
C? E^? ^J- S 3 D Annotations
Property Value Long
a rdfs:comment [G542X] ±
^ ® ^fti • Asserted Candrtions
--- . -- ..-__..._._.. .--- .. - ——— - —— - -- -..- - ........ NPCE^^aRV & iUFF CI6NT
• Patiert_CF_wSh_arT*io_acld_criarge [~^~ 
0 rasjnUatlonaljircperty some Gly542X | ___
• ReWed_Gly542X Pc^ 
• Stertement E 
O has_ethWc_origin »ome Spaniards ^g^ 
@ h8s_manifestabon some Pancreatic_hsulficiency C^ 
& has marifestabon some Meconiumjeus E
has_da^iosls some Cystic_«)roste [Irom Patient _CF] [^g^
<& ^ ^ *i % O Disjoint*
Figure H- 2 Whole screenshot for the representation of Patlent_CF_with_GlyS42X
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Appendix I: Construction example - Cochrane review topic description
Some Cochrane review conclusions about cystic flbrosis have been included in the 
knowledge base prototype. This is the part which can provide matching points with 
health information (such as symptoms). This health information has also been used in 
individualising patient information. The knowledge fact of Example 3 is: intravenous 
pamidronate treatment increases bone mineral density at axial sites in cystic flbrosis 
patient, although it can cause severe bone pain in participants not receiving 
corticosteroids.
11.1 Analyzing and dissecting the knowledge fact into basic concepts
The positive effect is to increase bone density at axial sites for cystic flbrosis patients 
with intravenous pamidronate treatment; the side effect is severe bone pain for patients 
not using corticosteroids.
Basic concepts include:
  drug: pamidronate, corticosteroids;
  drug administration: intravenous drug administration;
  clinical characteristics: bone density;
  spatial: axial;
  symptom: bone pain;
  human being: cystic flbrosis patient;
  functional concept: increase. 
12.2 Selecting concepts from UMLS
According to their definitions the selected concepts and their superclasses from UMLS 
are listed in Table 1-1 and 1-2.
Table I- 1 Pharmacologic related concepts from UMLS
Physical_object
Substance
Pharmacologic_substance
Diphosphonates
Pamidronate
Adrenal_cortex_hormones
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Table I- 2 Conceptual related concepts in UMLS
Conceptual_entity
Clinical attribute
Bone_density
Sign_and_symptom
Bone_pain
Idea_or_concept
Functional_concept
Increase
Spatial_concept
Axial
12.3 Creating and organising concepts
We created the 'Patient_CF_with_therapy' as a subclass of "PatientjCF in order to 
organise records for cystic fibrosis patients undergoing different types of therapy. 
iPatient_CF_with_pamidronate_intravenous' is a subclass of 
'Patient_CF_with_therapy\ The hierarchy is shown in Table 1-3.
'Patient_CF_with_pamidronate_intravenous' was defined as an intersection of (1) 
Patient_CF_with_therapy; (2) treat_by some Pamidronate_intravenous.
'treat by' is a property to describe patients with different treatments. 
The hierarchy for ' Pamidronate_intvavenous" will be shown in Table 1-4.
'Pamidronate_intravenous J was defined as an intersection of (1) Pharmacotherapy; (2) 
administrate^ intravenously some Pamidronate (Figure 1-1).
Table I- 3 Hierarchy ofPatient_CF_with_pamidronate_intravenous in OntoKBCF
Physical_object
Humanjbeing
Patient CF
Patient_ CF_with_therapy
Patient_CF_with_pamidronate_intravenous
'administrate Jntravenously is a sub property of'-administrate_drug_routes' to describe 
intravenous drug administration, one of the drug administration routes.
'Bone densityJncreasedjnxially is a subclass of 'Bone_density_increased\ which is 
in turn a subclass of 'Bone_densiry'. The hierarchy is shown in Table 1-5.
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Table I- 4 Hierarchy of Pamldronate_intravenous in OntoKBCF 
Therapy
Pharmacotherapy
Pamidronate intravenous
Pamidronate_intravenous_for_osteoporosis
Asserted Conditions
I Pharmacolherapy
0 administrate .intravenously some Pamidronate
——— NECESSARY* SUFFICIENT
—— NECESSARY
Figure I-1 Representation of Pamidronate_intravenous
Table I- 5 Hierarchy of Bone_density_increased_axially in OntoKBCF
Conceptual_entity
Clinical attribute
Bone_density
Bone_density_increased
Bone_density_increased_axially
'Bone_density_increased' was defined as an intersection of (1) Bone_density; (2) 
has^functional_property some increase.
'has^functionalproperty' is a property used for objects with some functional concepts 
as property, such as decrease, insufficient etc.
'Bone_density_increased_axially' was defined as an intersection of (1) 
Bone_density_increased; (2) has_spatialproperty some Axial (Figure 1-2).
'has_spatial_property' is a property used for some spatial property representation.
'Bone_pain_severe' was created as a subclass of 'Bone_pain' and it was defined as an 
intersection of (1) Bone_pain; (2) has_qualitative_property some Severe. Table 1-6 
shows the hierarchy for "Bone_pain_severe".
Asserted Conditions
NECESSARY S SUFFICIENT
Bone_density_increased 
© has.spatial.property some Axial
0 Therapeutic_resu«
has functionaLproperty some Increase
— NECESSARY
— ._.__._._.__..._... .__ ——— _.__. INHERITED
[from Bone_densrty_increased] | c |
Figure I- 2 Representation of Bone_density_increased_axialfy in OntoKBCF
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'has_qualitative_property' is a property used for some qualitative properties.
Table I- 6 Hierarchy of Bone_pain_severe in OntoKBCF 
Conceptual_entity
Sign_and_symptom
Bone pain
Bone_pain_severe
12.4 Representing the knowledge fact
By combining the classes and properties with logic symbols the final knowledge fact 
was represented under 'Patient_CF_with_pamidronate_intravenous' with the 
necessary conditions: (1) (has_side_effect some Bone_pain_severe) and not (treat_by 
some Adrenal_cortex_hormones); (2) hasjnanifestation some 
Bone_density_increased_axially. Figure 1-3 shows the representation of 
Patient_CF_with_pamidronate_intravenous, including hierarchy and properties 
descriptions.
'has_side_effecf is a property used for patients or therapies with side effects.
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Figure I- 3 Whole screenshot for the representation of 
Patient_CF_withjpamidronate_intravenous
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Appendix J: Genetic vocabulary used in OntoKBCF
All these definition are from the publications62 64 w 145 :
r Campbell NA, Reece JB, Taylor MR, Simon EJ. Biology-concepts & connections. 5th ed.
San Francisco, CA, USA: Benjamin Cummings, 2006. 
r Skirton H, Patch C. Genetics for healthcare professionals-a lifestage approach. Oxford, UK:
BIOS Scientific Publishers Limited, 2002.
> Raven PH, Johnson GB. Biology. 6th ed. New York, USA: McGraw-Hill Companies, 2002. 
r Lewis R. Human genetics: concepts and applications. 2nd ed. Dubuque: Wm. C. Brown
Publishers, 1997.
Chromosome
Nucleic acid
DNA
RNA
Gene
Codon
Mutation
Genotype
Phenotype
Transcription
Translation:
Exon
"The physical structures into which the DNA is packaged within the nucleus 
of cells. There are 46 chromosomes, 23 pairs in human somatic cell. Pairs 
numbered 1 to 22 are identical between males and females. There are two 
types of sex chromosome: X chromosome (females have two and males have 
one) and Y chromosome (only males have one)."
"A polymer consists of many nucleotide monomers; works as a blueprint and 
instruction for proteins, and for all cellular structures and functions through 
the actions of proteins. There are two types of nucleic acids. DNA 
(deoxyribonucleic acid) and RNA (ribonucleic acid)."
"The genetic material that organisms can inherit from their parents; DNA 
sequence can decide the sequence of amino acids; a double-helix 
macromolecule consisting of nucleotide monomers with deoxyribose sugar 
and the nitrogenous bases: adenine (A). c\tosine(C), guanine (G). and thymine 
(T)."
""Bridge" substance betueen DNA and protein; RNA sequence is transcripted 
from DNA sequence and is translated into amino acids sequences; a type of 
nucleic acid consisting of nucleotide monomers with a ribose sugar and the 
nitrogenous bases adenine (A), cytosine(C), guanine (G), and uracil (U)."
"The fundamental physical and functional unit of heredity; a gene can be a 
sequence of DNA nucleotides in a chromosome: a gene can encode a protein, 
or tRNA, or rRNA molecule, or regulate the transcription. Genes can decide 
manv traits of organisms."
"The fundamental unit of the genetic code; a three-nucleotide sequence in 
mRNA that decides a particular amino acid or polypeptide termination signal; 
most of the amino acids are encoded by more than one codon."
"A permanent change in a cell's DNA normally involves change in 
biochemical composition; includes changes in nucleotide sequence, gene 
position, gene loss or duplication, and insertion of foreign sequences."
"An individual's genetic constitution underlying a single trait or set of traits.
"The realised expression ot the genotype; the physical appearance or 
functional expression of a trait."
"To synthesise RNA through reading DNA sequence, new formed RNA is 
complementary to the DNA template."
"To synthesise and assemble protein from codons in the RNA sequences. 
Genetic information transfers from nucleic acid to protein in this process."
"A segment of gene sequence, which can code protein producing. Exons and 
introns are located alternatively in the gene. Exon also named as coding 
DNA."
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Intron
Nonsense 
codon
"A segment of gene sequence, which can't be translated into protein. Intron 
will be cut off during protein producing and only exon guides protein 
producing."
"It also named as stop codon or termination codon. They 
three nucleotides in DNA or RNA. The codon will lead 
polypeptide chain stops prematurely."
are composed of 
that synthesis of
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Appendix K: Events that occur when healthcare professional interacts with EHR
and EHR system
The following description is from the book:
r Van de Velde R, Degoulet P. Clinical information systems: a component-based approach. 
New York: Springer-Verlag New York, 2003.
From Van de Velde and Gegoulet's' 07(p94) these events occur when healthcare professionals 
interact with EHR:
"(1) relate to a single patient; (2) are registered at one moment; (3) are discovered at one 
moment; (4) originate with and are under the responsibility, authorisation, and 
authentication of a responsible physician"
The following items need to be identified for each event 107 (p94):
"(1) the subject of care; (2) the location of the patient; (3) the health service provider; (4) 
the time period; (5) the specialist service request or requester; (6) the source of the 
corresponding information; (7) the copy destination; (8) the item version; (9) the access 
and modification rights"
An EHR system has to offer following features"17(pl 18):
"(1) a problem list; (2) the ability to measure the patient's health status and functional 
levels; (3) a tool to document clinical reasoning and rationale; (4) a longitudinal view that 
provides timely linkages with other patient records; (5) guaranteed confidentiality, privacy 
and audit trails; (6) continuous access for authorised users; (7) support for simultaneous 
multiple user views; (8) direct data entry by physicians; (9) support for practitioners in 
measuring or managing costs and improving quality; (10) flexibility in supporting existing 
or evolving needs of clinical specialties'
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Appendix L: Major characteristics in the Protege-OWL converted table
There were several major characteristics in the data fields of the Protege-OWL 3.3.1 
converted table. These data fields' characteristics were critical for the data to be 
extracted from the converted table and to be populated into the different tables used by 
EHR. For example:
1) for class in OntoKBCF the data fields would follow the form, "frame_type" = 9, 
''slot" = 2002, and "value_type" =3;
2) "value_type" 3 was for concepts and annotation, some internal strings might 
be represented with logic symbols;
3) "frame_type" 9 was for concepts and annotations, 13 was for property, 15. 16, 
21.22, 26, 30 were for internal strings, 25 was for instances, 28 was for some 
annotations, 29 was for name spaces;
4) "slot" 2002 \\as for concepts and 9093 was for annotations, 9097 \\as for 
name spaces;
5) Query statement parameters: frame=1000, frame_type=9. slot=12570, 
value_t\pe=3.
The classes displayed as "text type" for the first time, and then they \\cre 
represented by their "frame" number. For example, for class 'Atresia', the "frame" 
was 11991, after the first time with the "text" name-"Atresia", 11991 used for the 
class afterwards each time the class was referred to in the table.
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Appendix M: Major coding design decisions in building the EHR system prototype
mplementation 
order
1
~>
3
4
5
6
7
8
9
10
Sub name
Loadlist
Patientlist Selected
FormMaster load
Bio-HealthAdd
Bio-HealthDelete
CheckPresence
LstOntoSelected
LoadTree
BtnAgeNew
AddNewPatient
Functions
Locate database's location; load 
patients' records list
Load FormMaster; load patient' 
demographic data and bio-health 
data; load OntoKBCF related list 
boxes (clear, check presence, add)
Load selected patient record with 
bio-health candidate data lists; 
show date;
Add patient's bio-health data and 
update the backstage tables
Delete bio-health data from 
patients' records/ backstage tables/ 
list boxes
Check if the target item is already 
in patients' records, if yes ignore 
and if no, add the item to record
Clear tree view, load tree view, 
show the selected concepts' 
hierarchy
Load OntoKBCF hierarchy for the 
target concepts
Add selected item to 
corresponding patient's bio-health 
list, update backstage tables, 
patient's list boxes and reload 
OntoKBCF related list boxes
Add new patient record and then 
update the backstage table
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Appendix N: Major coding design decisions in extracting tables automatically
from the original Protege-OWL converted table
Implementation 
order
1
2
2.1
2 2
2.3
2.4
2.5
2.6
2.7
Sub name
ClearOntology
LoadOntology
ScanDB
LoadCategory
GetParents
GetStatement
GetRelationship
ConstructDB
UpdateOnto
Functions
Clean the existing ontology table
Set target database; load tables; construct 
automatic database and update it
Extract all concepts in OntoKBCF
Load different bio-health data tables 
according to EHR structure in OntoKBCF
Get OntoKBCF hierarchies for the 
concepts
Get the concepts which need to be 
explained
Get group concepts, whose hierarchies 
were used to explain concepts
Construct the database according to 
loaded tables
Update OntoKBCF related tables- field 
"catid"
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